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Preamble 
Transforming academic research into a practical use for industry is certainly challenging. 
Yet, within the following work a large pharmaceutical producer and an academic institution 
have collaborated to reach a common target: Implementing innovation into quality control 
mechanisms applied to aseptic drug manufacturing procedures. Due to such interaction, a 
trade-off between scientific aspects and economic topics has been made in the writing of this 
doctoral thesis. This explains why this doctoral thesis often discusses efficiency 
improvements, process modifications and overall cost reductions based on scientific insights 
gathered experimentally. Finally, such interaction between science and practice led to 
mutual benefits being reflected in the following work. 
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Summary 
Aseptic manufacturing refers to bringing the sterile drug solution into decontaminated 
containers in a way that product sterility and therapeutic effectiveness is maintained. At this 
stage the produced drug has a significant value, reflecting relatively large financial risk in 
case of failure during manufacturing procedures. Therefore, environmental monitoring 
activities strictly control production surroundings to ensure that no accidental product 
contamination occurs. 
Media fills are part of environmental monitoring activities and imitate the aseptic (free from 
pathogenic microorganisms) filling procedure with microbial growth medium instead of the 
liquid drug product. After filling, media fills are inspected visually on turbidity, which 
represents the control on filling line asepticity. Such inspection is time-consuming, manually 
performed and therefore considered for potential automation. A laser-based technology was 
used (called tunable diode laser absorption spectroscopy) abbreviated as TDLAS to 
determine CO2 and O2 variations in media fill headspaces as related to metabolic activity of 
growing microorganisms. The study results demonstrated that TDLAS can automate the 
visual media fill inspection reliably (inspection rate of 100 containers per minute) allowing a 
roughly 90% faster inspection than achieved by the manual visual inspection on turbidity. 
TDLAS was further assessed on its potential in simplifying conventional measurement 
techniques in the field of calorespirometry. Calorespirometry deals with the simultaneous 
analysis of O2 consumption, CO2 production and heat emission by living systems such as 
tissues or organism cultures. TDLAS is a well-performing and convenient way to evaluate 
non-invasively the rates of O2 consumption, CO2 production during mentioned studies. 
In aseptic manufacturing the sterility assessment is the last control of product sterility before 
an entire batch is released to the market. The assessment usually consists of a final visual 
inspection on turbidity 14 days after drug preparation. Isothermal microcalorimetry (IMC) is a 
methodology measuring small amounts of emitted heat and can thereby detect growing 
microorganisms. It is more sensitive than the visual inspection on turbidity and was therefore 
applied as alternative test for microbial growth to sterility assessments. IMC appears to have 
a large potential to improve the sterility assessment as all tested microorganisms were 
earlier detected by IMC as by the visual inspection. 
Performed projects demonstrate that IMC and TDLAS can improve quality control 
mechanism by designing those more efficiently. Therefore, ongoing IMC and TDLAS based 
research is recommended to exploit the full potential of the aforementioned technologies. 
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1. General Introduction
1.1 Biologics and the Importance of Quality 
Biologics (or biopharmaceuticals) are the most elegant and innovative achievements in 
modern drug science among existing medication. The active component of biologics is 
derived from living cell systems by means of recombinant DNA and controlled gene 
expression in bacteria or yeast. In contrast to conventional chemically synthesized drugs, 
biopharmaceuticals are large and complex structures typically based on polypeptides, 
(glyco-) proteins, and nucleic acids. The specific form of biologics enables interacting 
remarkably well with corresponding targets permitting the use of highly effective and 
selective therapies (Declerck 2011, Otto et al. 2014). 
Product quality ought to be one of the superior assets delivered to patients when dealing 
with the manufacture of biologics (Haleem et al. 2015). All product contacting production 
steps are strictly regulated and controlled as already minor process variations could result in 
heterogenic, contaminated, not effective or even damaging medication (Declerck 2011). 
Biologics are administered through subcutaneous and intramuscular injections or 
intravenous infusions as an efficient drug uptake through the gastro-intestinal tract would be 
hindered by protein degradation in the stomach (Irvine et al. 2010). Therefore, drug sterility 
is indispensable and manufacturing procedures of rather complex nature. The slightest 
biological, chemical or physical contaminations may lead to exacerbated health conditions 
endangering the, in most cases, immunocompromised patients further (Figure 1). 
Due to the protein based composition, which is sensitive to variation in physical conditions, 
biopharmaceuticals cannot be terminally sterilized before market release as contained 
proteins would be denatured and therapeutic drug efficacy be lost (Stockdale 2016). Thus, 
biopharmaceutical manufacturers are faced with designing production processes in a way 
that product asepticity (free of microbial contamination) is enabled during the entire drug 
product manufacturing process. Such premises are challenging, subject to constant 
improvement (Food and Drug Administration 2004) and dedicated to the wording “aseptic 
manufacturing” (Figure 1). 
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Figure 1: End-to-end production steps for biopharmaceuticals. During upstream bioprocessing 
modified cell-lines are cultivated in media and successively transferred to larger bioreactors for 
fermentation. By the addition of optimized and cell line specific nutrient media, production of the 
desired protein is enabled. The protein is separated from the biomass followed by centrifugation, 
purification, and concentration steps. During aseptic manufacturing the extracted pure drug substance 
is formulated into a stable dosage form and filled under aseptic conditions in sterile primary (such as 
vials, syringes, cartridges, etc.) and secondary (such as folding boxes, etc.) packaging (see also 
orange sub steps 1-5, indicating fill-finishing procedures). After quality approval of the final drug 
product, packaged biologics are shipped and sold to customers. (BioPharma Asia 2015, Ams 
Biotechnology 2013, Arcane Industries 2017, Bandageer 2013, BioRefinery 2009) 
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1.2 Aseptic Manufacturing and Drug Product Quality Control 
Aseptic manufacturing is following aseptic upstream bioprocessing and refers to bringing the 
sterile drug substance into decontaminated containers in a way that sterility and 
effectiveness is maintained (Kovarcik 2016, Food and Drug Administration 2004). Such 
procedures include the formulation, mixture or general preparation of the sterile drug 
substance (for example in liquid or lyophilized form) as well as container filling and sealing 
(fill-finishing) (Figure 1). At the stage of aseptic manufacturing the final drug substance has 
significant value, reflecting noteworthy risk in case of failure during manufacturing activities 
(Scott et al. 2011). To minimize the risk of product contamination special measures are used 
to maintain and control surrounding cleanliness  (Food and Drug Administration 2016, 
European Pharmacopoeia 2007, U.S. Federal  Standard 2015b) and keep humans, the 
main source of pollution in aseptic manufacturing, away from the product (Figure 2). The 
concept of clean room areas is the basis for such risk minimization and separated into 
several zones (European commission 2008, U.S. Federal Standard 2015a). Zone A is the 
cleanliest area, in which products are filled. Zone F is the least cleanliest, where people are 
present in street clothes (no special measured applied); thus, zones B, C, and D, are in-
between with altering specification on allowed bio burden (Stockdale 2016). 
The zones are determined by the degree of allowed particulate contamination per cubic 
meter air and behave according the principle of onion skins: the closer the zone to the open 
product, the less particulate contamination is allowed implying additional measures needed 
to protect the product (see Figure 2, a & b). Therefore, operators entering zone D (the 
second least cleanliest zone after zone F) need to wear special clothing to keep 
contamination risk of bacteria colonizing their body  and clothes as low as possible (Park et 
al. 2014). In addition, clean rooms are regulated in terms of humidity and temperature and 
are constantly ventilated by sterile filtered air streaming from ceiling to floor, using the 
principle of laminar flow (Figure 2, c). Thus, generating less favorable conditions for fungal 
growth and lowering bio burden in the air (U.S. Federal Standard 2015b). Furthermore, 
standard cleaning procedures are applied, such as: hand disinfection, use of antimicrobial 
cleaning media, and alcohol application at workbenches. Fill-finishing is the action with the 
close proximity to the product in aseptic manufacturing and is therefore performed in 
isolators replicating the environment of zone A (no human presence allowed), and 
separating the valuable product entirely from potential sources of pollution (Figure 2, d). 
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Figure 2: Methods to control and maintain cleanliness in aseptic manufacturing. Figure a) and 
b) describe the recommended limits for microbial contamination in relation to the clean room concept.
Figure c) visualizes the principle of laminar flow applied in clean rooms and isolators. Illustration d) is 
an example of a standalone isolator. In large scale manufacturing such isolators are directly 
integrated into filling lines. Finally, e) shows applied techniques in environmental monitoring to 
determine and control bio burden in air (1 and 2), on surfaces (3 and 4) and in water (5). (Ingeniarg 
SA 2017, ESCO Pharma 2017, Pharmaceutical Online 2017, Biomérieux 2017, Xebios Diagnostics 
GmbH 2015, Sigma Aldrich 2017, European commission 2008, U.S. Federal Standard 2015b, 
Hygiena LLC 2017). 
Isolators are closed chambers widely used in the pharmaceutical industry and guarantee 
near absolute sterility due to their conceptual design. Chamber sterility is achieved by a 
routinely performed and fully automated bio-decontamination utilizing hydrogen peroxide 
(H2O2), an oxidizing agent reacting with organic matter, killing microbes potentially remaining 
in the isolator (Bayliss et al. 1980). In case of complications in the isolator, access to the 
concerned objects is exclusively possible through installed gloves (or robotic arms), whereat 
a constant flow of filtered air from ceiling to bottom (high efficiency particulate air filters of 
~0.3μm pore size are used) generates a steady air turnover enabling an air renewal in the 
isolator. Existing overpressure is additionally used to keep potential contaminants away from 
the sterile area. Consequently, the isolator technology allows proper performances of fill-
finishing procedures under aseptic conditions. In addition, environmental monitoring (EMT) 
controls microbiological quality of surfaces (in isolators and surroundings), water and air 
(Figure 2, e 1-5). Such controls permits immediate reaction in case of action level excess 
(U.S. Pharmacopoeia 2013, European Pharmacopoeia 2007) therefore allowing the defined 
levels of zone specific bio burden to be maintained. In the context of EMT, fill-finishing lines 
are evaluated semi-annually on their degree of sterility.  
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Such evaluations include the filling of culture media, tryptic soy broth (TSB), instead of the 
drug substance solution, into product containers, known as “media fills” (Figure 3). After filling, 
the media fill containers are inspected on integrity including the careful control of scratches, 
breaches, loose caps and further mistakes that may have occurred during the fill-finishing 
process. Subsequently inspected vials are incubated for a minimum of 7 days at 20- 25°C 
(22.5°C). Following the incubation process, operators visually inspect the media fills on the 
degree of turbidity (sometimes this intermediate inspection is skipped as not mandatory), 
which is an indicator for microbial growth relating to a contaminated filling line. The containers 
are once more incubated for a minimum of 7 days between 30-35°C (32.5°C) followed by a 
second mandatory visual inspection on turbidity (Food and Drug Administration 2004, 
Pastowski 2013). Finally, the number of contaminated units is counted (normally equal to 
zero) and the results documented in a manufacturing execution system. 
Figure 3: Media fill process description. First the vials are filled with TSB media at the filling line 
(inspection on integrity is not shown here). Subsequently vials are incubated for 7 days at 20-25°C 
and inspected on turbidity. Afterwards the process is repeated with an incubation temperature of 30-
35°C, to provide besides fungi also bacteria optimal growth conditions. The entire media fill process 
from filling to final inspection takes a minimum of 18 days. Some manufacturers even prolong 
incubation periods to ensure that also very slow growing or dormant organisms become detectable. 
(Metall & Plastic GmbH 2011, Direct Industry 2017a, gesund.at 2017, Astra Nova Ltd. 2015). 
The potential detection of contaminated units during the media fill inspection is linked with 
follow-up actions. The investigational extent of such actions is related to the number of units 
filled. For example if 5,000 to 10,000 media fill units are filled and one contaminated unit is 
detected, this should result in an investigation, including the consideration of a media fill 
repetition. In contrast, two contaminated units are considered cause for filling line 
revalidation, following diverse investigations (Stärk 2004, Food and Drug Administration 
2004). For proper drug product release the result of a media fill is of concern as it represents 
drug product quality through the analysis of the filling line asepticity. However, of additional 
importance is the final sterility assessment (Figure 4). It uses filtration practices of 
meticulously chosen samples (20 – 30 units) combined with a visual inspection on turbidity, 
which is considered to be representative for the degree of sterility of an entirely filled product 
batch  (20’000 – 100’000 units) (U.S. Pharmacopoeia 2011, European Pharmacopoeia 
2005a, Food and Drug Administration 2009). 
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Consequently, by this approach chances are relatively low to detect single contaminated 
vials in a product batch, thus a successful sterility assessment is required to release 
products to the market (Moldenhauer et al. 2004, Sandle 2012). Again, the visual inspection 
of filtered samples on turbidity is used to assess the degree of batch contamination after an 
incubation of 14 days. 
Figure 4: Sterility assessment procedure. From an entire batch ~30 samples are selected. In a 
H2O2 decontaminated isolator twice ~15 samples (the moiety) are filtered through two different filters. 
One filter is put into a tryptic soy broth (TSB) filled unit (aerobe cultivation), the other one into a fluid 
thioglycollate (FTM) filled unit (anaerobe cultivation). Subsequently the TSB unit is stored in a 20-
25°C incubator and the FTM unit in a 30-35°C incubator. After an incubation of 14 days both units are 
inspected on turbidity. The product batch is released for commercialization if in both units no turbidity 
was detected. (BacteriostaticWater.com 2017, Hardy Diagnostics 2017, Franz Ziel GmbH 2017, Direct 
Industry 2017b, gesund.at 2017, Brueckner 2016b). 
Despite the numerous quality control mechanisms utilized, approximately 207 injectable 
drugs (not only biologics) were recalled from the market within 2012 and 2016 (Table 1). Of 
the recalled cases, 38 were due to insufficient product sterility which could have led to 
infections in patients. Overall, it is hard to indicate a concrete number of potentially 
endangered humans if drug products were not recalled. However, the analysis illustrates that 
there is potential to design more secure and reliable quality control mechanisms, thus 
avoiding the release of products that are quality non-compliant. Technologies with the ability 
to facilitate the detection of drug quality defects and further allow a more efficient work 
performance are significantly supportive. Such methods could help to reduce recall rates as 
well as finally deliver manufacturers monetary benefits (in terms of lower recall rates or more 
efficient processes). 
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Table 1: Product quality related recalls. The analysis includes both recalls for injectable (207 
cases) and non-injectable (223 cases) drug products. The values in brackets state the relative amount 
of injectable drugs from total recalls per category. There were 38 recalls observed for injectable drugs 
during 2012 and 2016 caused by deficient sterility control mechanisms. Accessed recall databases 
belonged to World Health Organization (A), government of the United Kingdom (B), drug office of 
Hong Kong (C), Swissmedic (D) and Food and Drug Administration (E). (World Health Organisation 
2017, Gov.uk 2017, Drug Office Hong Kong 2017, Swissmedic 2017, Food and Drug Administration 
2017) 
Quality categories per recall database A B C D E Total 
Packaging and labelling 
(first and secondary packaging, leaflet, non-integer stoppers, wrong 
labelling, scratches, packaging with tendency for breakage) 
1 26 23 18 12 
80 
(45%) 
Impurities and quality control failure 
(Particles, contamination with drug, other non-biologic contamination, 
stability, crystallization, precipitation) 
4 24 46 31 38 
143 
(58%) 
Patient safety 
(Falsified drugs, wrong dosage, unexpected adverse events, general 
health hazards, treatment failures, organ failure) 
35 14 35 7 5 
96 
(27%) 
General sterility problems 
(deviations of EMT, linkage to packaging problems such as leakage or 
other risks of microbial contamination) 
1 8 9 2 22 
42 
(76%) 
Sterility issue with isolates 
(identified bacteria or fungi) 
0 1 0 0 6 
7 
(86%) 
Others 
(Clinical studies, market authorization, licensing, unexpected drug 
change) 
8 5 41 6 2 
62 
(38%) 
Total 49 78 154 64 85 
430 
(48%) 
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1.3 Approaching the Improvement of Drug Quality Control Mechanisms 
Since the use of modern isolator technologies in aseptic manufacturing, filling processes 
have become safer in terms of microbial contamination. As a result the need for media fills 
and sterility assessments are discussed (Glunz 2015). Still, regulatory authorities demand 
biologics manufacturers to perform media fills and sterility assessments as they are a 
fundamental part of the quality control concept in fill-finish processing. Therefore, the search 
for supportive and alternative approaches targeting a leaner and more efficient performance 
of the implied quality control processes is promoted. 
The visual media fill inspection is time-consuming, costly and tedious, adding minor value to 
the product. Therefore, an automation of the visual inspection is of interest. Indeed, a need 
for alternative approaches with easy handling, non-invasive measurement of bacterial 
growth, comparable or faster time to result, providing operational savings and data integrity, 
exists. The same fulfillment requirement is demanded for a replacement of microbial growth 
detection within the sterility assessment of finished goods, where rapid time to result is of 
even more importance. Shortened growth detection could reduce requested incubation 
durations and allow an earlier release of finished goods to market. 
Presently, various qualitative microbial methods exist, allowing faster detection of growing 
microorganisms compared to conventional approaches. Such methods are based on electro-
optical, spectroscopic or biochemical reaction analysis having advantages and drawbacks 
(Miller 2016). However, among existing microbial methods it is relatively difficult to find one 
that fulfills demanded requirements such as non-invasive, continuous, and cost-efficient 
determination of microbial growth in closed systems. Therefore, within this study the search 
for alternative methods which enable microbial growth detection was widened beyond the 
boundary of classical techniques. Two technologies were identified and considered to be 
appropriate for the automation of the visual media fill inspection and the potential 
replacement of the sterility assessment. Due to the technologies generic applicability their 
usability in manufacturing related research was of further interest. Thus, the additional 
assessment of an alternative way to control microbial growth during drug substance 
manufacturing (tracking CO2 and O2 based respiratory and overall metabolic activities during 
for example fermentation) was targeted. Both methods used parameters resulting from 
microbial metabolic activity allowing growth detection in concerned test units. 
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1.4 Microbial Metabolisms 
Microorganisms are subject to special attention in pharmaceutical and biotech industries. 
Although microbial cells are helpful for the production of biologics, their presence in aseptic 
manufacturing causes disturbances. The main threat of product contamination in aseptic 
manufacturing comes from organisms capable of surviving in aerobe surroundings; namely 
obligate aerobe, facultative-aerobe, or fermenting microbes (Table 2). Organisms such as 
Staphylococcus sp., Micrococcus sp. and Corynebacterium sp. are most frequently 
encountered in clean rooms as these organisms live on skin, lips, scalp, and within mouths 
and nostrils of humans (Park et al. 2014). Further, these species can easily access clean 
room areas through operators at work, yet are normally killed by means of standardized 
cleaning and sterilization procedures (Zuber 2014). In contrast, some microorganisms (e.g. 
Bacillus sp., Clostridium sp.) have spore-forming characteristics, meaning such 
microorganisms are capable of producing latent precursor units (spores) of fully developed 
cells, and are thus more robust against damaging environmental conditions. Therefore, they 
are hazardous to manufactured products. 
Table 2: Typical microorganisms isolated from clean rooms. Aside from the microbial name and 
group name the table shows the relative appearance frequency (App. frequency) and metabolism 
types. As depicted, a minimal amount of appearing isolates is of anaerobe nature, as anaerobe 
conditions are less frequently encountered in aseptic manufacturing. (Park et al. 2014, Brueckner 
2016a, Zuber 2014)
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Nevertheless, for survival and replication microorganisms need nutrients enabling the 
production of chemical energy driving cell processes and biomass formation. They normally 
use organic compounds such as sugars, amino acids, fatty acids and alcohols as primary 
energy and carbon source. Overall microbial metabolisms can be separated into two sets of 
metabolic processes – catabolism and anabolism (Figure 5). Catabolism is the set of 
reactions breaking down organic compounds (nutrients) into smaller molecules. Those are 
either used to construct new compounds during anabolism, or are degraded further to simple 
waste products (e.g. CO2, H2O, lactic acid, urea, etc.). The production of cellular waste 
occurs normally through oxidation, releasing free energy, some of which is lost as heat 
(~40%), and some of which (~60%) enables the production of chemical energy, stored as 
adenosine triphosphate (ATP) (Fuchs et al. 2014, Madigan 2015). 
 
Figure 5: Simplified illustration of catabolic and anabolic pathways. Catabolism is used to break 
down large molecules into smaller molecules (sometimes precursor molecules) whereby energy is 
released (lost as heat or used for ATP synthesis). The energy in form of ATP enables the 
performance of anabolic reactions used by the cell to construct necessary macromolecules for 
survival, replication or other constructive processes. (WorldNews Network 2016) 
Three main catabolic pathways used for ATP synthesis are encountered in cleanroom 
isolates. They are categorized into aerobe respiration, anaerobe respiration, and 
fermentation (Figure 6). Aerobe and anaerobe pathways are driven by electron accepting 
substances such as oxygen (O2; aerobe) or e.g. sulfate and nitrate (SO4
2− and NO3
−; 
anaerobe), using Glycolysis and the Krebs cycle to synthesize ATP (Cowan 2016).  
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Fermentation is mostly used if access to electron acceptors other than organic compounds is 
not possible or if organisms synthesize ATP strictly by fermenting metabolisms. Normally 
microorganisms are capable to switch between several different metabolism types 
depending on their survival strategy (see also Table 3). If oxygen can be used as electron 
acceptor aerobe respiration is considered as primary pathway until its depletion. This 
happens as theoretical yield is highest for aerobe respiration (38 ATP per glucose) if 
compared to anaerobe respiration (2-36 ATP per glucose) or fermentation (2 ATP per 
glucose) (Cowan 2016). 
Figure 6: Catabolic main cycles frequently used by microorganisms. Aerobic and anaerobic 
respiration use Glycolysis and the Krebs cycle as pathways to gain energy out of catabolic processes. 
Either oxygen or other electron acceptors are used for substrate oxidation, releasing besides others 
CO2 and heat as waste products. Fermentation occurs under exclusion of oxygen and uses organic 
compounds as electron acceptor. (Cowan 2016, modified)
ATP yield from catabolic reactions is driving anabolic pathways towards the construction of 
macromolecules out of precursor substances. More generally spoken, macromolecules allow 
the construction of cell structure (e.g. membranes, ribosomes, etc.), the performance of cell 
internal processes (e.g. maintenance, growth, cell division, etc.) or the assembly of energetic 
storages which can further be used for ATP regeneration. The sum of these constructive 
processes is dedicated to anabolism (Cowan 2016, Fuchs et al. 2014, Madigan 2015). 
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For environmental control in aseptic manufacturing the simple determination of microbial 
presence is of major relevance, much more than the understanding of cell internal processes. 
Methods applied perform a growth based assessment, treating microbial cells as black boxes 
that consume nutrients as well as electron acceptors (O2, NO3
-, etc.) and release waste such
as CO2 or heat, resulting under appropriate conditions in a detectable biomass increase 
(higher turbidity in liquid media or appearance of colony forming units on agar plates). 
However, besides the biomass increase also educts consumed and waste produced can be 
helpful in determining the presence of microorganisms (Table 3). 
Table 3: Some common catabolic pathways encountered in clean rooms. Reactants are related 
to the initial substances used for energetic gain. Products relate to the result of the entire metabolic 
reaction also dedicated to metabolic waste. Heat, an additional product of metabolic performance, is 
not listed in this table. (Fuchs et al. 2014, Madigan 2015, van Maris et al. 2006) 
Therefore, a basic metabolic understanding is required to identify techniques allowing 
uniform growth detection. As can be seen in Figure 5, Figure 6 and Table 3 heat emission, 
CO2 exhaust and O2 consumption are linked with most catabolic processes performed by 
microorganisms surviving in clean rooms. Therefore, the evaluation of such parameters by 
appropriate technologies could bring further innovation in the assessment of microbial 
presence. 
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1.5 Approaches Used for Non-invasive Microbial Growth Analysis 
Metabolic Heat Determination by Isothermal Microcalorimetry 
Virtually all biological and chemical processes emit (or consume) heat, thus thermal energy 
release is a suitable study parameter (Wadso et al. 2001). The analysis of heat dissipation 
can assist in evaluating presence of metabolically active cells, specifically in microbiology; 
where biological and chemical processes provide the cells necessary energy for survival 
(Trampuz et al. 2007, Braissant et al. 2015). In fact, metabolic heat dissipation can be 
utilized in the assessment of e.g. resistance to antibiotic drugs or optimal conditions for 
upstream bioprocessing (condition related yield maximization of a certain protein or other 
product) (Maskow et al. 2011, Braissant et al. 2010, Rohde et al. 2016b, Baldoni et al. 2009). 
Each compound of a reaction contains energy, which is termed inner energy (U). During a 
reaction in a system inner energy has the potential to amass in form of thermal energy 
known as reaction enthalpy ΔH. Reaction enthalpy is the sum of the inner energy change ΔU 
(energy of sum of reaction products (U2) – sum of reaction educts (U1)) and work performed 
by a system (product of system pressure (p) and change in system volume (ΔV)). If the 
system is not performing, ΔH becomes equal to ΔU: in such cases, heat can be used as a 
reliable proxy for metabolic cell activity. A reaction releasing heat is of exothermal nature 
and thus, has a negative ΔH (Mortimer et al. 2007). 
Metabolic reactions are by nature mostly exothermal (-ΔH) else the energetic gain needed 
for internal cell processes, could hardly be realized. The expected degree of heat dissipation 
from a metabolic reaction can be determined by calculations of enthalpy. Standard enthalpy 
values (ΔH0f) help realizing such calculations representing the enthalpy change during the 
formation of 1 mole substance from its initial compounds under standard conditions (25°C, 1 
atm, pH7). To calculate ΔH0 of an entire metabolic reaction (Equation 1), the difference 
between ΣΔH0f (products) and ΣΔH
0
f (reactants) is determined, which is based on the Hess’ 
law (Figure 7).  
𝛥𝐻0  =  𝛴𝛥𝐻𝑓
0 (𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠)  −  𝛴𝛥𝐻𝑓
0 (𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠)
Equation 1: Formula for enthalpy calculation of a reaction based on standard enthalpy values. 
(Mortimer et al. 2007) 
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The law of Hess states that: the enthalpy change associated with the reaction depends only 
upon the identity of the reaction educts and products being completely independent of 
whether the reaction takes place in a series of steps or all at once (Mortimer et al. 2007). 
Figure 7: The principle of Hess’ law is shown describing that the reaction enthalpy size is 
independent of whether the reaction takes place all at once (Reaction 1) or in a series of steps 
(Reaction 2), as long as reactants and educts remain the same. (Clark 2017) 
Respecting the principles of Hess’ law the calculated enthalpy change correlates directly 
with the amount of heat emitted (always considering that the system’s work is negligible) 
which in turn depends on both, the kind of metabolism and the number of active cells in the 
system. Thus the meaning of heat dissipation originating from growing bacteria in a system 
becomes comprehensible (Table 4). 
Table 4: Enthalpy calculations for frequent metabolism types. ΔH0 is the enthalpy of the entire 
reaction. The respective sum of enthalpy of formation (ΔH0f) is shown for products and reactants. 
Standard enthalpies of C6H12O6 (s) (-1271.0 kJ/mol), CO2 (g) (-393.5 kJ/mol), O2 (g) (0.0 kJ/mol), 
C3H6O3 (s) (-688.3 kJ/mol), H2O (l) (-285.8 kJ/mol), C2H5OH (l) (-277.6 kJ/mol), C3H6O2 (l) (-510.0 kJ/
mol), C2H4O2 (l) (-484.5 kJ/mol), C4H8O2 (l) (533.9 kJ/mol) and H2 (g) (0.0kJ/mol) were taken from 
(Bigler 2017, NIST 2016, Earhart 2016, Crosby 2015, Li et al. 2016). 
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Isothermal microcalorimetry (IMC) allows for non-invasive and continuous monitoring of the 
rate of heat coming from the test sample, which is proportional to the rate of performed 
processes in the living system. Such heat is measured by means of heat-flow sensors (e.g. 
peltier elements) located between the sample and the heat sink (Figure 8). The sample, the 
sensor and the heat sink are placed in a thermally insulted bath with constant temperature to 
record minimal temperature variations in the reaction vessel. In case of heat variations in the 
sample, sensors test the sample against a reference and transform the corresponding heat 
flow into an electrical signal. This transformation is realized by the Seebeck effect where a 
voltage difference is generated across two different semiconductor materials if a temperature 
gradient is recognized through two junctions of the material (Kemp 1998, Wadso et al. 2001). 
The monitored voltage difference is normally converted into a Watts per second signal, 
which is the obtained output parameter of a calorimetric measurement enabling calculations 
in Joule. 
Figure 8: The concept of a calorimeter. On the left side (A) the inner life of a calorimeter is shown. 
Reference and sample unit are positioned each on a peltier element placed on a heat sink. The 
voltage signal originating from the temperature change in the sample is captured by the peltier 
elements, evaluated by a computer and transformed to a Watt signal. On the right side of the graph 
(B) the principle of a peltier element is shown transforming emitted heat into an electrical signal 
(Woodbank Communications Ltd 2005, Braissant 2016) 
Merely 104 – 105 microbial cells are sufficient to reach the detection limit of an isothermal 
microcalorimeter (e.g. Tam III from TA Instruments) which corresponds to a sensitivity of 
20nW – 200nW (Braissant et al. 2015). There are two different ways to analyze activity of 
microorganisms in an experimental sample, being either based on heat flow (raw data from a 
calorimeter) or on heat (integrated heat flow over time) assessments. 
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To determine the activity related time to detection of an organism or a culture, a threshold of 
heat or heat flow must be defined in order to determine the influence the media is having on 
the measurement over time (Figure 9, A & B). However, if going beyond simple activity 
assessments a better understanding of mentioned parameters is required to avoid 
misconceptions. 
 
Figure 9: Activity and growth profiles. Figure A shows a typical heat flow profile (black curve) of 
Escherichia coli in basal medium eagle medium having three peaks that are potentially linked with the 
switch from one substrate to others. In figure B the corresponding heat profile (integrated heat flow 
over time shown as dotted grey line) and its approximation by the Gompertz growth model (black 
sigmoidal curve) are depicted together with the extracted microbiological parameters λ (lag phase), μ 
(growth factor) and A (maximal heat reached). In figure A and B the time point of microbial presence 
determination (Ttd = time to detection) is marked (red dot) considering that a heat flow and heat 
threshold was defined earlier. Figure C shows a typical microbial growth profile consisting out of 4 
different phases. Figure D illustrates another typical heat (black curve) and heat flow (blue curve) 
profile of Pseudomonas putida indicating that optical density measurements (red dots - relating to the 
amount of produced cells), rather correlate with heat as with heat flow. (Braissant et al. 2015, 
Braissant et al. 2013) 
Typical microbial growth goes through 4 main phases: the lag, the exponential growth, the 
stationary and the death phase (Figure 9, C). Similarly, a heat flow profile during a microbial 
growth experiment also follows rising and declining periods (Figure 9, A - black curve & D – 
blue curve); however, such curve comparability does not infer similarity between the involved 
processes. Microorganisms are often confronted with several carbon sources and might 
consume those successively by adjusting their metabolisms to the substrate. 
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During the transition state from one substrate to another the synthesis of new enzymes 
might be requested leading to a decrease in heat flow (Braissant et al. 2013).  
In addition, heat flow must be used carefully as a proxy for microbial growth detection (or the 
cell number) as accuracy is only given as long as a correlation between heat flow and cell 
count (or optical density) exists. Such correlation typically exists, if at all, during the early 
exponential growth phase (Figure 9, D). Non-correlation is due to the heat production rate 
per cell, fluctuating as a result of the metabolism and the growth phase. However, the 
energetic cost of a cell should remain relatively constant. Thus, a constant amount of heat 
generated to produce a cell can be expected (Braissant et al. 2013, Maskow et al. 2006), 
making heat a more reliable proxy for microbial growth studies. 
When an entire growth related heat flow pattern is collected in such a way that heat flow is 
allowed to rise and return to levels close to baseline, the heat-over-time curve typically 
reflects a sigmoidal profile. Sigmoidal profiles can be approximated by using the modified 
Gompertz growth model (Figure 9, B; Equation 2). Model based calculations are normally 
programmed in R by the “grofit” package (Kahm et al. 2010). Thereby, the extraction of 
microbial growth parameters, such growth rate (μ), lag phase duration (λ), and maximal heat 
reached (A), from a calorimetric dataset, is automated providing the basis for further 
assessment (Braissant et al. 2013). 
𝑦 = 𝐴 ∗ 𝑒−𝑒[(𝜇∗
𝑒
𝐴)∗
(𝜆−1)+1]
Equation 2: The modified Gompertz model allows an approximation of an entire sigmoidal growth 
curve, such as heat, resulting from the integration of the heat flow. A is the maximum value reached 
(maximum heat production), μ the maximum growth factor (growth speed or maximal steepness of 
the approximated growth profile) and λ the lag phase duration. 
In contrast to the heat flow, heat profiles bear certain advantages in terms of assessing 
microbiological data, such as facilitated statistical analysis (extraction of parameters), easier 
correlation of growth data among organisms and estimation of microbial growth in relation to 
biomass production. Yet, the research purpose determines the suitability for the use of heat 
flow versus heat. In the case of simple analyses on microbial presence in test units, it is 
practical to employ both parameters. 
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Determining Metabolic O2 Consumption and CO2 Production by Tunable Diode 
Laser Absorption Spectroscopy 
Carbon-dioxide and oxygen are additional parameters that can be used separately or in 
combination with isothermal microcalorimetry to detect microbial presence in test units, as 
directly related to active metabolisms and growth. In systems with closed boundaries 
(fermenters, vials, etc.) not allowing an exchange with the environment, growing 
microorganisms influence gas concentrations (such as CO2 and O2) strong enough to cause 
detectable changes in headspace compositions of used containers. Such an influence is 
proportional to the degree of metabolic activity and the rate of gas consumption or 
production, characteristic for the metabolism used by the microbial strain. Therefore, 
technologies, with the potential of detecting such and other gas changes non-invasively, can 
be a valuable tool for the analysis of microbial presence and growth (AS et al. 2017, 
Martinez-Cruz et al. 2012) (Figure 10). 
Figure 10: Description of the TDLAS measurement principle in closed containers contaminated 
with microbial cells. Headspaces of such containers are tested on changing CO2 and O2 
concentrations being an indicator for active microbial metabolisms. Through several successive 
measurements growth profiles can be obtained. (Alibaba Group 2017, Lighthouse Instruments 2016) 
Tunable diode laser absorption spectroscopy (TDLAS) can determine non-invasively and 
with a sensitivity ranging from ppm to ppb a large variety of gases (e.g. O2, CO2, N2, NH3, 
CH4, etc. at T = 20-25°C) as such molecules absorb emitted laser light in the near and mid 
infrared spectral region (Lackner 2007). TDLAS is nowadays used for combustion, leakage, 
quality and emission control but found additional use in health care (i.e. the analysis of 
breath gas) and environmental (i.e. control of volcanic activities) industries (Giubileo et al. 
2001, Webber et al. 2000, Pedone et al. 2014, Frish et al. 2005). Due to its measurement 
reliability TDLAS started to be increasingly applied in pharmaceutical process control 
enabling the assessment of lyophilisation processes (i.e. testing for residual vaporized water 
in product units) as well as the control of primary packaging material integrity (i.e. glass 
vials) (Schneid et al. 2011, Posset et al. 2015). 
28 
Although in the past TDLAS was only applied to a limited extent in detecting microbial 
presence, large potential remains for this technique in the field of applied microbiology. High 
sensitivity, user comfort and non-invasive nature make TDLAS attractive for process 
analytics and automation in the quality control sector. Especially in the pharmaceutical 
production where the detection of mainly aerobe and fermenting organisms is part of the 
daily business, a TDLAS based CO2 and O2 growth detection is reasonable (Figure 10). 
Most TDLAS lasers applied measure in the near-infrared region. Thus, they can be operated 
at room temperature without need for cooling. The measurement principle is based on 
fundamental spectroscopic laws. Highly monochromatic laser light emitted from a distribution 
feedback electrode is passed through a sample of interest exciting molecules to rotational 
and vibrational movements. The resulting laser light attenuation is monitored with a detector 
which allows determining the gas concentration in the specimen headspace (Figure 10). 
Such determination is based on the Beer-Lambert law (Equation 3), stating a logarithmic 
relation between the transmission of the light through a gas, being equal to the product of 
the molar attenuation coefficient of the gas (ε), the distance (d) the light is travelling through 
the sample and the gas concentration (c) in the sample. (nanoplus 2015, Lackner 2007) 
log (
𝐼0
𝐼
) = 𝐴 =  𝜀 ∗ 𝑑 ∗ 𝑐 
Equation 3: Beer-Lambert law. It describes the relation among the laser light intensity (before (I0) 
and after (I) passing through the sample), the absorption (A), the gas concentration (c), the sample 
path length (b) and the molar attenuation coefficient (ε). (Lackner 2007) 
During the measurement TDLAS adjusts the emitted laser to the absorption wavelength of 
the target molecule and performs a tuning in its emission wavelength (λ) over the absorption 
band of the respective gas (Figure 11, A). This is done by altering the temperature or the 
injection current applied to the laser, targeting an exclusion of non-absorption regions into 
curve integration. Wavelength or frequency modulations are used to allow measurements 
with a better signal to noise ratio, raising the technique’s result accuracy. As often the 
concentration of a single gas in a gas mixture is of interest, the selection of a suitable 
absorption line is of major importance, as otherwise interferences with prevailing gases 
might coexist and alter measurement results (Figure 11, B) (Zolo Technologies 2013, 
nanoplus 2015, Lackner 2007).  
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However, when using TDLAS as method for the analysis of microbial presence it needs to 
be considered that in more extreme fields than pharmaceutical production areas organisms 
often use other metabolic pathways, - sometimes even CO2 and O2 independent (Madigan 
2015). This challenges a CO2 and O2 based measurement approach in terms of microbial 
growth detection. Therefore, TDLAS applied in microbiology shall always be linked with 
initially specified experimental purposes and microorganisms tested. An application in 
isolated systems is recommendable to keep external variable minimal. Such considerations 
can finally limit misinterpretation of measured parameters and allow users to identify TDLAS 
as a valuable tool for microbiologic assessments. 
Figure 11: Technical principles of TDLAS measurements. The recording of an individual 
absorption line is shown in A. (a) gives an example for the current ramp applied to the laser and the 
baseline Io; (b) shows the transmitted signal I and (c) provides the calculated absorbance according 
the Beer-Lambert law. In figure B absorption peaks of different gas types are illustrated. It becomes 
clear that choosing the right wavelength for TDLAS measurements of a certain gas is important, 
minimizing interferences with other prevailing gases. In our project the wavelength for O2 was set to 
760nm (red circle with dotted line) and for CO2 to 2000nm (red circle) (Lackner 2007, Fleagle et al. 
2006) 
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1.6 Dissertation Structure 
The entire work was performed through research collaboration between industry (F. 
Hoffmann-La Roche Ltd., Novartis Ltd., Lighthouse Instruments Ltd., Wilco AG) and 
academia (University of Basel, Department of Biomedical Engineering, Center of 
Biomechanics and Biocalorimetry). F. Hoffmann-La Roche provided financial support and 
allowed use of facilities and materials for realizing planned work in the form of case studies. 
Other industrial partners participated by providing devices or access to data. Academia was 
the main contributor in terms of calorimetry and data modelling. 
TDLAS Based Automation of the Visual Media Fill Inspection 
Assessing the feasibility of automating the visual media fill inspection by TDLAS was the 
main project of the dissertation and included three subprojects. First, a proof of concept 
study was performed testing if TDLAS is generally capable to detect microbial growth in 
media fills. CO2 and O2 TDLAS benchtop devices (Lighthouse Instruments) were used to 
evaluate an obligate aerobe and a homo-fermenting (expected to have lower metabolic 
activity) microorganism on the potential in influencing O2 and CO2 media fill headspace 
concentrations (Brueckner et al. 2016). Second, growth detectability of a larger variety of 
microorganisms was targeted using again TDLAS benchtop devices (Brueckner et al. 2017). 
Novartis and F. Hoffmann-La Roche contributed equal amounts of data for a joint 
publication. Finally, an automated platform provided by Wilco AG, allowed assessing the 
automated media fill inspection on its reliability. 
An Alternative Sterility Assessment 
IMC was used to evaluate if a potential substitution of the sterility test’s visual inspection on 
turbidity is possible. In addition, it was assessed if IMC allows a more sensitive growth 
analysis than the inspection approach in use, leading to a potential reduction of incubation 
and product holding times at aseptic manufacturing sites. 
Combining TDLAS and IMC in Calorespirometric Analysis 
Calorespirometry is the simultaneous analysis of the rate of heat emission, O2 consumption, 
and CO2 production by living systems such as tissues or organism cultures. The analysis 
provides useful knowledge about thermodynamic parameters relevant for e.g. biotechnology 
where parameter based yield maximization (fermentation) is highly relevant (Wadso et al. 
2015). However, conventional techniques to determine CO2 production and O2 consumption 
rates are laborious. Therefore, tunable diode laser absorption spectroscopy (TDLAS) was 
assessed as an alternative approach for microbial respirometric analysis in order to facilitate 
the data collection procedure. 
References 
31
Alibaba Group. 2017. Infrared Laser Diode 2017 [cited April 2017]. Available from 
https://www.alibaba.com/product-detail/980nm-100mw-Infrared-Laser-Diode_1969174595. 
html. 
Ams Biotechnology, Ltd. 2017. Extensive portfolio of ready to use cell lines  2013 [cited 
March 2017]. Available from http://www.amsbio.com/cell-lines.aspx. 
Arcane Industries. 2107. Adaptation des produits - formulation sur mesure  2017 [cited 30. 
April 2107]. Available from http://www.arcane-industries.fr/details-
adaptation+des+produits+formulation+sur+mesure-103.html. 
AS, Zarin, Arup Chakraborty, and Abhishek Upadhyay. 2017. "Absolute non-invasive 
measurement of CO2 mole fraction emitted by E. coli and S. aureus using calibration-free 2f 
WMS applied to a 2004 nm VCSEL." Optical Letters no. 42 (11):2138-2141. 
Astra Nova Ltd. 2017. Good documentation practice - what, how and why?  2015 [cited 
February 2017]. Available from https://crotraining.co.uk/good-documentation-practices-what-
how-and-why/. 
BacteriostaticWater.com. 2017. Sterile Empty Glass Vial  2017 [cited May 2017]. Available 
from http://bacteriostaticwater.com/empty-sterile-vial. 
Baldoni, Daniela., Heinz. Hermann, Reno. Frei, Andrej. Trampuz, and Andrea. Steinhuber. 
2009. "Performance of microcalorimetry for early detection of methicillin resistance in clinical 
isolates of Staphylococcus aureus." Journal of clinical microbiology no. 47 (3):774-776. 
2013 [cited March 2017]. Available from Bandageer. 2017. Vials and Syringes 
http://bandageer.info/vials-and-syringes/. 
Bayliss, C. E., and W. M. Waites. 1980. "The effect of hydrogen peroxide and ultraviolet 
irradiation on non-sporing bacteria." J Appl Bacteriol no. 48 (3):417-22. 
Bigler, Jeff. 2017. Standand Enthalpies of Formation & Standard Entropies of Common 
Compounds  2017 [cited April 2017]. Available from http://www.mrbigler.com/misc/energy-of-
formation.PDF. 
Biomérieux. 2017. Manual solution for environmental monitoring  2017 [cited April 2017]. 
Available from http://www.biomerieux.co.uk/biopharma/irradiated-3ptm-range. 
BioPharma Asia. 2017. Sartorius stedim biotech launches a new single-use harvesting 
technology for high cell density cultures up to 2000L  2015 [cited March 2017]. Available 
from https://biopharma-asia.com/sections/sartorius-stedim-biotech-launches-a-new-single-
use-harvesting-technology-for-high-cell-density-cultures-up-to-2000-l/. 
BioRefinery, CRIP;. 2017. De l’Ingénierie de procédés au Bioraffinage  2009 [cited March 
2017]. Available from http://www.groupes.polymtl.ca/crip/fr/bio_1eregen.php. 
Braissant, O, G Bonkat, Dieter Wirz, and A Bachmann. 2013. "Microbial growth and 
isothermal microcalorimetry: growth models and their application to microcalorimetric data." 
Thermochimica Acta no. 555:64-71. 
32
Braissant, O., A. Bachmann, and G. Bonkat. 2015. "Microcalorimetric assays for measuring 
cell growth and metabolic activity: methodology and applications." Methods no. 76:27-34. 
doi: 10.1016/j.ymeth.2014.10.009. 
Braissant, Olivier. 2016. The inner side of a calorimeter. 
Braissant, Olivier, Dieter Wirz, Beat Göpfert, and A.U. Daniels. 2010. "Biomedical use of 
isothermal microcalorimeters." Sensors no. 10 (10):9369-9383. 
Brueckner, D., D. Roesti, U. G. Zuber, R. Schmidt, S. Kraehenbuehl, G. Bonkat, and O. 
Braissant. 2016. "Comparison of Tunable Diode Laser Absorption Spectroscopy and 
Isothermal Micro-calorimetry for Non-invasive Detection of Microbial Growth in Media Fills." 
Scientific Reports no. 6. doi: 10.1038/Srep27894. 
Brueckner, D., D. Roesti, U. Zuber, M. Sacher, D. Duncan, S. Krahenbuhl, and O. Braissant. 
2017. "Tunable diode laser absorption spectroscopy as method of choice for non-invasive 
and automated detection of microbial growth in media fills." Talanta no. 167:21-29. doi: 
10.1016/j.talanta.2017.01.088. 
Brueckner, David. 2016a. Appearance frequency of microorganisms in clean room areas. 
Brueckner, David. 2016b. Picture from own experiments. 
Clark, Jim. 2017. Hess's law and enthalpy change calculations  2017 [cited March 2017]. 
Available from http://www.chemguide.co.uk/physical/energetics/sums.html. 
Cowan, Marjorie K.; Bunn, Jennifer. 2016. Microbiology Fundamentals: A Clinical Approach. 
2 ed: McGraw-Hill Education. 
Crosby, Alan. 2017. Standard Enthalpy of Formation for Various Compounds 2015 [cited 
April 2017]. Available from http://nshs-science.net/chemistry/common/pdf/R-
standard_enthalpy_of_formation.pdf. 
Declerck, J. 2011. "Biologicals and biosimilars: a review of the science and its implications." 
GaBI-Generics and Biosimilars Initiative Journal no. 1 (1):13-16. 
Direct Industry. 2017. Laboratory incubator  2017a [cited April 2017]. Available from 
http://www.directindustry.com/prod/thermo-scientific-laboratory-equipment/product-21327-
1244359.html. 
Direct Industry. 2017. Laboratory incubator / forced convection / refrigerated / Peltier effect  
2017b [cited March 2017]. Available from http://www.directindustry.com/prod/thermo-
scientific-laboratory-equipment/product-21327-231018.html#product-item_1244359. 
Drug Office Hong Kong. 2017. Medicines Recalls  2017 [cited January 2017]. Available from 
https://www.drugoffice.gov.hk/eps/do/en/pharmaceutical_trade/safety_alerts_and_medical_r
ecalls/medicine_recalls.html. 
Earhart, Alan D. 2017. Standard Enthalpies of Formation  2016 [cited April 2017]. Available 
from http://chemistry.alanearhart.org/resources/Handouts/enthalpy-qr.pdf. 
33
ESCO Pharma. 2017. Unidirectional or Turbulent Airflow: Which is best for Sterile Pharmacy 
Compounding? 2017 [cited April 2017]. Available from 
http://www.escopharma.com/news/47/. 
European commission. 2008. EudraLex - The Rules Governing Medicinal Products in the 
European Union. edited by Pharmaceuticals Consumer Goods. Brussels. 
European Pharmacopoeia. 2005. 2.6.1 Sterility. Council of Europe. 
European Pharmacopoeia. 2007. 2.6.12 Microbiological examination of non-sterile products: 
Total viable aerobic count. Council of Europe. 
Fleagle, R.G., and J.A. Businger. 2017. Absorption spectra for CH4, NO2, O2, O3, CO2 and 
H2O and of the atmosphere  2006 [cited February 2017]. Available from 
https://scienceofdoom.com/2009/11/28/co2-an-insignificant-trace-gas-part-one/. 
Food and Drug Administration. 2004. Sterile Drug Products Produced by Aseptic Processing 
- Current Good Manufacturing Practice  
Food and Drug Administration. 2009. Evaluation and Recommendation of Pharmacopoeial 
Texts for Use in the ICH Regions on Sterility Test General Chapter Annex 8. edited by Office 
of food and verterinary medicine. 
Food and Drug Administration. 2016. Code of Federal Regulation (CFR), section 21 CFR 
211.113 (b). 
Food and Drug Administration. 2017. Safety Alerts for Human Medical Products  2017 [cited 
January 2017]. Available from 
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProdu
cts/ucm479348.htm. 
Franz Ziel GmbH. 2017. Sterility Testing Isolator  2017 [cited April 2017]. Available from 
http://www.ziel-gmbh.com/en/products/isolator-rabs/sterility-testing-isolator.html. 
Frish, MB, RT Wainner, BD Green, MC Laderer, and MG Allen. 2005. Standoff gas leak 
detectors based on tunable diode laser absorption spectroscopy. Paper read at Optics East 
2005. 
Fuchs, Georg, Thomas Eitinger, Johann Heider, Börries Kemper, Erika Kothe, Jörg 
Overmann, Bernhard Schink, Erwin Schneider, and Gottfried Unden. 2014. Allgemeine 
Mikrobiologie. Edited by Georg Fuchs: Thieme. 
gesund.at. 2017. Das Auge 2017 [cited April 2017]. Available from 
http://www.gesund.at/f/auge. 
Giubileo, G., R. Fantoni, L. De Dominicis, M. Giorgi, R. Pulvirenti, and M. Snels. 2001. "A 
TDLAS system for the diagnosis of Helicobacter pylori infection in humans." Laser Physics 
no. 11 (1):154-157. 
Glunz, Alexander. 2015. Media fills and their role in aseptic manufacturing. edited by David 
Brueckner. 
34
Gov.uk. 2017. Alerts and recalls for drugs and medical devices  2017 [cited January 2017]. 
Available from https://www.gov.uk/drug-device-alerts. 
Haleem, R. M., M. Y. Salem, F. A. Fatahallah, and L. E. Abdelfattah. 2015. "Quality in the 
pharmaceutical industry - A literature review." Saudi Pharm J no. 23 (5):463-9. doi: 
10.1016/j.jsps.2013.11.004. 
Hardy Diagnostics. 2017. Sterisart® Universal Pump, upgraded version, stainless steel, 
approximately 336x260x210 (with lever), each, by Sartorius Stedim Biotech  2017 [cited 
March 2017]. Available from https://catalog.hardydiagnostics.com/cp_prod/product/16420-
sterisart-universal-pump-upgraded-version-stainless-steel-approximately-336x260x210-with-
lever-each-by-sartorius-stedim-biotech-membrane-filtration-microbiology. 
Hygiena LLC. 2017. ATP Surface Test - UltraSnap  2017 [cited March 2017]. Available from 
http://www.hygiena.com/ultrasnap-food-and-beverage.html. 
Ingeniarg SA. 2017. Estrategias de Suministro de aire en salas limpias. Distribución  2017 
[cited May 2017]. Available from http://www.ingeniarg.com/blog/36-estrategias-de-
suministro-de-aire-en-salas-limpias-distribucion. 
Irvine, Darrell J., Xingfang Su, and Brandon Kwong. 2010. Routes of Delivery for Biological 
Drug Products. In Pharmaceutical Sciences Encyclopedia, edited by Shayne C. Gad. 
Kahm, M., G. Hasenbrink, H. Lichtenberg-Frate, J. Ludwig, and M. Kschischo. 2010. "grofit: 
Fitting Biological Growth Curves with R." Journal of Statistical Software no. 33 (7):1-21. 
Kemp, R. B. 1998. Handbook of Thermal Analysis and Calorimetry. Edited by Patrick K. 
Gallagher. Vol. Principles and practice: Elsevier. 
Kovarcik, Don Paul. 2016. Critical Factors for Fill–Finish Manufacturing of Biologics. 
http://www.bioprocessintl.com/manufacturing/fill-finish/critical-factors-for-fill-finish-
manufacturing-of-biologics/. 
Lackner, Maximilian. 2007. "Tunable diode laser absorption spectroscopy (TDLAS) in the 
process industries—a review." Rev. Chem. Eng no. 23 (2):65-147. 
Li, Yebo, and Samir Kumar Khanal. 2016. Bioenergy: Principles and Applications: Wiley-
Blackwell. 
Lighthouse Instruments, LLC;. 2016. The principle of headspace analysis. 
Madigan, Michael T.; Martinko, John M.; Bender, Kelly S.; Buckley, Daniel H.; Stahl, David 
A. 2015. Brock - Biology of Microorganisms. 14 ed: Pearson Education, Inc. 
Martinez-Cruz, K., A. Sepulveda-Jauregui, N. Escobar-Orozco, and F. Thalasso. 2012. 
"Methanogenic activity tests by Infrared Tunable Diode Laser Absorption Spectroscopy." 
Journal of Microbiological Methods no. 91 (1):89-92. doi: 10.1016/j.mimet.2012.07.022. 
Maskow, T., and H. Harms. 2006. "Real time insights into bioprocesses using calorimetry: 
State of the art and potential." Engineering in Life Sciences no. 6 (3):266-277. doi: 
10.1002/elsc.200520123. 
35
Maskow, T., T. Schubert, A. Wolf, F. Buchholz, L. Regestein, J. Buechs, F. Mertens, H. 
Harms, and J. Lerchner. 2011. "Potentials and limitations of miniaturized calorimeters for 
bioprocess monitoring." Appl Microbiol Biotechnol no. 92 (1):55-66. doi: 10.1007/s00253-
011-3497-7. 
Metall & Plastic GmbH. 2017. Pharmaceutical filling and closing now united with isolator 
technology 2011 [cited February 2017]. Available from 
https://www.healthcarepackaging.com/pharmaceutical-filling-and-closing-now-united-
isolator-technology. 
Miller, J. Michael. 2017. The rapid microbial method product matrix  2016 [cited May 2017]. 
Available from http://rapidmicromethods.com/files/matrix.php. 
Moldenhauer, J., and S. V. Sutton. 2004. "Towards an improved sterility test." PDA J Pharm 
Sci Technol no. 58 (6):284-6. 
Mortimer, Charles E., and Ulrich Müller. 2007. Das Basiswissen der Chemie. Vol. 9: Thieme. 
nanoplus. 2017. Tunable Diode Laser Absorption Spectroscopy (TDLAS)  2015 [cited April 
2017]. Available from http://nanoplus.com/en/technology/tunable-diode-laser-absorption-
spectroscopy-tdlas/. 
NIST. 2017. The NIST Chemistry WebBook  2016 [cited April 2017]. Available from 
http://webbook.nist.gov/. 
Otto, Ralf, ., Alberto Santagostino, ., and Ulf Schrader, . 2017. Rapid growth in biopharma: 
Challenges and opportunities  2014 [cited January 2017]. Available from 
http://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-
insights/rapid-growth-in-biopharma. 
Park, H. K., J. H. Han, Y. Joung, S. H. Cho, S. A. Kim, and S. B. Kim. 2014. "Bacterial 
diversity in the indoor air of pharmaceutical environment." J Appl Microbiol no. 116 (3):718-
27. doi: 10.1111/jam.12416.
Pastowski, Andrea. 2013. Mikrobiologische Prozess-Validierung durch Media Fill in PKau 
(Bau 235 und Bau 231). F. Hoffmann-La Roche, Ltd. 
Pedone, M., A. Aiuppa, G. Giudice, F. Grassa, V. Francofonte, B. Bergsson, and E. 
Ilyinskaya. 2014. "Tunable diode laser measurements of hydrothermal/volcanic CO2 and 
implications for the global CO2 budget." Solid Earth no. 5 (2):1209-1221. doi: 10.5194/se-5-
1209-2014. 
Pharmaceutical Online. 2017. Air Monitoring For Pharma / Biotechnology: MAS-100 NT  
2017 [cited April 2017]. Available from https://www.pharmaceuticalonline.com/doc/air-
monitoring-for-pharma-biotechnology-mas-nt-0001. 
Posset, Tobias, Misael Schleger, Fredric J. Lim, Marco Mumenthaler, Sebastian Schneider, 
and Thomas Kaiser. 2015. "100% Container closure integrity testing of lyophilized drug 
products by the oxygen head space analysis methodology." Pharm. Ind. - die 
pharmazeutische Industrie no. 77 (5):739-747. 
36
Rohde, Maria‐Teresa, Sven Paufler, Hauke Harms, and Thomas Maskow. 2016. 
"Calorespirometric feeding control enhances bioproduction from toxic feedstocks—
Demonstration for biopolymer production out of methanol." Biotechnology and 
bioengineering no. 113 (10):2113-2121. 
Sandle, Tim. 2012. "Sterility test failure investigations." Journal of GXP Compliance no. 16 
(1):66. 
Schneid, Stefan C, Henning Gieseler, William J Kessler, Suman A Luthra, and Michael J 
Pikal. 2011. "Optimization of the secondary drying step in freeze drying using TDLAS 
technology." Aaps Pharmscitech no. 12 (1):379-387. 
Scott, Cherly, Anne Montgomery, and Lorna McLeod. 2011. Fill and Finish for Biologics. 
http://www.bioprocessintl.com/manufacturing/fill-finish/fill-and-finish-for-biologics-316516/. 
Sigma Aldrich. 2017. Selective growth media for E. coli  2017 [cited April 2017]. Available 
from http://www.sigmaaldrich.com/technical-documents/articles/analytix/selective-growth-
media.html. 
Stärk, Alexandra. 2004. "Media Fill bei mehrstufigen Prozessen." Wissenschaft und Technik: 
Originale no. 66 (5):588-593. 
Stockdale, Douglas. 2017. Overview of Aseptic Fill Finish Manufacturing  2016 [cited April 
2017]. Available from http://www.biorealty.com/blog/overview-of-aseptic-fillfinish-
manufacturing/. 
Swissmedic. 2017. Batch recalls  2017 [cited January 2017]. Available from 
https://www.swissmedic.ch/marktueberwachung/00135/00166/index.html?lang=en&start=0&t
easerFlex=5. 
Trampuz, Andrej, Simone Salzmann, Jeanne Antheaume, and Alma U Daniels. 2007. 
"Microcalorimetry: a novel method for detection of microbial contamination in platelet 
products." Transfusion no. 47 (9):1643-1650. 
U.S. Federal Standard. 2015a. ISO 14000 - environmental management. 
U.S. Federal Standard. 2015b. ISO 14644-1:2015 - Cleanrooms and associated controlled 
environments. 
U.S. Pharmacopoeia. 2011. <71> Sterility Test. 
U.S. Pharmacopoeia. 2013. <1113> Microbial Control and Monitoring of Aseptic Processing 
Environments. 
van Maris, A. J. A., D. A. Abbott, E. Bellissimi, J. van den Brink, M. Kuyper, M. A. H. Luttik, 
H. W. Wisselink, W. A. Scheffers, J. P. van Dijken, and J. T. Pronk. 2006. "Alcoholic 
fermentation of carbon sources in biomass hydrolysates by Saccharomyces cerevisiae: 
current status." Antonie Van Leeuwenhoek International Journal of General and Molecular 
Microbiology no. 90 (4):391-418. doi: 10.1007/s10482-006-9085-7. 
Wadso, L., and L. D. Hansen. 2015. "Calorespirometry of terrestrial organisms and 
ecosystems." Methods no. 76:11-9. doi: 10.1016/j.ymeth.2014.10.024. 
37
Wadso, L., A. L. Smith, H. Shirazi, S. R. Mulligan, and T. Hofelich. 2001. "The isothermal 
heat conduction calorimeter: A versatile instrument for studying processes in physics, 
chemistry, and biology." Journal of Chemical Education no. 78 (8):1080-1086. 
Webber, M. E., J. Wang, S. T. Sanders, D. S. Baer, and R. K. Hanson. 2000. "In situ 
combustion measurements of CO, CO2, H2O and temperature using diode laser absorption 
sensors." Proceedings of the Combustion Institute no. 28:407-413. 
Woodbank Communications Ltd. 2017. Semiconductors Without the Quantum Physics  2005 
[cited March 2017]. Available from http://www.mpoweruk.com/semiconductors.htm. 
World Health Organisation. 2017. Full List of WHO Medical Product Alerts  2017 [cited 
January 2017]. Available from http://www.who.int/medicines/publications/drugalerts/en/. 
WorldNews Network. 2017. Microbial Metabolism Chapter 5 Part 1 of 2  2016 [cited April 
2017]. Available from https://wn.com/microbial_metabolism. 
Xebios Diagnostics GmbH. 2017. Caseinpepton-Sojamehlpepton-Agar nach harm. 
EP/USP/JP (CASO-Agar)  2015 [cited April 2017]. Available from https://www.xebios.de/. 
Zolo Technologies. 2017. Tunable Diode Laser Absorption Spectroscopy (TDLAS)  2013 
[cited April 2017]. Available from http://zolotech.com/technology/what-is-tdlas/. 
Zuber, Ulrich. 2014. Auswertungen der jährlichen Keimidentifkationen in PKau. edited by 
Andrea; Kockelkorn Pastowski, Daniel: F. Hoffmann-La Roche, Ltd. 
38 
CHAPTER 2 
Comparison of Tunable Diode Laser Absorption Spectroscopy 
and Isothermal Microcalorimetry for Non-invasive Detection of 
Microbial Growth in Media Fills 
David Brueckner1,2, David Roesti3, Ulrich Georg Zuber2, Rainer Schmidt2, Stefan 
Kraehenbuehl4, Gernot Bonkat1,5 & Olivier Braissant1,5 
1
Center of Biomechanics & Biocalorimetry, University Basel, Gewerbestr. 14, CH-4123 Allschwil; 
2
F.
Hoffmann – La Roche, Ltd., Sterile Drug Product Manufacturing, Wurmisweg, CH-4303 Kaiseraugst; 
3
Novartis Pharma Stein AG, CH-4332 Stein; 
4
Clinical Pharmacology & Toxicology, Universitätsspital
Basel, Markgräflerhof, Hebelstrasse 2, CH-4031 Basel; 
5
Department of Urology, Universitätsspital
Basel, Spitalstrasse 21, CH-4031 Basel, Switzerland. 
Published in NATURE Scientific Reports, June 2016
(Vol. 6, DOI: 10.1038/srep27894) 
1Scientific RepoRts | 6:27894 | DOI: 10.1038/srep27894
www.nature.com/scientificreports
Comparison of Tunable Diode Laser 
Absorption Spectroscopy and 
Isothermal Micro-calorimetry for 
Non-invasive Detection of Microbial 
Growth in Media Fills
David Brueckner1,2, David Roesti3, Ulrich Georg Zuber2, Rainer Schmidt2, 
Stefan Kraehenbuehl4, Gernot Bonkat1,5 & Olivier Braissant1,5
Two methods were investigated for non-invasive microbial growth-detection in intact glass vials as 
possible techniques for automated inspection of media-filled units. Tunable diode laser absorption 
spectroscopy (TDLAS) was used to determine microbially induced changes in O2 and CO2 concentrations 
within the vial headspaces. Isothermal microcalorimetry (IMC) allowed the detection of metabolic heat 
production. Bacillus subtilis and Streptococcus salivarius were chosen as test organisms. Parameters as 
robustness, sensitivity, comparability and time to detection (TtD) were evaluated to assess method 
adequacy. Both methods robustly detected growth of the tested microorganisms within less than 
76 hours using an initial inoculum of <10CFU. TDLASO2 turned out to be less sensitive than TDLASCO2
and IMC, as some false negative results were observed. Compared to the visual media-fill examination 
of spiked samples, the investigated techniques were slightly slower regarding TtD. Although IMC 
showed shorter TtD than TDLAS the latter is proposed for automating the media-fill inspection, as 
larger throughput can be achieved. For routine use either TDLASCO2 or a combination of TDLASCO2 and 
TDLASO2 should be considered. IMC may be helpful for replacing the sterility assessment of commercial 
drug products before release.
Aseptic processing is used to manufacture products that are intended to be sterile and ultimately injected to 
patients. The process is periodically simulated by filling microbial culture media (tryptic soy broth – TSB) instead 
of the drug product. This simulation is designated as a “media fill” and ensures the reliability and repeatability of 
aseptic processing1,2 as even in pharmaceutical clean room environment a diverse microbial community can be 
found3. In conventional media fill procedures, intact media-filled vials are incubated for 7 days at 20–25 °C and 
another 7 days at 30–35 °C4,5. After 7 and 14 days, microbial contamination of media filled units is assessed by an 
operator through a visual inspection (VI), searching for an increased media turbidity as well as modifications in 
the aspect of media. However, VI is limited by several drawbacks including high and repetitive workload, weak 
data integrity, assumptions on media turbidity that is prone to human error, and inefficient data collection6,7. 
Although these drawbacks ensure patient safety and good manufacturing practices (GMP), they are associated 
with costs. Also the long turnover time required by incubation and examination of media fills leads to busi-
ness risk regarding the sterility requirements if manufacturing has already resumed. Therefore, the establish-
ment of new, non-invasive, more efficient, objective and faster methods replacing the conventional visual media 
fill inspection is needed. In this paper tunable diode laser absorption spectroscopy (TDLAS), measuring gas 
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concentrations in vial headspaces, and isothermal micro-calorimetry (IMC), measuring metabolic heat produc-
tion of microorganisms, are investigated as alternative methodologies.
The development of spectroscopic measurement techniques in the near- and mid-infrared spectral region8–10 
has led to their extensive use in the pharmaceutical industry for e.g., the determination of trapped gas inside 
vials, the analysis of porosity in tablets and the control of freeze-drying processes11–13. Considering parenteral 
drug production, contamination by microbes from the environment is a constant threat during aseptic filling3. 
These microbes are mostly aerobic and thus the standard media fill incubation is performed in aerobic condi-
tions. Microorganisms using respiration as metabolic pathway consume oxygen and release carbon-dioxide (see 
equation 1). Non-invasive spectroscopic measurement techniques, such as TDLAS, can be used to detect growth 
related changes of O2 and CO2 concentrations in headspaces of sealed vials14. This provides insights on microbial 
contamination of media filled units. However, microbial fermentation can also occur and result in other end 
products such as lactic acid and alcohols (see equations 2 and 3). Nevertheless, many of these fermenters are not 
limited to their primary pathways and may therefore remain detectable by TDLAS. Still for some of those fer-
menters differences in cultivation medium composition (i.e., from different manufacturer, or different batches) 
might lead to use of metabolic pathway with little to no O2 consumption and CO2 production.
+ → + ∆ = −HRespiration C H O 6O 6CO 6H O 2804, 90kJ/mol (1)6 12 6 2 2 2
→ + ∆ = − .HEtOH fermentation C H O 2C H OH 2CO 68 92kJ/mol (2)6 12 6 2 5 2
→ ∆ = − .HLactic acid fermentation C H O 2CH CHOHCOOH 75 70kJ/mol (3)6 12 6 3
In addition, metabolic reactions resulting from microbial proliferation emit heat which can be quantified con-
tinuously and non-invasively by isothermal micro-calorimetry (IMC). IMC therefore detects enthalpy changes 
associated with the cell metabolism (see Δ H of equations 1–3) and has been used already to monitor microbial 
growth15–19.
Here TDLAS and IMC are evaluated and compared as possible alternatives to current inspection procedures 
for parenteral drugs, aiming at a high-throughput substitution of the visual media fill inspection. Parameters such 
as robustness, sensitivity (i.e., the proportion of false negative), sensibility (i.e., the instrumental detection limit 
in our conditions), time to detection and comparability are investigated for each method, using the fast-growing, 
metabolically versatile Bacillus subtilis and the lactic acid fermenter Streptococcus salivarius as model contami-
nants. These organisms have been chosen as they represent extremes in terms of O2 depletion and CO2 produc-
tion found in a preliminary screening. Growth measurements obtained using the different methods are compared 
using the Gompertz growth model20.
Results
To determine microbial growth of Streptococcus salivarius and Bacillus subtilis by TDLAS and IMC a threshold 
was defined by a 4σ confidence interval defined on unicolutated samples. Repeated measurements of sterile TSB 
samples on heat production and headspace change in CO2 and O2 concentration provided data on the biochemi-
cal processes occurring in the medium, influencing heat flow and gas levels (Fig. 1 - section 2.1).
For inoculated samples, the intersection of fitted growth curves with the respective threshold defined the time 
to detection (TtD) (section 2.2). In turn, the distributions of TtD allowed making assumptions on method robust-
ness, sensitivity, sensibility and comparability to visual inspection. In addition, an absolute TtD was determined 
for each organisms and method. Therefore worst-case fitting parameters of the Gompertz model (i.e., maximal 
λ (i.e., the longest lag phase) with smallest μ (lowest growth rate) and lowest Xmax (minimum gas concentration 
change or heat produced)) were combined in this model to create a worst-case growth curve. The intersection of 
this worst-case growth curve with the respective threshold determined absolute TtD (Fig. 2). In parallel to each 
TDLAS and IMC measurement vials were inspected visually on the increase in turbidity. In addition, optical 
density was measured to allow a comparison of this commonly used measure with TDLAS and IMC profiles 
(Table 1, Fig. 3).
Thresholds for gases concentration (TCO2, TO2), heat production (TH) and optical density (TOD).
In sterile TSB filled vials slight variations of oxygen and carbon-dioxide concentration were observed. Overall 82 
vials out of 84 (2 contaminated samples were rejected) filled with two TSB lots differing in age were used to inves-
tigate these fluctuations in vial headspace. From the 14′ 645 TDLAS measurements obtained, 2′ 460 data points 
(16.8%) were omitted due to non-normal distribution of the data series, hindering the use of the 4σ approach. 
Another 2′ 025 (13.8%) points below detection limit were removed. Based on the remaining data (69.4%) TCO2 and 
TO2 were determined. To define the IMC threshold for growth detection 24 vials filled with three TSB lots differ-ing in age were continuously measured. No vials or measurement points were rejected.
After 7 days TCO2 was defined at 0.366% and TO2 at 1.754%. TH was defined at 0.416J and TOD at 0.02 (Fig. 1).
Growth Profile and Parameter Analysis. The two microorganisms tested were detected by all methods 
used with robust and reproducible results across all the independent experimental runs (Fig. 3). However, TtD 
and number of false negative results varied slightly (Table 1). Lag phase duration, growth rate and maximal con-
centration/heat/biomass reached could be calculated for all organisms investigated and methods used. Bacillus 
subtilis showed higher reproducibility in λ and μ and reached higher changes in gas concentration and heat 
production compared to S. salivarius (Table 1). Differences in heat production and gas concentration patterns 
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Figure 1. Plot (A) describes the inverted O2 baseline development. It was determined by calculating the 
difference of O2max − O2 for all measurement series. The red and blue dots describe the upper and lower 
4σ confidence intervals. Plot (B) describes the CO2 baseline development. The red dots show the upper 4σ 
confidence intervals whereby the blue dots stand for the physical limits being equal to zero. The CO2 and O2 
data is based on an old (grey) and a new (black) TSB lot being measured during at least 14 days. Plot (C) shows 
the heat emission during 145 hours of 24 blank TSB samples of three TSB lots differing in age. The super-
ordinated red curve shows the 4σ confidence interval. Its maximum peak defines the threshold parameter for 
IMC.
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between the 2 microorganisms is mainly attributed to the differences in S. salivarius and B. subtilis metabolism. 
Three TDLAS S. salivarius vials were not included due to secondary contamination.
TtD, the intersection between threshold and curve considered, for single curves of TDLASO2, TDLASCO2, OD595 and IMC were determined. TDLAS, OD595 and IMC measurements detected all B. subtilis inoculated rep-
licates between 28.3 h and 57.0 h. S. salivarius samples became positive between 40.5 h and 70.7 h. However, 10% 
of the S. salivarius oxygen profiles did not reach the threshold, meaning that less than 1.754% O2 was consumed 
after 7 days (Table 1). This emphasizes that the sensitivity of TDLASO2 remained rather high as values were 100% and 90% for B. subtilis and S. salivarius respectively. Also, this supports the use of S. salivarius as worst-case sce-
nario microbe.
Absolute TtD was modeled by using worst case parameters obtained for each organism with TDLASO2, 
TDLASCO2 and IMC data. This time point was defined by the intersection of Blow (computed using largest λ , min-imal μ and smallest Xmax – see section 5.4) with the respective threshold and was comprised between 45.9 and 
76 hours (Table 1). The absolute TtD values showed that IMC outperformed TDLAS but that VI remained the 
fastest detection method. TtD for OD595 (used only for comparison purposes) was comparable to visual TtD and 
in most cases faster. However VI is performed only after day 7.
Discussion
TDLAS and IMC were evaluated for non-invasive microbial growth-detection in intact glass vials aiming at a 
rapid and automated inspection of media-filled units. Both methods proved to be technologies capable of detect-
ing growth of Bacillus subtilis and Streptococcus salivarius in sealed vials. The results were robust and showed 
good reproducibility. In addition, TDLAS and IMC are comparable to the conventional visual media fill inspec-
tion performed after 7 days in terms of detection speed. However, 10% of all S. salivarius vials did not reach the 
set threshold (false negatives). This phenomenon was mainly linked with the auto-oxidative characteristic of 
TSB which affected the threshold chosen and resulted in a 4.8 times higher oxygen threshold compared to CO2. 
Furthermore, the metabolism from S. salivarius led to relatively low O2 consumption and CO2 production, which 
might indicate the use of alternative pathways. As a consequence, oxygen depletion in vial headspaces was insuf-
ficient to reach the threshold. Considering reproducibility and robustness, different sources of variations exist. 
The origin of variations between runs of the same microorganism could be due to the different TSB lot used as 
this medium is not defined and variations in composition exist between batches and between manufacturers. The 
low CFU count used for the inoculation might be an additional source of errors as very little variation in the CFU 
number or the viability of the cells might have affected their growth. Finally the tendency of streptococci for self 
aggregation might also have influenced the reproducibility for this organism as inoculum size might have varied.
The sensibility for each method with respect to detection speed of microbial growth was clearly demonstrated 
(Fig. 3). With an inoculum < 10 CFU per vial IMC outperformed TDLAS in terms of TtD. Still, it might be even 
optimized further. The calorimeter used in our experiment is an instrument of the mid-range performance class, 
TDLASO2 (min–max) 
(TO2 = 1.754%)
TDLASCO2 (min-max) 
(TCO2 = 0.366%)
IMCHEAT (min-max) 
(TH = 0.416J)
OD595 [remaining 
values] (TOD = 0.02) Visual (all vials turbid)
Bacillus subtilis
n 60 60 18 3 60
TtD (time to detection) [h] 
(intersection of Blow with 
threshold)
58.0 (36.7–57.0) 52.6 (35.7–54.4) 45.9 (34.4–47.2) 33.6 [28.3; 31.8] 45.0 (24.5–45.0)
λ (lag phase) [h] 39.85 (34.59–55.38) 45.65 (41.08–58.37) 40.58 (37.80–48.45) 36.40 (33.78–37.58) n.a.
μ (growth rate) [% or J/h] 0.46 (0.35–0.61) 0.46 (0.38–0.58) 0.40 (0.30–0.63) 0.06 (0.05–0.06) n.a.
Xmax (Cmax/Heat) [% or J] 19.89 (19.35–20.93) 17.93 (17.13–18.69) 12.79 (11.11–13.98) 1.55 (1.44–1.57) n.a.
Streptococcus salivarius
n 57 57 22 3 57
TtD (time to detection) [h] 
(intersection of Blow with 
threshold)
ND (51.0–ND) 76.0 (45.2–70.7) 71.2 (44.3–69.3) 51.9 [40.5; 50.0] 61.0 (37.3–61.0)
λ (lag phase) [h] 34.74 (17.75–57.20) 48.14 (40.12–68.96) 46.67 (42.20–65.74) 50.78 (41.55–52.40) n.a.
μ (growth rate)[ [% or J/h] 0.06 (0.017–0.1) 0.15 (0.05–0.33) 0.12 (0.08–0.20) 0.23 (0.08–0.57) n.a.
Xmax (Cmax/heat) [% or J] 2.12 (1.41–3.4) 2.22 (1.13–3.14) 2.37 (1.79–2.90) 1.25 (0.78–1.75) n.a.
Table 1.  Time to detection, lag phase, growth factor and reached Xmax for B. subtilis and S. salivarius, 
related to methods under investigation are presented. General TtD is expressed as number of hours where the 
lower growth boundary (Blow) crosses To2, Tco2 or TH. In brackets the TtD distribution of each single replicate. ND stands for not detected and is a direct measure for sensitivity as related to false negative results. Lag phase 
(λ ), growth factor (μ ) and maximal value reached (Xmax) are demonstrated in form of median and range (in 
brackets). Unit for λ is hours, for Xmax percentage, whereby μ goes without unit. Parameters were received from 
applying the Gompertz model in R (“grofit” package) on each individual growth profile. Measured OD595 values 
are of descriptive nature and used as reference method to show meaningfulness of results obtained for TDLAS 
and IMC. As a substantial number of OD595 samples was investigated it would lead to misconceptions in 
statistics if used differently. The single number is the maximal value of all three OD595 measurement runs. In 
brackets the remaining values.
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originally designed for studying cement curing21. The 2 ml vial format did not perfectly fit in the calorimeter’s 
sample holder and results with even higher quality would have been obtained with samples of higher heat capac-
ity and conductivity (i.e., 15–20 ml vials). The setup with a 2 ml vial inserted in a 20 ml plastic vial fitting into 
the IMC sample receiver probably resulted in additional measurement noise (i.e., increased limit of detection). 
Overall, there are many possibilities to further improve the IMC setup and to decrease the threshold thus result-
ing in lower TtD. The TDLAS setup had also some drawbacks. The short diameter of the 2 ml format results in a 
shorter measurement path than compared to containers of larger size. This leads to analytical fluctuations12 and 
causes additional measurement errors. An improvement of measurement precision could be reached by using 
containers with larger diameters. However, the use of larger formats is also linked with bigger headspaces that 
might require more O2 to be consumed or CO2 to be produced to reach a similar gas concentration level. Thus, in 
contrast to IMC that measures heat produced in the whole vial independently of the vial format, TDLAS might be 
less appropriate for larger formats when fermenting microorganisms are considered as the larger filling volume is 
compensated by a larger headspace.
From an operational perspective, the visual inspection of a media fill assessment is comparable to the alterna-
tive methods investigated if growth detection occurs before the first inspection step. Indeed, first visual inspection 
activities are performed after 7 days (168 hours), meaning that despite variations in TtD all methods would have 
detected growth of B. subtilis or S. salivarius before the standard visual inspection.
However, it was observed that within the first 7 days OD595 delivered best performance in detection speed 
whereby IMC and TDLAS were slower than the visual inspection. Despite OD595’s advantage in TtD its use in 
replacing the visual read-out of all vials (ca 10, 000 per media fill) is not an option as sediments of growing micro-
organisms can fall to the vial bottom or form micro colonies. In this context, a shaking or vortexing step would 
be difficult to implement in an automated production line. Alternatively, in some cases such measurements might 
be impaired by autolysis as well (Fig. 3B,D). This would promote the risk for obtaining false negative results 
and complicate automated vial inspection. In addition, further applications of optical density measurements to 
poorly soluble drugs, provided as suspension or dispersion, is not possible due to the optical characteristic of such 
products.
Before a substitution of visual media fill read-out can be realized by either IMC or TDLAS, additional exper-
iments are necessary to create a reliable decision base. Besides evaluating the impact on precision by using larger 
vial formats such studies should incorporate a specificity analysis by looking at a broader range of organisms with 
different metabolic pathways that are known contaminants in pharmaceutical drug manufacturing. Depending 
on the method and format the threshold will require a reassessment to provide an optimal specificity combined 
with a short TtD. Furthermore, microorganisms in drug manufacturing facilities are likely exposed to a lack 
of nutrition, heat shocks, hyperacidity, remnants of antibiotics, disinfectants, or other external influences. This 
results in cellular stress and in an extended lag phase, having a direct impact on TtD. Within this context it 
might be valuable to also include a growth development analysis of stressed organisms in future studies. Vial 
non-integrity is another issue that needs to be investigated as an exchange of gases between headspace and 
atmosphere could considerably impact the results. Indeed the false negative rate and TtD might be increased by 
impaired vial integrity.
When dealing with such technologies it is crucial to know what can be achieved, taking into account advan-
tages and drawbacks of each method individually (Table 2).
Besides IMC’s benefit of short TtD, the measurements are easy to handle and provide continuous real-time 
data15. Measuring heat-flow continuously can be an advantage as it allows getting some additional insights on 
metabolism of the potential contaminants, but also be a drawback since the throughput is limited to the number 
of measurement slots. In addition, metabolic heat emission is a temporary limited process, meaning that once 
growth terminates IMC cannot retrospectively assess bacterial contamination22. Growth of B. subtilis and S. sali-
varius stops after less than 150 hours (6.25 days), whereby the first inspection is planned at the 7th day of 
Figure 2. Example of an inverse O2 growth profile of Bacillus subtilis. The inverted profile was determined by 
calculating the difference of O2max − O2 out of a collection of 60 inoculated vials. The red s-shaped curves 
illustrate upper (Bup) and lower (Blow) boundaries of growth associated oxygen consumption. The individual 
blue profile is the averaged fit of the entire sample collection. The dashed vertical line illustrates the time needed 
to detect visually 100% of all inoculated samples. The solid vertical line defines the absolute TtD for Bacillus 
subtilis based on oxygen measurements. The red dot marks the intersection of the lower boundary and the 
threshold TO2.
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incubation. This calls for a method where metabolic activities remain detectable independently of the moment of 
inspection. O2 and CO2 changes in intact vial headspaces remain rather constant after bacterial growth took place. 
Because of this and the characteristic of enabling a high-throughput read-out, the individual TDLASCO2 system 
(or in combination with TDLASO2) is recommended here as the method of choice for automated inspection of media fills. Nevertheless, IMC remains of interest in areas where continuous measurements are demanded with 
lower throughput requirements, e.g. sterility control of commercial drug products before release. Finally the 
combination of IMC and TDLAS for CO2 and O2 measurement allows to perform metabolic studies focusing on 
different pathways or microorganisms in which this pathways would have been altered by mutagenesis. Such 
studies are referred to as calorespirometric studies and could be of much use oustide the field of sterility testing 
for example in assessing product formation23–25.
Conclusions
The non-invasive application together with an accurate detection of bacterial growth render IMC and TDLAS as 
valuable tools for inspecting media-filled units and potentially commercial drug product as well. TDLASCO2 and IMC were capable to detect growth of B. subtilis and S. salivarius reliably within much less than 7 days. False neg-
ative results were observed for TDLASO2 which makes its single use without parallel TDLASCO2 measurements questionable.
Although the verification of microbial growth by human visual inspection remained faster than TDLAS and 
IMC, its replacement stays a beneficial intention as augmented inspection objectivity, higher-throughput via auto-
mation, increased data integrity and efficient data collection can be realized. Due to the fact that automated vial 
handling for IMC is more difficult to achieve and less advanced than for TDLAS, the latter technique is suggested 
as substitution for visual media fill inspection despite IMC shorter TtD for growth detection. More potential is 
attributed to IMC in replacing the sterility assessment of commercial drug products before release. Nevertheless, 
further studies covering a wider range of microorganisms and formats are required to decide on whether or not 
IMC and/or TDLAS are appropriate method for a safer and more efficient sterility assessment procedures.
Materials and Methods
Microorganisms and culture conditions. Bacillus species are of obligate aerobe or facultative anaerobe, 
sporulating, gram-positive, rod-shaped nature and, appearing frequently in pharmaceutical environments3. They 
are often used in validation studies of microbial methods. In our study, B. subtilis (ATCC 6633) was obtained as 
bio balls® (Thermo Scientific) validated to a cell count of < 100 CFU and was routinely maintained aerobically at 
30 °C on tryptic soy agar (TSA).
Streptococcus salivarius (ATCC 7073; DSM 20560) is a facultative-anaerobe, gram-positive, catalase- and 
oxidase-negative bacteria that belongs to the group of lactic acid fermenters. Indeed it produces mostly lactate 
from glucose, therefore affecting minimally CO2 and O2 concentrations. The organism was provided by DSMZ as 
cryo-culture and maintained aerobically at 37 °C on TSA.
Preparation of experimental containers and bacterial suspensions. For all experiments 2 ml trans-
parent, sterile tubed glass vials (Schott AG, Germany) were used. After manual filling of 1 ml TSB under aseptic 
conditions, containers were stoppered and capped with sterilized material and stored at 20–25 °C. As headspace 
gas concentrations are known to vary over time due to auto-oxidative processes in TSB14, each container was 
flushed for six seconds with sterile air at a flow rate of ~0.25 l/min before inoculation. This “headspace flushing” 
was intended to simulate the conditions prevailing in newly produced units.
Inoculation through the self-sealing rubber stopper was performed using a syringe filled with 0.1 ml bacterial 
suspension containing < 100 CFU/ml (i.e., < 10 CFU per vial). Suspensions including B. subtilis were prepared 
by dissolving a bio ball® in Remel buffer, followed by diluting this suspension 1:10 times. S. salivarius was cul-
tured twice for 48 h at 37 °C in TSB. The second culture was diluted by a factor of 1:10−6 in buffered sodium 
chloride-peptone bouillon and, with the addition of 15% glycerin, stored at − 83 °C. The appropriate cell count for 
0.1 ml suspension was determined by standard dilution series on agar plates.
Experimental Design. Devices and Settings. Single pass bench-top TDLA Spectrometers (Lighthouse 
Instruments, Charlottesville, VA) were used. O2 and CO2 concentrations were determined at 762 nm and 2000 nm 
respectively. Before each experiment the devices were preheated for at least 30 minutes. A two-point calibration 
with certified standards (0%, 20%) provided by the manufacturer was performed before each measurement series. 
Advantages/Disadvantages TDLAS IMC VI
Objective inspection (quantitative 
results) + + + + − − 
High throughput rate + + + − − 
Efficient and automatic data collection + + + + − − 
Measurement Sensibility/Speed in 
detection + + + + 
Non-invasive inspection + + + + + + 
Table 2.  Describes and compares advantages and drawback of TDLAS, IMC and visual inspection.  
+ + fully applicable, + partly applicable, − partly not applicable, − − not applicable.
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The measurement series were initiated after the measurement cap has been flooded with nitrogen (4 l/min) and 
the repeated analysis of standards with known concentration (4% and 8% respectively) was within specification 
limits (i.e., ± 0.25% deviation). Standards used were made of the same glass as the experimental containers to keep 
the signal to noise ratio minimal. In parallel to each TDLAS measurement (lasting 5 seconds), a spectrophotome-
ter (Bio Photometer plus, Eppendorf) was used to measure the optical density at 595 nm (OD595). OD595 data was 
gathered to allow comparison of this commonly used measure with TDLAS and IMC.
As initial experiments with TDLAS showed that the exponential growth phase of the organisms investigated 
had already stopped within less than hundred hours, it was decided to perform IMC experiments at 20°–25 °C 
only. For that, an eight-channel TamAir calorimeter (Waters/TA, Delaware, USA) was used. Once the eight sam-
ples were placed in the calorimeter, heat produced was recorded by the thermoelectric module placed between 
the samples and the heat-sink15. Reference vials used were identical to the experimental containers, but filled with 
sterile water thus providing an inert reference of similar heat capacity and conductivity. All 2 ml containers were 
additionally placed in a 20 ml plastic vial fitting the IMC sample receiver.
Baseline and Threshold Determination. To determine the threshold for microbial growth detection, sterile TSB 
samples were repeatedly measured for their heat production and headspace change in CO2 and O2 concentration. 
For TDLAS two sets of 42 vials were filled with new (0 days) and old (56 days) TSB. Their CO2 and O2 concentra-
tion was measured every 24 hours for at least 14 days. Each vial was analyzed 5 times to account for measurement 
variations26. The thresholds were defined after 7 and 14 days in order to be consistent with established inspection 
intervals.
To define the IMC threshold three sets of 8 vials containing TSB (3 up to 135 days in age) were measured 
continuously during 145 hours. This was considered as a sufficient time as the heat flow of all inoculated samples 
turned back to baseline after less than 100 hours.
For the definition of the OD595 threshold 100 measurements were performed with sterile TSB, filled in a 
cuvette.
Detection of bacterial growth by the different methods. For TDLAS measurements, three sets of TSB filled vials 
were prepared for both organisms. Each set included 20 inoculated vials and TSB lots varying from 1 day to 31 
days in age. To reproduce the conditions of a real media fill, containers were incubated at 20–25 °C during 7 
days and another 7 days at 30–35 °C. Before each measurement, vials were taken out of the incubator and were 
inspected visually by a qualified person for increased turbidity. After the 5 seconds lasting TDLAS measurement 
the containers were rapidly returned to the incubator. Measurements were taken every four hours during the 
growth phase.
Figure 3. Fitted gas and thermogenic profiles together with raw data of OD595 measurements for B. subtilis 
and S. salivarius. Plots (A,B) illustrate plotted data for Bacillus subtilis, (C,D) plotted data for Streptococcus 
salivarius. The development of CO2 (dotted) and O2 (solid) profiles in fitted form are visualized in graph (A,C) 
for both organisms, whereby the color red describes the development of the first run, blue the second run and 
green the third run, including 20 samples each. Plot (B,D) visualize fitted heat (solid) of three runs with TSB 
differing in age and raw data of various OD595 measurements (Δ ) over time. Considering the heat and gas 
profiles in more detail it becomes obvious that despite small deviations in profile development reproducibility 
and robustness is given for TDLAS and IMC measurements.
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Optical density (OD595) measurements were performed in parallel to the TDLAS measurements with vials 
from an additional set prepared identically. Their content was transferred into transparent plastic cuvettes and 
then measured on absorption at 595 nm. Blank samples were determined in TSB.
IMC experiments used three sets of TSB filled vials for both organisms. Each set included at least 6 inoculated 
vials. Measurements were taken continuously and resampled to achieve an effective sampling rate of 1 data point 
per minute.
All evaluated samples showing differences from typical and expected growth profiles of the organism under 
investigation, were sent to the PCR identification lab and omitted in case of non-conformity.
Data Analysis. The data analysis described below was performed using the R statistical software27 in combi-
nation with the grofit package28.
Analyzing Threshold Data for CO2, O2, Heat, OD595, and VI. Each TDLAS measurement series (i.e., for each 
different time point) was checked on normality using the Shapiro-Wilk test. Non-normally distributed datasets, 
values equal to zero (i.e., below physical detection limit) and contaminated replicates were omitted from the 
analysis. The threshold parameters were estimated using a 4σ approach where the probability of receiving false 
positive results is around 0.006%. For the purpose of this study we choose to use 4σ instead of 3σ (commonly used 
in industry settings) to ensure safety of our results. The maximum value of mean plus four fold standard deviation 
was taken for the data gathered during the periods of 0 to 7 days and 7 to 14 days (see Fig. 1A,B) and considered 
as the threshold. The threshold parameter for emitted heat was defined by applying the 4σ approach to collected 
data and selecting the maximum of the 4σ confidence interval (Fig. 1C). The OD595 threshold was defined by the 
rounded 4σ confidence interval and the VI threshold by the perception of visible changes in turbidity of 100% of 
the inoculated samples.
Growth Profile Analysis and Data Transformation. Typical microbial growth appears in form of ascending sig-
moidal curves (i.e., s-shaped curve). From a microbiology point of view, such curves can be described mathemat-
ically by 3 main parameters: lag phase duration (λ ), exponential growth factor (μ ) and maximal value reached 
(Xmax). Those parameters can easily be estimated for TDLAS, OD595 and IMC curves by using the Gompertz 
model, Oxygen concentration profiles are inverted growth curves by nature as they reflect oxygen consumption. 
To allow the use of the Gompertz model the oxygen profiles were converted to conventional s-shaped curves. 
For this O2 depletion was described as O2max − O2. Heat flow [in μ W (μ J/s)] over time is usually composed of 
one single (or several) peak(s). Therefore, the Gompertz model was fitted on the integrated profile (i.e., the heat 
[J] over time curve), resulting in an s-shaped curve considered as a good approximation for microbial growth15. 
Additionally, OD595 curves are hill-shaped as some microorganisms might undergo lysis. To neglect this effect in 
the analysis the OD595 values were considered to be constant once they had reached the maximum, which allowed 
an adequate modelling of the OD595 curve.
All those transformations enabled to compare directly all the curves generated by IMC, TDLAS and OD595.
Determination of Time to Detection (TtD). Once the thresholds for CO2 (TCO2), O2 (TO2), Heat (TH) and OD595 
(TOD) were determined, each TDLAS, IMC and OD595 profile was described by λ , μ and Xmax and the intersection 
with the respective threshold identified. For TDLAS and IMC a clear definition of lower (and upper) growth 
boundaries was needed to account for biological variation in growth and to determine a representative 
organism-related absolute TtD (see Fig. 2). Lower growth boundaries (Blow) were defined by combining maximal 
λ with smallest μ and lowest Xmax in the Gompertz model. The intersection of Blow and the respective threshold 
determined the absolute TtD that CO2, O2 or heat measurements needed to detect either S. salivarius or B. subtilis 
(Fig. 3). Upper boundaries (Bup) were defined through combining minimal λ with highest μ and largest Xmax in 
the Gompertz model. The definition of Blow and Bup imposes a measure for estimating total growth distribution. 
TtD for VI was defined as point where 100% of all inoculated samples turned turbid and is of qualitative nature.
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A B S T R A C T
Tunable diode laser absorption spectroscopy (TDLAS) was evaluated on its potential to detect bacterial growth
of contaminated media ﬁll vials. The target was a replacement/ automation of the traditional visual media ﬁll
inspection. TDLAS was used to determine non-invasively O2 and/or CO2 changes in headspaces of such vials
being induced by metabolically active microorganisms. Four diﬀerent vial formats, 34 microorganisms
(inoculation volume < 10 cells) and two diﬀerent media (TSB/FTM) were tested. Applying parallel CO2 and
O2 headspace measurements all format-organism combinations were detected within < 11 days reliably with
reproducible results. False negatives were exclusively observed for samples that were intentionally breached
with syringes of 0.3 mm in diameter. Overall it was shown that TDLAS functionality for a replacement of the
visual media ﬁll inspection is given and that investing in further validation and implementation studies is
valuable. Nevertheless, some small but vincible challenges remain to have this technology in practical use.
1. Introduction
Aseptic manufacturing is periodically evaluated by aseptic process
simulations using microbiological culture media substituting the sterile
product bulk-solution (i.e. typically tryptic soy broth [TSB] is used for
aerobic micro-organisms, less frequently ﬂuid Thioglycollate [FTM] for
(facultative) anaerobic strains and ﬁnally vegetable peptone broth
[VPB] where there is concern about prions). This simulation is
designated as “media ﬁll” and provides supportive data on the
capability and reliability of aseptic processing activities. It is also used
to qualify sterile working-techniques of aseptic cleanroom operators. In
addition, media ﬁlls may identify potential weaknesses with regard to
microbiological contamination during production line modiﬁcation and
qualiﬁcation or during investigations of microbiological deviations (e.g.
positive sterility test). The industrial standard in analyzing media ﬁlled
units is the visual inspection (VI) performed by qualiﬁed human
operators who check for turbidity increase and abnormality in the
aspect of media [1,2]. Regulations and guidelines [3,4] specify that
such inspections must be performed at least once after no less than 14
days with media ﬁlled units that have been incubated for minimally 7
days at 20–25 °C and another 7 days at 30–35 °C. Several manufac-
turers perform an intermediate VI after the ﬁrst incubation period
lasting 7 days since fast growing microorganisms would have grown
and become visible by then. VI ensures good manufacturing practices
(GMP) and contributes to a high standard of patient safety but is
associated with high workload related to manual vial and data
handling. Furthermore, the detection of medium turbidity by human
eye may be prone to error, and requires regular qualiﬁcation of
operators. All this results in unnecessary cost.
Alternative non-invasive methods with the potential for media ﬁll
inspection automation could reduce cost, increase process eﬃciency,
and decrease the risk of false negative media ﬁll units (i.e. not detecting
microbial growth) by eliminating the human factor. First advance-
ments and proposals in this ﬁeld were recently made [5,6]. Tunable
Diode Laser Absorption Spectroscopy (TDLAS) was evaluated in
determining non-invasively microbial growth related O2 and CO2
concentration changes in sealed (non-breached) media ﬁll vial head-
spaces. Microorganisms in TSB were tested on their CO2 emission and
O2 consumption. In addition, TDLAS data was compared to VI, optical
density measurements and isothermal micro-calorimetry (IMC) to
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conclude on the sensibility of TDLAS and assure that gathered O2/CO2
data was growth related. Tested microorganisms were detected without
observing false negatives and results were reproducible when using a
combined O2 and CO2 TDLAS measurement. Method development
studies for TDLAS including the analysis of a wider range of micro-
organisms in 2 diﬀerent media, stressed microbial cells (having
normally a prolonged lag phase), additional format sizes and breached
containers (headspace equilibration with environment leading to false
negative results) are outlined in this work. The ﬁndings shall provide
the basis for method implementation and validation in sterile drug
product manufacturing.
2. Materials and methods
2.1. Basic study design
Two production sites dealing daily with aseptic production and
media ﬁll inspection were involved in the study (site X: F. Hoﬀmann-
La Roche (Wurmisweg, 4303 Kaiseraugst, Switzerland), and site Y:
Novartis (Schaﬀhauserstrasse 101, 4332 Stein, Switzerland)). Media
ﬁll incubation times were set to 7 days at 20–25 °C and 7 days at 30–
35 °C (overall incubation time > 336 h) and kept during the experiment
to allow a comparison of growth detection by VI and TDLAS.
Next to the standard pharmacopoeia (PhEur) reference strains,
several plant isolates (i.e., local isolates) from site X and Y (selection
based on relative occurrence during routine monitoring in cleanrooms,
unpublished internal sources), worst-case organisms (i.e., organisms
with little metabolic activity, known long lag phase) and microorgan-
isms with homofermenting characteristics (reduced O2/CO2 consump-
tion/release) were included in this study (see Table 1 for strain details).
Both sites used benchtop TDLAS analyzers (Lighthouse
Instruments, Charlottesville) with integrated single pass laser beams
able to determine O2 (λ=762 nm) and CO2 (λ=2000 nm) concentra-
tions respectively. Prior to use analyzers were warmed-up for at least
30 min and then calibrated with attested standards (20%, 0% of the
respective format) supplied by the manufacturer. Standards were made
of the same glass as experimental containers to keep measurement
noise minimal. The experiments started as soon as the measurement
chamber was ﬂushed with nitrogen (4 l/min) and the analysis of O2/
CO2 reference standards (4%, 8%) was inside limits of deﬁned
speciﬁcation ( ± 0.25%).
3. Preparation of working suspensions
Despite small site speciﬁc diﬀerences in preparing the microbial
working suspension, the main steps were identical. Both sites acquired
the PhEur organisms from ThermoFisher Scientiﬁc in form of lyophi-
lized cultures adjusted to an approximate cell count of < 100 colony
forming units (CFU) per 0.1 ml. Fungi (yeast and mold), homo-
fermenting, aerobic and anaerobic microorganisms were either ob-
tained from the site internal microbial strain collection (plant isolates)
or from DSMZ (Deutsche Sammlung von Mikroorganismen und
Zellkulturen). Plant isolates and DSMZ strains were cultured twice at
30–37 °C in tryptic soy broth (or blood agar) to obtain suspensions
with unstressed and viable organisms. By using 0.2 ml of these
suspensions their cell-density was determined on appropriate media
(tryptic soy agar, angular agar or blood agar). After cultivation the
suspensions were diluted in sodium chloride-peptone buﬀer and
enriched with 15% glycerin to obtain an appropriate inoculum size
(working suspension: site X < 10 CFU in 0.1 ml; site Y < 20 CFU in
0.1 ml) and stored at less than −80 °C. The working suspensions of the
eight PhEur organisms were created by dissolving the lyophilisates in
Remel buﬀer being followed by a dilution (1:10) in sterile water
according the desired CFU count. In addition site Y created suspen-
sions of heat stressed microorganisms (see Tables 1, 2). The suspen-
sions were exposed to a water bath (T=50–70 °C) during maximally 1–
2 min, depending on the test microorganism. An additional experiment
for Corynebacterium afermentans was executed by adding 0.1% of the
detergent Tween80 to TSB media, acting as growth stimulant by
increasing the lipophilicity of TSB [7].
3.1. Sample preparation and testing
At site X experimental media ﬁlled containers were either prepared
manually (manual ﬁlling, stoppering and capping under aseptic con-
ditions), or directly taken from inspected media ﬁll batches. As gas
concentrations in vial headspaces were known to change over time due
to media related oxidation processes [5], the headspace of each sample
unit was ﬂushed prior inoculation with sterile compressed air until
CO2/O2 concentrations were comparable to those in atmospheric air.
This “headspace ﬂushing” was intended to simulate the conditions
prevailing in newly produced media ﬁll units. Experimental containers
of site Y were prepared comparably. Filling volumes amounted for FTM
(ﬂuid thioglycollate media) ﬁlled units to 20% and for TSB ﬁlled units
to 35–60% of the respective format capacity. Filling levels were deﬁned
according internal standards following the regulatory requirement that
all inner vial surfaces get in contact with media when units are moved
[8].
Samples were then inoculated by injecting 0.1 ml of bacterial
suspension through the self-sealing rubber stopper using a syringe
(Microlance BD, 0.8 mm in diameter). Site X preparations were
incubated for 7 days at 20–25 °C and for another 7 days at 30–
35 °C. CO2 and O2 measurements were performed every 12 ± 2 h until
changes in headspace concentrations remained minimal. After this
time-point the measurement interval was increased to 24–48 h. Each
organism and format was evaluated by 10 inoculated replicates. At site
Y samples were incubated for 7 days at 20–25 °C and 10 days at 30–
35 °C and mainly tested on CO2 production. Besides start- and end-
point measurements at least 3 additional CO2 measurements were
performed per week. The sample size per organism consisted of a total
of 2 independent test runs with minimally 3 independent replicates. At
every time point of a TDLAS measurement the visual inspection was
performed in parallel to check for an increase in media turbidity.
Detection thresholds for each format and media combination were
needed to identify the time point of growth detection. Medium induces
changes in vial headspaces which are related to TSB auto-oxidation and
CO2 degassing eﬀects [5,9]. Site X evaluated 42 blank 2 ml, 20 ml and
2×50 ml (TSB media from diﬀerent producers) TSB vials for CO2 and
O2 concentration change in the vial headspace every day (see Fig. 1).
Their ﬁlling volumes were identical to those mentioned before. At site
Y, 50 blank 10 ml vials ﬁlled with 2 ml TSB and 20 blank 10 ml vials
ﬁlled with 6 ml FTM were used to determine every 3–4 days the
respective media induced variation in CO2 concentration (see Fig. 2).
The age of media was between 1 and 120 days and originated either
from Merck Millipore (50 ml vials), Siﬁn (10 ml vials), Becton
Dickinson & Company (2 ml and 20 ml vials) or Oxoid (10 ml FTM
vials) (see Table 3).
4. Design of leakage study
CO2 and O2 headspace concentrations were analyzed in intention-
ally breached vials to evaluate if growth detection remained possible
over 14 days. The aim was to assess if leakage related O2 inﬂow or CO2
escape altered headspace concentrations exposed to microbial activity
strong enough to produce false negative results. Samples were pre-
pared and tested as described above but punctured through the gum
stopper using a stainless steel needle of ~0.25 mm inner diameter
imitating a worst case leakage. Site X used ten TSB ﬁlled 2 ml, 20 ml
and 50 ml vials inoculated with the respective organism and tested
their CO2 and O2 concentrations over time. Site Y used per (stressed)
organism at least 15 replicates and investigated their CO2 proﬁles in
10 ml TSB/FTM ﬁlled vials (Table 2). Microorganisms in this study
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Table 1
Microorganisms and formats tested on their respective CO2/O2 concentrations during 14 days at the respective site. Applied stress (exposure to heat) and media used are also indicated.
PhEur Organisms Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Bacillus subtilis, X, Y CO2 CO2 CO2 CO2 No TSB
(ATCC 6633) O2 O2 O2
Staphylococcus aureus, X, Y CO2 CO2 CO2 CO2 No TSB
(ATCC 6538) O2 O2 O2
Salmonella typhimurium, X CO2 – CO2 CO2 No TSB
(ATCC 14028) O2 O2 O2
Escherichia coli, X, Y CO2 CO2 CO2 CO2 No TSB
(ATCC 8739) O2 O2 O2
Candida albicans, X, Y CO2 CO2 CO2 CO2 No TSB
(ATCC 10231) O2 O2 O2
Aspergillus brasiliensis, X, Y CO2 CO2 CO2 CO2 No TSB
(ATCC 16404) O2 O2 O2
Pseudomonas aeruginosa, X, Y CO2 CO2 CO2 CO2 No TSB
(ATCC 9027) O2 O2 O2
Clostridium sporogenes, Y – CO2 – – No FTM
(ATCC 11437)
Aerobic Isolates Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Bacillus cereus X CO2 – CO2 CO2 No TSB
(plant isolate) O2 O2 O2
Bacillus clausii Y – CO2 – – No TSB
(plant isolate)
Micrococcus luteus X, Y CO2 CO2 CO2 CO2 No, Yes TSB
(plant isolate) O2 O2 O2
Staphylococcus warnerii Y – CO2 – – No TSB
(plant isolate)
Pseudomonas stutzeri Y – CO2 – – No TSB
(plant isolate)
Staphylococcus epi-dermidis (plant isolate) Y CO2 CO2 CO2 CO2 No TSB
O2 O2 O2
Bacillus iridiensis Y – CO2 – – No TSB
(plant isolate)
Staphylococcus capitis Y – CO2 – – No TSB
(plant isolate)
C. afermentans + 0.1% Tween80 (DSM 44280) Y – CO2 – – Yes TSB
O2
Methylobacterium radio-tolerans (DSM 1819) X, Y CO2 CO2 CO2 CO2 No, Yes TSB
O2 O2 O2
Kokuria palustris Y – CO2 – – No TSB
(plant isolate)
Corynebacterium afer-mentans (DSM 44280) X, Y CO2 CO2 CO2 CO2 No, Yes TSB
O2 O2 O2
Homofermenters Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Enterococcus faecalis X, Y CO2 CO2 CO2 CO2 No, Yes TSB, FTM
(DSM 20478) O2 O2 O2
Lactococcus lactis X CO2 – CO2 CO2 No TSB
(DSM 20481) O2 O2 O2
(continued on next page)
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Table 1 (continued)
PhEur Organisms Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Streptococcus salivarius X CO2 – CO2 CO2 No TSB
(DSM 20560) O2 O2 O2
Streptococcus pyogenes X CO2 – CO2 CO2 No TSB
(DSM 20565) O2 O2 O2
Lactobacillus delbrueckii X CO2 – CO2 CO2 No TSB
(DSM 20072) O2 O2 O2
Anaerobic Isolates Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Propionibacterium acnes X, Y CO2 CO2 CO2 CO2 No, Yes TSB, FTM
(plant isolate) O2 O2 O2
Bacteroides vulgaris Y – CO2 – – No FTM
(DSM 1447)
Fungi Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Cladosporium sp. X CO2 – CO2 CO2 No TSB
(plant isolate) O2 O2 O2
Penicillium sp. X, Y CO2 CO2 CO2 CO2 No, Yes TSB
(plant isolate) O2 O2 O2
Penicillium chrysogenum Y – CO2 – – Yes TSB
(ATCC 10106)
Penicillium olsonii Y – CO2 – – No TSB
(plant isolate)
Aspergillus ustus Y – CO2 – – No TSB
(plant isolate)
Aspergillus sp. Y – CO2 – – No TSB
(plant isolate)
Leptospaerulina chartarum (plant isolate) Y – CO2 – – No TSB
Table 2
Leaking media fill vial formats were prepared, inoculated with different microorganisms and tested on their respective CO2/O2 concentrations during 14 days at the respective site.
Applied stress (exposure to heat) and media used are also indicated.
Organisms used in Leakage study Site (X/Y) 2 ml 10 ml 20 ml 50 ml Stress Media
(O2/CO2) (O2/CO2) (O2/CO2) (O2/CO2)
Bacillus subtilis X, Y CO2 – CO2 CO2 No, Yes TSB
(ATCC 6633) O2 O2 O2
Cladosporium sp. X CO2 – CO2 CO2 No TSB
(plant isolate) O2 O2 O2
Enterococcus faecalis X, Y CO2 CO2 CO2 CO2 No, Yes TSB
(DSM 20478) O2 O2 O2
Streptococcus salivarius X CO2 – CO2 CO2 No TSB
(DSM 20560) O2 O2 O2
Salmonella typhimurium X CO2 – CO2 CO2 No TSB
(ATCC 14028) O2 O2 O2
Methylobacterium radio-tolerans (DSM 1819) Y – CO2 – – Yes TSB
Micrococcus luteus Y – CO2 – – Yes TSB
(plant isolate)
Penicillium sp. Y – CO2 – – Yes TSB
(plant isolate)
Penicillium chrysogenum Y – CO2 – – Yes TSB
(ATCC 10106)
D. Brueckner et al. Talanta 167 (2017) 21–29
24
were selected due to their nature of consuming and exhausting O2 and
CO2 and general phenotypical characteristics, targeting the analysis of
fast/slow growing bacteria, fungi and homo-fermenting organisms
(based on experiences made during subsequent studies). There was
no diﬀerence detected among thresholds of leaking containers to those
of sealed ones.
5. Data analysis and determination of time to detection (TtD)
With the collected data of blank samples a format speciﬁc three
sigma (3σ) conﬁdence interval (CI) was deﬁned for O2 and CO2
headspace concentrations, specifying for each format the correspond-
ing threshold for growth detection. In previous studies [6] it was shown
that 10% of the TDLASO2 S. salivarius measurements remained
undetected with a 4σ CI. To improve the detection rate, CI was reduced
to 3σ which might however lead to an increased rate of false positives.
For O2 the minimal, and for CO2 the maximal point of the 3σ CI after
14 days deﬁned the threshold parameter of interest, which was taken as
reference to determine the time point of growth detection also called
time to detection (TtD) (see Figs. 1 and2). TtD was reached when the
gas concentration exceeded (CO2) or passed below (O2) the deﬁned
threshold. TtD of VI was reached as soon as 100% of all grown/
inoculated samples turned turbid. All TtD points of O2, CO2 and VI
were recorded and plotted in ranges (horizontal lines) to provide a
condensed overview for all formats investigated per microorganism
(Fig. 3). A false negative was deﬁned as contaminated vial visually
detectable but remaining undetectable for TDLASO2 and TDLASCO2.
Vice versa false positives were deﬁned as containers where media
stayed clear but O2 and CO2 concentrations steadily reached the critical
baseline level. Comparability among VI and TDLAS was given if
microorganisms were detected by VI and TDLAS (O2 and CO2) within
14 days, as this is the requirement for a media ﬁll demanded from
regulatory agencies.
6. Results
6.1. Deﬁnition of format- and media-speciﬁc thresholds
It is important to set a format and media speciﬁc threshold prior
study execution to allow the detection of microbial growth. Measured
O2 and CO2 values, during the analysis of inoculated media ﬁll units,
that were below (for O2) or above (for CO2) these thresholds (3σ) were
considered indicative of microbial growth and were deﬁned accordingly
(see Table 3, Figs. 1 and2).
Considering medium providers and vial format only small diﬀer-
ences for TDLASO2 (less than 1.2% diﬀerence on O2 thresholds >
17.5%, see Table 3) were observed showing consistency in the results.
In 50 ml vials TSB from BD versus TSB from Merck showed a rather
small diﬀerence in the O2 threshold ( < 0.8%). A larger relative
diﬀerence was observed for those two media when tested in the
50 ml vial on CO2 that has a much lower initial concentration in vial
headspace ( > 1.4% diﬀerence). This indicates vendor or batch speciﬁc
Fig. 1. Development of CO2 and O2 headspace concentrations of diﬀerent formats with diﬀerent TSB media from diﬀerent producers evaluated at site X. A1-A2 (2 ml vials), B1-B2
(20 ml vials) and D1-D2 (50 ml vials) contained TSB from Becton Dickinson & Company. C1-C2 (50 ml vials) were ﬁlled with TSB from Merck Millipore. The red dots indicate the 3σ
conﬁdence intervals for each measurement point whereas the lowest (O2) or highest (CO2) 3σ level deﬁned the threshold used for growth detection (see Table 3).
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diﬀerences and underlines the importance to set thresholds individu-
ally for a medium-format combination.
6.2. Analyzing the microbial spectrum (speciﬁcity analysis)
In total 34 diﬀerent microorganisms were evaluated together with 4
diﬀerent formats and two diﬀerent media (TSB/FTM – Fig. 3A-F). All
combinations of formats and microorganisms were detected by
TDLASO2 and/or TDLASCO2 reliably. First the compendia reference
strains from PhEur were investigated since they are routinely used in
pharmaceutical industry for method suitability and growth promotion
testing. As expected these strains were reliably detected between 24 h
and 215 h by TDLAS (O2 and CO2) in all formats (see Fig. 3B). Most
abundant strains from pharmaceutical clean rooms were also included
in the study as they are highly relevant for media ﬁll detection. Again
TDLAS (O2 and CO2) was able to detect all plant isolates within less
than 300 h (see Fig. 3C and F) proving its capability to detect relevant
microorganisms. With regard to worst-case organisms such as P. acnes
(slow grower), to stressed microorganisms and homofermenters (re-
duced O2/CO2 consumption/ exhaust) TDLAS was also able to detect
their microbial proliferation (see Fig. 3D and E). Raw data (minimal,
median, and maximum detection time) are presented in Tables S1-S5
for all formats and organisms tested.
Concerning the TtD some diﬀerences between VI, TDLASO2 and
TDLASCO2 were observed. TtD using CO2 was slightly faster for a
majority of tested samples compared to TtD using O2 (see Fig. 3A-F).
Overall VI enabled the shortest TtD (range of 20.5–245.0 h). It is
noteworthy that TDLAS and VI provided equivalent results for ca. 90%
of all tested microorganisms after 7 days (i.e., intermediate inspection).
Exceptions (ca. 10%) were samples inoculated with A. brasiliensis
(50 ml), Cladosporium sp. (50 ml), Penicillium sp. (50 ml), C. afer-
mentans (50 ml without Tween80 in TSB), M. radiotolerans (10 ml,
20 ml and 50 ml), S. epidermidis (2 ml), K. palustris (10 ml),M. luteus
(50 ml) and B. vulgaris (10 ml). Some or all of those inoculated
replicates remained for TDLAS undetectable within 7 days and needed
up to maximally 11 days to reach the critical gas concentration. Overall,
VI detected microbial growth slightly faster than TDLAS indicating that
a bacterial cell mass of 107 CFU/ml (J. Mordenhauer et al., 2004) was
in most cases not suﬃcient to allow a signiﬁcant drop/increase of O2/
CO2 in vial headspaces.
6.3. The Corynebacterium afermentans case
Corynebacterium sp. are present in the clean room ﬂora [10] and
grow slowly even on enriched media, whereas better growth is observed
under aerobe than under anaerobe conditions [11]. Corynebacterium
afermentans was selected in this study as model organism since it was
recovered at site Y from monitoring in grade B area (in non-operating
state max. 29 particles with size≥5.0 µm per m3; see EC GMP Guideline
Annex 1 for more details). Using 10 ml vials with TSB from Siﬁn
allowed visual detection after 8 days. Small hardly detectable cell
clumps appeared in the media around that time whereas an explicit
turbidity increase was not detected. A signiﬁcant change in CO2 and O2
headspace concentrations could also not be observed, even not after 14
days. This could be interpreted as a false negative result. At the same
time, it is generally known that media with higher lipophilicity
promotes growth of certain Corynebacterium species (Riegel et al.,
1993). Adding 0.1% of the detergent Tween80 to TSB clearly improved
the detection of C. afermentans within 7–8 days by VI as well as by
TDLASO2 and TDLASCO2. This might reason future media adaptation
for media ﬁlls in sterile drug product manufacturing. In TSB from
Becton, Dickinson & Co. being ﬁlled in 2 ml, 20 ml and 50 ml formats
no growth could be observed at all. However, the organism grew
unexpectedly in 50 ml vials ﬁlled with TSB from Merck Millipore and
could be detected visually (between 215.5 and 245.0 h) and by
TDLASO2/CO2 (between 245.0 and 292.5 h). This is the longest organ-
ism speciﬁc detection time observed for TDLAS which positions C.
afermentans as worst-case bacteria. The CO2 measurement detected its
growth slightly faster (max. 268 h) than compared to the O2 (max.
292.5 h) measurement.
6.4. False negative and false positive results
From the collection of inoculated samples (753 vials) including the
2 ml, 10 ml, 20 ml and 50 ml formats 93 samples showed no growth
despite inoculation. Thereof 60 samples were inoculated with
Lactobacillus delbrueckii (which is not a typical organism in clean
room areas but an organism with homofermenting characteristics) and
Propionibacterium acnes. Apparently both organisms did not grow due
to their need for diﬀerent growth conditions. The two strains normally
prefer (slightly) anaerobic conditions and 37 °C. The most probable
root cause for a lack of growth in the remaining 33 samples (ca. 4.3%
from 753) may be the small inoculation volume. As working suspen-
sions were prepared with less than 10 CFU (site X) and less than 20
CFU (site Y), it is statistically expected that some vials do not contain
any/little CFU (less than 3) reducing chances for successful outgrow.
Fig. 2. Development of CO2 headspace concentrations for TSB (E) and FTM (F) in blank
10 ml vials evaluated at site Y. The red dots indicate the 3σ conﬁdence intervals for each
measurement point whereas the highest 3σ level deﬁned the threshold used for growth
detection (see Table 3).
Table 3
Format specific O2 and CO2 thresholds (highest 3σ level) relating to the producers of the
respective media. Data is based on repetitive measurements of blank media ﬁll samples
during minimally 14 days (see Fig. 1).
2 ml 10 ml 20 ml 50 ml
O2 Thresholds
TSB from Becton, Dickinson and Company 18.3% n.a. 18.7% 18.3%
TSB from Merck Millipore n.a. n.a. n.a. 17.5%
CO2 Thresholds
TSB from Siﬁn n.a. 1.3% n.a. n.a.
TSB from Becton, Dickinson and Company 0.3% n.a. 0.2% 0.3%
TSB from Merck Millipore n.a. n.a. n.a. 1.7%
FTM from Oxoid n.a. 2.4% n.a. n.a.
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False positives were neither detected after 7 days nor after 14 days
when applying parallel CO2 and O2 headspace concentration measure-
ments (non-parallel measurements would have resulted in 4 false
positives for CO2 and 3 false positives for O2 after 14 days in the 2 ml
format).
6.5. Leakage study
Container closure integrity (CCI) testing is a standard procedure in
the release of sterile drug products. CCI evaluates the goodness of
container integrity as it directly relates to keeping the aseptically ﬁlled
drug product sterile. Because leakages may occur also in media ﬁlls and
could potentially inﬂuence CO2/O2 growth curves by headspace
equilibration eﬀects with the environment it is of high relevance to
evaluate inoculated but leaking samples. Within the study a leakage
representing worst case conditions was applied by inserting a needle
into the stopper (inner needle diameter ~0.25 mm). As expected it was
shown that non-integrity has an impact on growth related CO2 and O2
gas proﬁles leading in some few cases (3 out of 232 cases) to the
appearance of false negatives. Still most samples were detected with at
least the CO2 measurement reliably. CO2 and O2 proﬁles were hill-
(CO2) or valley-shaped (O2) (Fig. 4), whereas the impact of the gas
Fig. 3. Detection times in form of range (line) and median (black dot on line) are depicted per microorganism for the visual method (green), TDLASCO2 (red) and TDLASO2 (blue). Plot A
illustrates an overall summary of the ﬁve organism groups in terms of detection speed per analyzed parameter (VI, O2 and CO2). Plot B represents detection times for PhEur organisms,
Plot C for aerobic, plot D for homofermenting, plot E for anaerobic microorganisms and plot F for fungi including yeast and mold. The (*) refers to organisms that were heat stressed in
10 ml vials at site Y. The subscript 1) is indexing the microorganisms that were tested in 2, 10, 20 and 50 ml vials. 2) refers to organisms tested in 2, 20 and 50 ml vials only. 3) marks the
10 ml C. afermentans experiment being executed by site Y with TSB+0.1% Tween80. 4) relates to the TSB samples (no Twenn80) inoculated with C. afermentans being detected visually
at site Y in 10 ml vials and at site X by TDLAS and VI in 50 ml vials (TSB from Merck Millipore). Organisms without subscript indexes were exclusively tested in 10 ml vials. Anaerobic
organisms as well as C. sporogenes and part of E. faecalis were cultured in FTM instead of TSB. Lactobacillus delbrueckii was also part of the study but did not show any growth which is
the reason for not being part of this table. Inconsistencies in TtD due to ﬂuctuations around the baseline of either O2 or CO2 are shown as hollow dots in the respective color.
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concentration equilibration with the environment became more visible
when the growth plateau phase was reached. At this point the
respective gas concentration increased or decreased as O2 inﬂow and
CO2 escape from the vial headspace became the leading process.
Usually this happened between day 5 and 9. Indeed, compared to the
remaining three evaluated organisms (see Table 2, Organisms used in
leakage study), the majority of Enterococcus faecalis (2 ml) and
Streptococcus salivarius (2 ml – CO2 only) inoculated vials were
detectable in the course of analysis (i.e. between 38.0 h and 263.0 h).
However, after 14 days those samples were interpreted as false
negatives as gas concentrations had equilibrated with the environment.
It was not observed that the organism speciﬁc TtD was increased due to
the leakage applied.
7. Discussion
To test an alternative microbial monitoring method several valida-
tion parameters need to be evaluated [12–14]. Within this study
speciﬁcity (detectability of a wide organism spectrum as deﬁned by
[12]), robustness (reproducibility), sensitivity (ratio of false negative
results) and comparability (to the conventional method VI) were tested
for TDLAS. TDLAS was used to detected microbial growth in sealed
glass vials by measuring non-invasively O2 and CO2 headspace
concentrations aiming at a substitution of the visual media ﬁll
inspection (VI). The study included 34 diﬀerent microorganisms in
four glass vial formats (2 ml, 10 ml, 20 ml and 50 ml) ﬁlled with mainly
TSB (and FTM) whereas growth of organisms was detected reprodu-
cibly without observation of false negative/positive results [5] during
the period of 14 days. An increased rate of false positives can be
expected when performing measurements after 14 days and needs
further evaluation if applicable. Although the visual detection was in
most cases faster than TDLAS, growth was determined within 14 days
(11 days). This is in agreement with regulatory requirements for media
ﬁll inspection (specifying an incubation duration of not less than 14
days before the ﬁnal visual inspection) and proof for method compar-
ability [4]. Sites with isolator technology in use might therefore think
about abolishing the intermediate inspection when using TDLAS since
the intermediate inspection of a media ﬁll after 7 days is not
mandatory. This would save time and appears to be safe considering
that 100% of the tested organisms used in this study were detected by
TDLAS after 14 days.
An implementation and application of an automated TDLAS plat-
form (machinery) would lead to diverse advantages. One of them is a
~17x faster read-out than what can be achieved today by the visual
media ﬁll inspection (TDLAS platform inspects at least 100 vials/min;
visual inspection approx. 6 vials/min; average batch size ~15'000 units,
two inspections), resulting in 17x higher cost eﬀectiveness. In addition,
TDLAS would increase data integrity, facilitate data handling including
its transmission and help to eﬃciently realize technology transfers (e.g.
implementation of a new format) as such transfers are often linked to
three media ﬁlls in a row for validation purposes. In addition, higher
safety could be expected when dealing with the determination of
bacterial growth in contaminated vials that contain lysed bacteria as
those would remain hardly visible for human eyes. In turn this would
lead to false negative results. Such events are rare but tend to happen
sometimes in units with scarce growth induced by autolysins [15].
Finally, false positive units that turned turbid due to chemical
precipitation or haziness and not due to microbial growth would
unlikely result in CO2 or O2 headspace concentration variations, thus
avoiding unnecessary investigations and/or uncertainty.
High-throughput will be needed to deliver the expected eﬃciency
increase, which is linked to short measurement times (results are based
on 5 s measurements). Accuracy and precision are dependent on the
measurement path length (vial diameter) and duration of the measure-
ment becoming worse with decreasing vial size. It was experienced that
a ~10 fold decrease in measurement time increases the measurement
ﬂuctuation by a factor of 3–4, independently of the format size.
Therefore a trade-oﬀ between threshold deﬁnition and measurement
speed will be needed to achieve a successful site-speciﬁc validation with
zero false negative values.
To optimize and shorten detection times (i.e., < 11 days) of
bacterial growth (TtD) ﬁlling levels could be increased thus lowering
headspace volumes, resulting in higher gas concentration changes in
such lower headspace volumes. Such adaptations are only recom-
mended as long as an unhindered TDLAS headspace measurement is
enabled, organisms are exposed to enough oxygen (dependent on the
headspace size), and regulatory ﬁlling levels are respected [8]. Results
also suggested that microbial stress had rather less inﬂuence on lag
phase extension and TtD (data not shown). Much more impact on TtD
was attributed to metabolic characteristics combined with unfavorable
headspace volumes. Therefore, during validation studies we would
recommend to focus rather on optimal ﬁll-headspace volumes instead
of applying stress to microorganism.
When thriving towards an implementation of the TDLAS metho-
dology the case of Corynebacterium afermentans shall not be ne-
glected. This bacterium was identiﬁed during ﬁrst experiments as worst
case organism because growth detection was possible by VI exclusively
(false negative by TDLAS) in media from Siﬁn. The lack of detection
was then resolved by adding 0.1% of Tween80 to ﬁlled TSB [7].
Furthermore, growth and TtD of C. afermentans was heavily depen-
dent on the TSB media producer/composition and should be consid-
ered carefully when planning a substitution of the visual media ﬁll
inspection by TDLAS. Therefore growth of C. afermentans in com-
monly used TSB needs to be evaluated carefully as it could lead to
relatively long TtD or even to false negative results, demanding for
media adjustments (increase of lipophilicity). These ﬁndings are
important since Corynebacterium strains may belong to the usual
clean room ﬂora. However, we are aware that this was a single
experiment and that results cannot be generalized to all
Corynebacterium species. Anyhow, media modiﬁcation would only
make sense if the risk of observing false negative results by using a
certain media is existent.
It was also observed that non-integrity did have an impact on
microbial growth proﬁles and could even lead in some cases to non-
detectability. However, leakages applied here were of much bigger size
than normally encountered in production as the absolute worst case
was constituted. Therefore, it can be assumed that leaking contami-
nated vials passing the inspection on quality before the media ﬁll
Fig. 4. Example for growth curve development of leaking vials inoculated with
Enterococcus faecalis. Diverse leaking vials were tested on their O2 and CO2 related
growth. On the bottom the CO2 proﬁle and on the top its corresponding O2 proﬁle. The
hill- and valley shaped proﬁles are typical for leaking vials. In this experiment the
equilibration was that strong that gas concentrations turned back to their initial level,
leading to false negative results after 14 days.
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inspection will become detectable and should not result in false
negative ﬁndings caused through headspace equilibration eﬀects.
Anyhow, container closure integrity testing is a state of the art analysis
integrated in quality control processes reducing the risk of dealing with
leaking units even further [16]. Alternative approaches inducing
leakages close to more realistic size such as copper wires of the size
10–120 µm to simulate leakages [17] could be used during subsequent
validation studies to further evaluate the degree of impact on microbial
growth curves.
Hence, the discussed points illustrate that TDLAS is a technology
with much potential in substituting the visual media ﬁll inspection and
may even lead to a reconsideration of incubation time and temperature
for media ﬁlls [5].
8. Conclusion
TDLAS was evaluated as a potential method for automating the
visual media ﬁll inspection based on CO2 and O2 headspace measure-
ments. Growth of a wide collection of (stressed) organism-format
combinations without observing false negative/positive results was
possible. Therefore, the method appears to be a promising alternative
whereas the optimization of ﬁlling volumes might allow even faster
growth detection. The risk of not-detecting contaminated vials due to
leakages was estimated as minimal but needs further analysis.
An implementation should take into account that a high-through-
put approach implies shorter measurement times, potentially aﬀecting
measurement precision negatively. Nevertheless, with the proposed
ﬁlling modiﬁcations and a combined CO2 and O2 TDLAS headspace
analysis it is expected that TDLAS satisﬁes regulatory requirements
following an appropriate validation.
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Abstract 
Media fills are process simulations imitating the aseptic filling procedure with microbial 
culture medium instead of the liquid drug product. The visual inspection on turbidity of fill-
finished media fills represents the control on filling line asepticity and is a rather time-
consuming activity. Former studies have discussed the feasibility of automating this visual 
media fill inspection by tunable diode laser absorption spectroscopy (TDLAS) benchtop 
devices. The idea of using TDLAS was based on determining non-invasively CO2 and O2 
headspace concentration changes as indicator for microbial growth in test samples. Since 
the results from former studies were highly promising in terms of detecting contaminated 
media fill samples, a follow-up case study was performed with a semi-automated system 
provided by Wilco AG, enabling high-throughput detection (100 vials per minute). The study 
delivered very promising results in terms of media fill inspection automation and gives 
evidence for a more efficient design of the entire media fill process. Therefore, an 
implementation in aseptic drug product manufacturing is highly recommendable. 
Keywords: Absorption spectroscopy, Automation, Microbial growth, Media fill, TDLAS 
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Introduction 
Media fills are simulations imitating the aseptic filling procedure with medium (tryptic soy 
broth [TSB]) instead of the liquid drug product. The simulation’s purpose is to identify 
deficiencies in the aseptic conditions during the filling process leading to microbial 
contamination. Several thousands of vials are filled, stoppered and crimped within one of 
such process simulation. The fill-finished media units are normally incubated for minimally 7 
days at 20-25°C and for 7 days at 30-35°C, followed by a visual inspection (VI) through 
qualified human operators assessing the increase in media turbidity or abnormalities in 
medium appearance. Industrial regulations state that such inspections have to be performed 
after minimally 14 days [4,8,12,13]. However, a first VI after 7 days (intermediate inspection) 
is sometimes performed as fast growing microbes could already be detectable by then. A 
more efficient design of the media fill inspection procedure could be beneficial for 
manufacturers as VI is a qualitative assessment and therefore prone to subjectivity and 
errors. In addition manual vial and data handling during media fills are time-consuming 
resulting in unneeded costs for production facilities. 
Previous studies [2,3,5] evaluated the potential of tunable diode laser absorption 
spectroscopy (TDLAS) as an alternative for VI. Benchtop TDLAS devices were used to 
detect microbial growth in media fills by measuring CO2 and O2 concentration changes in vial 
headspaces. Such changes were mainly resulting from metabolic activity of growing 
microorganisms and allowed non-invasive growth detection. The methodology detects 
growth of many different micro-organisms reliably and reproducibly, in various combinations 
of format sizes and media types as well as in vials subject to leakage. A transfer of the 
TDLAS technology to an automated platform leading potentially to a higher inspection rate 
(100 vials / min is targeted) can thus be a valuable investment. In turn, a more objective 
assessment, increased data integrity and monetary cost savings would result from such 
automation. 
A first platform prototype allowing a high-throughput media fill inspection was assessed on 
its capability to detect microbial growth by a CO2 and O2 headspace analysis. In parallel, a 
comparison to previously published results [2,5] obtained from measurements with benchtop 
devices consolidated the experimental results. In this study, the media fill inspection 
automation is assessed based on sensitivity and specificity. The use of such an automated 
platform is deemed reasonable by the authors. 
63
Materials and Methods 
Automated Platform and Experimental Start-up 
An automated tunable diode laser absorption spectroscopy (TDLAS) platform for high-
throughput media fill inspection was provided by Wilco AG, Rigackerstrasse 11, 5610 
Wohlen (see figure 1). It contains a slide-in unit (fig. 1 [a]) where operators can prepare up to 
200 vials for the imminent analysis. A conveyor belt (fig. 1 [a]) transports the prepared 
samples towards a rotary plate (fig. 1 [b]) with format specific sample holders picking up the 
approaching vials. Subsequently the rotary plate passes the samples through the installed 
O2 and CO2 lasers (fig. 1 [c]) with a throughput speed of 100 vials per minute. The lasers 
measure each headspace of passing vials for 0.1 seconds. After the measurement 
corresponding vials are classified in two groups: non-sterile (fig. 1 [d]) and sterile units (fig. 1 
[f]). 
Figure 1: A) shows the top view and B) the side view of the inspection platform in use (Wilco AG, 
Rigackerstrasse 11, 5610 Wohlen). a) is attributable to the slide in unit as well as to the conveyor belt 
used for sample preparation and sample transportation towards the rotary plate marked as b). c) 
refers to the CO2 and O2 laser heads whereby d) is the sample exits for non-sterile units. e) is the 
connection between the rotary plate and the sterile sample exit f). g) refers to the human machinery 
interface allowing interaction with the device [1]. 
The classification is based on defined CO2 and O2 threshold values and allows operators to 
inspect samples (identified as non-sterile) visually on turbidity, controlling if the separation 
was justified or attributable to false positive measurements. Units that are determined as 
sterile are transported to the final sterile exit, taken off by an operator and put back for 
incubation. Fig. 1 [e] shows the transport channel being the connection between rotary plate 
and exit for sterile units. All interaction with the machinery, such as specification of 
baselines, batch initiation etc. occurred over a human machine interface (HMI, fig.1 [g]). 
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All experiments were done with 20ml vials having a diameter of 31.5mm, an overall height of 
58.0mm and a filling volume of 8.0ml. The automated platform determined with two adjusted 
single pass TDLAS laser beams the corresponding O2 (λ=760nm) and CO2 (λ=2000nm) vial 
headspace concentrations. Prior its use, the system was preheated for minimally 10 minutes 
and measuring gaps were flushed with nitrogen (max. 4 l/min) enabling an unbiased 
measurement. Nitrogen flushing was constant during the experimental phase. The system 
validation was performed with certified standards before each measurement series (O2: 
0.1%, 1.9%, 19.9%; CO2: 0.00%, 0.52%, 2.06% made and certified by Wilco AG). All 
standards were manufactured of the same glass as tested samples to keep background 
noise minimal. 
Determination of Threshold Parameters 
The definition of the CO2 and O2 thresholds was performed using 500 blank vials of a freshly 
produced media fill batch (B019) filled with TSB on an operative aseptic filling line. Vials 
were stored for 7 days in a 20-25°C incubator and subsequently transferred to a 30-35°C 
incubator and kept for another 7 days. O2 and CO2 concentrations in vial headspaces were 
tested 9 times during 14 days. After 14 days the upper (for CO2) and lower (for O2) 3σ 
confidence interval (CI) was defined for each measurement series whereas the highest and 
lowest values defined the threshold used as reference for microbial growth determination. 
A confidence interval of 3σ was considered appropriate as minimal detection times of 
microbial growth were targeted by risking as few false negative results as possible but, 
instead, potentially accepting false positive samples.  
Feasibility of Automated Growth Detection 
The automated platform was first evaluated by performing a growth study for checking if the 
platform was generally capable to detect microbial growth. Fresh media fills (batch B019) 
manually inoculated with microorganisms were used for this purpose. Microorganisms used 
for vial contamination were chosen based on previous studies [2,3,11] targeting a well-
balanced distribution of fast/slow growing organisms and the inclusion of worst case 
microorganisms (e.g. long lag-phase or reduced drop/increase of O2/CO2). Organism’s 
availability, relative occurrence in cleanroom monitoring and their relevance in PhEur for 
validation studies [7] were also respected. 
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The selection involved Bacillus subtilis (ATCC6633), Cladosporium sp. (site isolate), 
Micrococcus luteus (site isolate), Methylobacterium radiotolerans (DSM1819), Penicillium sp. 
(site isolate), Staphylococcus epidermidis (site isolate), Streptococcus salivarius 
(DSM20560) and Aspergillus brasiliensis (ATCC16404). Microbial suspensions in use were 
created according published procedures [2,3]. 
Ten vials were prepared per microorganism and each inoculated with <10 colony forming 
units (CFU). The prepared samples were tested once a day during two weeks using the 
automated platform so that a growth profile could be obtained. Between the measurements, 
vials were placed in an incubator at 20-25°C, for day 0 till day 7 and at 30-35°C for day 8 till 
day 14. The defined O2 and CO2 thresholds (3σ CI [10]) were used to determine detection 
points for each microorganism species by checking the time point when the growth profile 
passed these thresholds. This provided insight into microorganism specific time to detection 
determined through the automated platform and confirmed that the detection points were 
comparable with former study results. 
Determining Detection Reliability of Contaminated Units 
Determining whether the automated platform enables a reliable detection and separation of 
contaminated media fill vials randomly distributed within a batch of sterile samples is of 
major importance. Therefore a second assessment was performed also using B019 batch 
vials. However, the age of the batch amounted already 14 days (Tstorage = 20-25°C). As CO2 
and O2 headspace gas concentrations are known to change over time induced due to media 
auto-oxidation [3,5], the previously defined baseline values were shifted accordingly. The 
values of the shifted CO2 and O2 threshold were defined by first assessing the lower (for O2) 
and upper (for CO2) 3σ CI of aged media fills before the experimental start. To this 3σ CI the 
variation in 3σ CI (rounded values) of fresh media fills after 14 days was added or subtracted 
and considered as the shifted baseline (fig. 2). This approach is justified as during former
studies (D. Brueckner, 2017, unpublished data) the extent of media induced changes in 
headspace gas concentrations remained similar in 20ml vials independent of the medium 
age. 
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Figure 2: The illustration shows the approach of shifting the defined baseline for aged (14 days) 
media fills according the time-dependent CO2 and O2 headspace concentration variation induced by 
the media. The empty and filled rhombs define the 3σ confidence intervals (CI) of initial and changed 
headspace concentrations of fresh media fills. Empty circles depict the initial headspace 
concentration (3σ CI) of media fills after storage for 14 days at 20-25°C. The filled circles define finally 
the values for the shifted baselines which were used to determine the Wilco platform’s detection 
reliability of contaminated media fill vials. 
From a collection of 1208 sterile media fill samples 80 units were chosen at random, marked 
and contaminated with the same microorganisms used for the above described growth 
study. Always 10 units were inoculated with the same microorganism. Inoculation volume, 
suspension preparation, media fill incubation process, preheating, system validation and 
nitrogen purging remained identical. Inoculated samples were randomly mixed with sterile 
units whereas the entire collection was measured iteratively every ~24h during 14 days. In 
parallel to the automated inspection by the platform a visual inspection on turbidity was 
performed every day, assessing if and when growth of contaminated samples became 
detectable. Indeed, the visual inspection served as reference to determine the number of 
true positive (TP), true negative (TN), false positive (FP) and false negative (FN) 
measurements performed by the automated inspection platform. In addition, sensitivity 
(TP/(TP+FN)) and specificity (TN/(TN+FP)) were individually calculated for O2 and CO2 
measurements. 
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Results 
Threshold Parameters 
All previous studies that investigated TDLAS as method for automated media fill inspection 
used media fills considerably older than encountered in production. Since CO2 and O2 
headspace concentrations are known to change over time due to media auto-oxidation and 
CO2 degassing, aged vials were flushed with sterile compressed air to neutralize that effect. 
Therefore, using fresh and unaffected media fills for this study is important to confirm that 
headspace concentrations are exposed to comparable variations as observed in previous 
studies. This is especially important for the threshold definition of growth determination done 
here by the analysis of 500 freshly produced media fills whose development over time is 
shown in figure 3 and table 1. The calculated lower (fig. 3 A) and upper (fig. 3 B) 3σ 
confidence interval (CI) after 14 days defined the final threshold for growth detection. 
Figure 3: Development of O2 and CO2 headspace concentrations during 14 days. In red the 
continuous 3 sigma confidence interval is shown whereby the last value of the 3σ CI defines the 
baseline for O2 or CO2 based growth detection in fresh media fills. 
The threshold for O2 was set to 19.048% and the one for CO2 to 0.133% (fig 3, tab. 1). Four 
O2 values from the entire threshold study (4’500 measurements) were below and two CO2 
values above the defined threshold parameters, being theoretically attributable to six false 
positive results. 
Table 1: Calculated continuous 3σ CI values. Grey shaded and bold values define the baseline for O2 
and CO2 for freshly produced media fills. 
Time [h] 0.0 45.5 98.0 140.0 171.5 192.5 238.5 291.0 336.0 
3σ baseline O2 [%] 19.837 19.732 19.698 19.676 19.604 19.445 19.097 19.053 19.048 
3σ baseline CO2 [%] 0.080 0.090 0.088 0.093 0.090 0.106 0.120 0.132 0.133 
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Automated Growth Detection 
The automated platform was capable to readily detect microbial growth in media fills. 
Headspace concentrations from 75 out of 80 inoculated samples fell below or exceed the 
defined O2 and/or CO2 baseline(s) within 172h (figure 4). Only one sample inoculated with 
Staphylococcus epidermidis was detected after 172h (growth detection of that single sample 
occurred at 246h).  
Figure 4: CO2 and O2 vial headspace developments (raw data) of eight selected microorganisms. 
Each illustration included 10 inoculated sampled which were tested by the Wilco inspection platform 
every ~24h during 14 days on their CO2 and O2 headspace concentration. 
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Four inoculated samples remained clear neither turning turbid nor experiencing any relevant 
change in CO2 or O2 headspace concentration. The automated platform detected growth in 
35 units at the same time as the visual inspection on turbidity (applicable for all samples 
inoculated with Methylobacterium radiotolerans, Micrococcus luteus and Bacillus subtilis as 
well as for samples inoculated with of Streptococcus salivarius (1), Staphylococcus 
epidermidis (3) and Aspergillus brasiliensis (1)). Slightly lagged growth detection by the 
automated platform was observed for the remaining 41 samples. 53 samples were detected 
~24h earlier by the CO2 than by the O2 measurement. 
Detection Reliability of Contaminated Units 
Results from the growth study demonstrated that microorganisms could be detected within 
<14 days by the automated platform. Those results were confirmed by letting the system 
randomly find 80 inoculated samples among a batch of 1’128 sterile media fill samples. As 
the media fill vials were aged (14 days) and TSB had slightly impacted CO2 and O2 
headspace concentrations, for this study the previously defined baselines were shifted to 
values of 0.17% CO2 and 18.50% O2 (over the considered time period the changes of the 
headspace concentrations induced by TSB were assumed to be linear [2]), defining the new 
growth detection limits (fig. 2). Visual inspection on turbidity (VI) was used as reference for
growth detection by the automated platform. Again, VI detected microbial growth in media 
fills slightly faster than measurements on CO2 and O2 headspace concentrations. A 
temporary appearance of false negative results was observed for CO2 measurements 
between 45h - 137h and for O2 measurements between 45h - 161h (fig. 5, A and B).
Nevertheless, after 161 hours sensitivity for CO2 reached 1 (100%) (fig. 5 C). There were no
false positive results observed (neither for CO2 nor for O2 measurements) leading to an 
overall specificity of 1 (100%) during the entire test period. 
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Figure 5: The number of false negatives and true positives is shown for CO2 in plot A and for O2 in 
plot B. Plot C shows the increasing sensitivity of the CO2 and O2 related headspace analysis during 
14 days. The reference for determining false negatives was the visual inspection on turbidity. Values 
equal to zero are also indicated. 
Discussion & Conclusion 
It was clearly demonstrated that an automated and TDLAS-based media fill inspection, 
controlling 100 vials per minute, allows a reliable detection of contaminated 20ml TSB filled 
vials. In fact, besides one single vial (it contained Staphylococcus epidermidis and needed 
246h until growth detection), all inoculated samples that were visually detected were also 
identified by the automated platform as non-sterile after ~7 days without observing any false 
negative or false positive results (fig. 5A-C).  
As experienced during previous studies [2] performed with benchtop devices (manufactured
for single measurements only) from another supplier (Lighthouse Instruments (LHI)), again 
the CO2 measurement was more sensitive (fig. 5C, fig. 6A and B) and detected two third of 
contaminated units one day earlier than the O2 analysis. Indeed, the O2 headspace 
concentration is subjected to much stronger changes than for CO2, because of auto-
oxidation. Thus, the delta between O2 threshold level and initial O2 headspace concentration 
is much larger as compared to CO2. As a consequence more time is needed until O2 growth 
profiles reach the O2 threshold, which explains the different periods of time needed for 
growth detection using CO2 and O2 measurements. 
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In addition the CO2 measurement was more precise. Indeed the relative standard deviation 
(stdev) of a sample collection of 500 units was 0.0045% for CO2 and higher for the O2 
analysis (stdev = 0.120%). In comparison to studies performed with older TSB no difference 
of the degree of media induced headspace variation of CO2 and O2 was detected between 
fresh (unaffected) and aged (regased) media fills. 
A comparison to the mentioned previous studies that evaluated a visual media fill inspection 
substitution by TDLAS benchtop devices was of further interest. Such result comparability is 
valuable as knowledge is generated about what can be expected from the automated 
platform assessment if testing other formats (e.g. 2ml, 10ml, 15ml, and 50ml vials). Fresh 
media fill samples used in this work for baseline and growth analysis, were tested in parallel 
with an older generation of benchtop devices from LHI. The devices were set to the shortest 
measurement duration of 0.5s to achieve the closest possible comparability with the 
automated platform in use. The automated platform from Wilco AG achieved slightly shorter 
times to detection (fig. 6) as the benchtop devices. Indeed the slightly larger measurement 
fluctuations of the benchtop lasers imposed higher standard deviations for blank 
measurements (0.077% for CO2 and 0.390% for O2) and led to higher shifts in baseline 
values (17.856% O2 and 0.365% CO2) delaying time to detection. It is important to mention 
at this place that such benchtop devices are designed for optimum performance in a 
laboratory environment. They are not customized for assessments with short measurement 
durations as the internal data acquisition system and scanning rate are not fully designed for 
such measurement speed. Therefore, the comparison of benchtop devices and automated 
platform cannot be seen as an “apple-to-apple” comparison but shall be treated as additional 
experience being helpful for a future method transfer to an automated system. Furthermore, 
such comparison shall not be interpreted as a rating of the LHI benchtop device performance 
or their corresponding competences. 
72 
Figure 6: Comparison of detection times per microorganism obtained through measurements by the 
Wilco platform and the benchtop devices from LHI. It depicts clearly that devices developed for high-
throughput inspection achieve even better results than laboratory equipment. 6A shows the results of 
O2 measurements and 6B the results of CO2 measurements. The end of each bar is attributable to the 
median of the detection time resulting from the analysis of 10 samples per microorganism inoculated 
with <10 colony forming units. The error bars define the maximal and minimal value for the detection 
time of microbial growth. (Please refere to fig. 4 or the materials and methods chapter to see  the full 
microorganism names assignable to the abbreviations used in this figure).
Technical and methodological feasibility of automating the media fill inspection could be 
shown within this work. During media fills diverse process interventions are performed which 
need to be assignable to individual trays (a collection of multiple vials) filled during the 
intervention of concern. This is important as in the case of microbial growth detection a 
connection needs to be established between intervention and tray containing the 
contaminated unit. Such a connection allows finding and eliminating the source of filling line 
contamination. However, the actual design of the automated platform hardly allows 
separating one tray from the other. By letting trays pass the device individually the very last 
several vials of each tray remain in the transport channel (fig. 1, e) once left the rotary plate. 
Additional vials from the subsequent tray would need to undergo the measurement and 
transportation procedure pushing then the remaining vials in the exit for sterile units (fig.1 f). 
This makes a tray by tray separation challenging. The problem can easily be solved by 
tagging each vial with a specific barcode allocating it to the tray units or by customizing a 
baton, allowing operators to empty the transport channel manually (manual tray separation).  
Besides this technical challenge the analysis of smaller formats (e.g. 2ml vials being filled 
with 1 ml TSB) and intentionally breached samples could additionally be performed as 
sealed 20ml vials are the most convenient format to be tested. In addition the technique 
provides a base for discussions in simplifying the inspection and incubation procedure. 
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It was shown in this work that worst case organisms defined in previous studies were reliably 
detected within ~7 days. Therefore, a single inspection after e.g. 8 days might be 
reasonable, but of course, demanding additional investigation in form of several 
experiments. However, if realized further monetary benefit can be expected for media fill 
processes applying two visual inspections as the second one would be eliminated. 
Based on former studies [9], an alternative incubation approach using incubation 
temperatures of 28°C during the entire 14 days could be of further investigational interest 
influencing (shortening or prolonging) times to detection of bacteria and molds/fungi 
accordingly. By such temperature normalization a steadier baseline development could be 
expected as the transfer to 30-35°C is eliminated which normally slightly worsens CO2 and 
O2 headspace variation (caused through oxidation and degassing effects). If such a process 
adaptation was targeted more investigational effort would be required.  
An easy, fast and safe electronic documentation of individual tray units or concerned vials 
attributed to process interventions must be allowed by the platform to fulfill efficiency 
expectations and requirements existing in a GMP environment. Therefore the impact of the 
documentation procedure on the overall inspection duration is subject to further clarifications 
involving exchanges of experience with subject matter experts. Depending on how the 
automated documentation approach is solved and how many media fills are produced per 
year a company could face acceptable savings after acquisition and implementation of a 
media fill inspection platform. Normally operators inspect ~6 media fill vials per minute 
during the visual inspection on turbidity. Considering that e.g. 16 batches are filled per year, 
one batch contains 15’000 units, and inspections are done after 7 and 14 days, operators 
would invest yearly ~1’300 hours in inspecting media fills. Using the automated platform 
would allow a throughput speed of 100 vials / minute (higher throughput speed is not 
recommended with this set up as pressure on vials might increase risk for breakage [6]). 
However, if higher throughput rates are requested machineries exist with a different vial 
handling system enabling such intention) and reduce the yearly inspection time to ~80 hours 
(6.2% of the time needed for the visual inspection). Such fact allows a strong efficiency 
increase in terms of visual media fill inspection and would shorten reaction times in case of a 
sterility breach at the filling line. However, such benefit can only work if documentation does 
not generate extra workload and is easily performed besides the automated inspection in a 
convenient, safe and user-friendly way. 
Overall the automated platform is an excellent tool enabling an automated and secure media 
fill inspection. 
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Although some minor challenges have to be overcome for the inspection platform 
investigated here, such a platform can release employees from a rather repetitive task and 
allow manufacturing sites to save costs in case of method implementation. 
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Abstract
Aims: Production and release of injectable drug solutions are highly regulated
since the administration of injectables bypasses natural body barriers. The
sterility test is the last opportunity of product quality assessment. However,
sterility is currently assessed by visual inspection (VI) that is time consuming
and somewhat subjective. Therefore, we assessed isothermal microcalorimetry
(IMC) as a replacement for the VI of the filtration based state-of-the-art
sterility control.
Methods and Results: We used ATCC strains and house isolates to artificially
contaminate frequently produced monoclonal antibodies (Avastin, Mabthera,
Herceptin). After filtration, growth was assessed with IMC. Growth of all
micro-organisms was reliably and reproducibly detected 4 days after
inoculation, which was significantly faster than with VI.
Conclusions: The reliability and the sensitivity of IMC have a large potential
to improve sterility controls. Further evaluation of this alternative method is
therefore highly recommended.
Significance and Impact of the Study: Drug safety is of great concern for
public health. Faster and safer drug production could be achieved using the
technique described here. All the tests were performed with real manufactured
drugs and complied with pharmaceutical standards. This suggests that drug
sterility testing can be improved with potentially increased safety and cost
reduction.
Introduction
Public health is dealing primarily with the protection of
people’s health, including the promotion of healthcare
quality and accessibility and the limitation of healthcare
disparities. Considering healthcare quality, fostering safe
environments and developing sound health policies remain
public health systems’ key responsibilities (Centre of Dis-
ease Control 2016). That is why drug producers are
required to strictly comply with regulations and guidelines
targeting the highest possible level of drug product quality
(Wilder and Kerrigan 2012). The design and control of
manufacturing processes according to quality-compliant
specifications is therefore crucial. Indeed, the execution of
product-related quality assessments during the production
process by analytical methods is important to achieve these
requirements (Rathore and Winkle 2009). Injectable drugs
have the highest quality requirements (including sterility of
the solution) as parenteral applications bypass natural
body barriers and could severely affect patient health in
case of microbial contamination. Despite strict adherence
to guidelines by producers, several drug recalls (approxi-
mately 430 out of which ~200 were related to injectables)
occurred within the last 3 years (Fig. 1). A major reason
was unmet specifications in the sterility assurance processes
(Drug Office Hong Kong 2016; European Pharmaceutical
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Reviews 2016; Food and Drug Administration 2016;
Medicines and Healthcare Products Regulatory Agency
2016; Swissmedic 2016; World Health Organization 2016)
and the sample selection within a batch. Manufacturers can
attempt to improve the sample selection by taking samples
from the ‘near start’, ‘middle’ and ‘near end’ of a batch as
contamination is unlikely to be evenly distributed (Sandle
2012). In addition an inclusion of samples close to any pro-
duction process intervention performed is recommended.
Still the probability remains low to find single contami-
nated units in one entire lot (Sandle 2012). Sterility tests
are the last opportunity for product quality assessment.
Sterility tests are, however, limited in their ability to detect
microbial contamination in large production batches (up
to 100 000 units) due to small sampling sizes (20–30 com-
mercial units) (Food and Drug Administration 2004). Such
tests include filtration of the sample through cellulose
membranes under sterile conditions. Filters are then incu-
bated during 14 days in tryptic soy broth (TSB) at 20–
25°C and fluid Thioglycollate media (FTM) at 30–35°C
enabling growth of aerobe and anaerobe micro-organisms.
A final visual inspection (VI) on media turbidity assesses
the cumulative sample sterility and allows approval for
batch release (Food and Drug Administration 2009; Japa-
nese Pharmacopoeia 2016; Ph Eur 8.0th edition 2014; US
Pharmacopoeia-National Formulary 2016). Because of its
low sensitivity (small sample size), positive results are not
expected but, if occurring, are considered as a serious GMP
issue that must be thoroughly investigated (Food and Drug
Administration 2004). Therefore, use of quantitative meth-
ods detecting microbial growth faster than by VI on media
turbidity (the human eye needs 107 cells per ml to detect a
biomass increase in liquid medium (Moldenhauer and Sut-
ton 2004)) would be advantageous. Reduced incubation
duration (<14 days through a higher detection speed of
microbial growth) decreasing product holding times until
market release (direct monetary savings), higher growth
detection objectivity, less inspection duration, shortened
reaction time for GMP investigations as well as an opti-
mized release duration of high-quality drug products deliv-
ered to patients could be achieved.
Different rapid microbial methods (RMM) such as, for
example, Milliflex Rapid Microbiology Detection and
Enumeration System, BacT/ALERT 3D, BD BACTECTM,
Celsis Advance IITM, ScanRDI, Growth DirectTM, etc. are
available. Growth detection of the RMM are based on
electro-optical, spectroscopic or biochemical reaction
analysis which all have advantages and drawbacks (Thorpe
et al. 1990; Chollet et al. 2008; London et al. 2010; Parveen
et al. 2011; Jimenez et al. 2012; Celsis 2017), and are often
invasive by nature (Sandle 2016; rapidmicromethods 2017).
Isothermal microcalorimetry (IMC) is a method capable to
detect heat produced by biochemically active cells such as
growing bacteria or fungi (Tan et al. 2012; Braissant et al.
2013). In theory, with the most sensitive instrument avail-
able, already 20 nW (104 cells)—200 nW (105 cells) are suf-
ficient to allow noninvasive detection of microbial activity
by IMC (Braissant et al. 2010). However, one needs to be
aware that these value are only theoretical and that they vary
a lot depending on micro-organism type, metabolic state
(i.e. actively growing or dormant) and metabolisms type
(i.e. respiration, fermentation, nitrate or sulphate reduction)
(Braissant et al. 2010; Maskow et al. 2012). In this work, we
will evaluate IMC as a possible alternative for the above
described sterility control and highlight its advantages,
drawbacks and potential impact on existing procedures.
Materials and methods
The experimental set-up targeted close simulation of the
prevailing conditions during the sterility test of liquid
drug products. For this, we used three commercial par-
enteral drug products (the monoclonal antibodies
  Packaging 
QC failures &
impurities
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safety
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Figure 1 Approximation of the absolute recall number from January
2014 to October 2016 for US, JP, UK, CH (and few other countries)
assigned to five categories. Various drug formulations (parenteral,
oral, topic, etc.) were included in the study. However, the majority of
the ‘Sterility issues’ section is assignable to injections and related to
unmet specifications in sterility assurance processes such as identified
micro-organisms in products, deviations from environmental monitor-
ing, failed sterility tests and failed media fills. ‘Packaging’ refers to
mistakes on leaflet, packaging damages, stopper issues, wrong label-
ling and scratches. ‘QC failures and impurities’ include particles (glass,
rubber, etc.) in the product, cross-contamination with drugs, stability
problems, precipitation and crystallization. ‘Patient safety’ is linked
with falsified drugs, wrong dosage, unexpected adverse reactions,
general health hazards and treatment failure, whereas ‘Others’ cover
issues in clinical studies, market authorization, licensing and indication
change.
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Avastin, Herceptin and Mabthera) easily available from
the production site. All other material used was pur-
chased from Merck Millipore (Schaffhausen, Switzerland).
For practical reasons (to avoid disturbances in the daily
operations) product filtration was done by a multistation
filtration device under laminar flow (instead of a certified
and qualified isolator). Filtration units with installed fil-
ters (Microfil V, pore size 045 lm, 47-mm diameter)
were filled with 10 ml fluid A (01% peptone, pH 7) and
20–60 ml of drug product were added. The entire solu-
tion was inoculated with 01 ml of micro-organism sus-
pension (<10 colony forming units per 01 ml) imitating
biologic product contamination. The inoculated solution
was filtered by applying vacuum (EZ-Stream Pump;
Merck Millipore) to the filtration unit. Subsequently, the
filters were washed twice with 20 ml fluid A to get rid of
excessive product protein and conservatives. Using sterile
forceps, filters were folded and carefully introduced into
sterile 4-ml glass vials fitting the measurement channels
of an isothermal microcalorimeter (Tam48; TA instru-
ments, New Castle, DE, USA). After having filled all glass
vials with 3 ml of liquid media (either TSB or FTM
(fluid thioglycollate)), they were sealed and introduced
into the calorimeter for heat flow analysis following the
two step thermal equilibration procedure recommended
by the manufacturer. Anaerobe experiments were started
as soon as the change in colour of the FTM medium was
detected.
For each combination of medium—organism—filtered
product, 5–10 replicates were prepared and investigated.
Aerobic micro-organisms included Candida albicans
(ATCC 10231), Staphylococcus aureus (ATCC 6538), Peni-
cillium sp. (site isolate), Bacillus subtilis (ATCC 6633),
Aspergillus brasiliensis (ATCC 16404) and Pseudomonas
aeruginosa (ATCC 9027) and were incubated in the
Tam48 at 25  01°C in TSB. Clostridium sporogenes
(ATCC 19404) was selected as model organism for anaer-
obe studies and cultured in FTM at 325  01°C in the
Tam48 calorimeter (for details about creation of micro-
bial suspensions see (Brueckner et al. 2017)). The ratio-
nale for selecting the micro-organisms intended to
include one house isolate with high growth variability
(and long lag phase) and to cover the pharmacopoeia
strains in use excluding fast growing species.
In addition, noninoculated samples (eight per product
and media) were tested during ~100 h and went through
the same preparation process as described above. This
allowed creating a reference threshold for each medium.
The threshold was defined by the fitted upper six sigma con-
fidence interval of the respective sample collection (Fig. 2)
as a high level threshold was targeted (decrease in false posi-
tive number). Since calorimetric baseline data are not flat
by nature due to the insertion of the sample, producing a
thermal perturbation, the baseline fitting was done using
the R statistical package assuming a second-order exponen-
tial decay (allowed an approximation of such asymptotic
curves). Growth detection was considered positive once the
heat flow curve from inoculated samples crossed this
threshold. Visual detection times for C. sporogenes were
determined by the read-out of 38 individually inoculated
(<10 organisms) FTM samples. The remaining visual data
was taken from previous internal measurements using the
same procedures. The organism-specific visual detection
point was reached once all inoculated samples became tur-
bid. In both cases the VI was performed by a qualified
human operator (inspection results might vary among
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Figure 2 The left figure shows the upper six sigma confidence interval and its fit (red curve) based on the function of second order exponential
decay. The fitted curve defines the growth threshold (noise from blank samples). The right figure describes the concept of determining the time
point of growth, based on the intersection of growth curve and threshold (using Pseudomonas aeruginosa).
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different human operators). The difference between the two
detection methods (visual detection and IMC detection)
was assessed using the Wilcox Test as values were non-nor-
mally distributed according to the Shapiro–Wilk test. The
influence of the filtered drug product on microbial growth
was analysed by the Kruskal–Wallis test. In addition, col-
lected heat flow curves were integrated and fitted using the
Gompertz growth model (Braissant et al. 2013, 2015).
Thereby, additional descriptive parameters such as total
heat, growth rate and lag phase duration could be extracted
(Table 1).
Results
Several blank TSB and FTM samples were tested on their
heat emission which determined the thresholds (a fitted six
sigma confidence interval) for bacterial growth detection
(Fig. 2). Due to equilibration processes between samples
and measurement channels the thresholds showed a decline
within the first 20 h and equilibrated at approximately
157 9 1006 W (TSB) and 473 9 1006 W (FTM).
Detection times for IMC were extracted once the defined
threshold was crossed by the growth curves and then com-
pared to the detection time of VI.
All inoculated samples were detected by VI and IMC
within 100 h. IMC identified microbial growth in 92% of
the prepared filter samples (n = 138) earlier than VI. In
addition, IMC was significantly faster (P < 005) for six
of the seven microbes when compared to VI (Fig. 3). In
comparison, VI detected growth in few samples inocu-
lated with Penicillium sp. (35%) and C. sporogenes (11%)
sooner than IMC.
Highest fluctuations in total heat and lag phase were
observed for Penicillium sp. and A. brasiliensis. Their
maximal emitted heat (4482 J and 2495 J) reached high
values. It is likely that the formation of biofilms on the
incubated filter was responsible for the higher heat pro-
duction rates (Donlan and Costerton 2002; Astasov-
Frauenhoffer et al. 2012). The remaining organism sam-
ples showed uniform growth curves, whereas B. subtilis
and P. aeruginosa grew with highest reproducibility. A
significant (P < 005—sample size in Table 1) influence
of the filtered product on the time to detection (TtD) of
growing micro-organisms was observed. Nevertheless, dis-
tributions of TtD values for the tested organisms were
rather small (Fig. 3). Although statistically significant,
such differences remain negligible for practical use.
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Figure 3 Comparison of detection times for
IMC (light grey) and VI on turbidity (dark
grey). Bar height represents the median of all
detection points per organism. Dots represent
maximal values of the respective sample
collection. The samples size for IMC data was
between 15 and 38, for VI between 9 and
38. Stars mark if the two groups (detection
with VI or IMC) are significantly different
(P < 005; Wilcox test) for one micro-
organism. The visual inspection was
performed by a single human qualified
operator.
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Discussion
In this publication, the potential of IMC as a substitution
for the VI of the sterility test for parenteral drug products
(filtration, incubation and VI on turbidity) was assessed.
IMC detected microbial growth in all inoculated samples
and in a large majority of them (92%), microbial growth
was detected significantly faster than with VI (Fig. 3).
A previous study (Tan et al. 2012) has suggested that
IMC could be used for replacing the sterility assessment.
However, this study used conditions that were neither rele-
vant for sterility testing nor compliant with the respective
guidelines (Food and Drug Administration 2009; Ph Eur
8.0th edition 2014; US Pharmacopoeia-National Formulary
2016). In addition, only few micro-organisms were investi-
gated and no mention of replication was stated, rendering
the results of this study doubtful. In the current study,
growth profiles showed a high degree of reproducibility and
reliability. This advocates for further assessment of IMC
using additional micro-organisms (e.g. slow growers) and
allowing the investigation of the applicability of this method
in practice.
The real-time applicability of this technology is advan-
tageous compared to VI, supporting the use of IMC in a
GMP environment. As a consequence, the subjective
visual analysis of sterility could be replaced by an elec-
tronically documented, objective assessment of microbial
growth over time. Importantly, implementation of IMC
in practice would require only minor changes in the
existing procedures, since sample preparation and han-
dling processes during sterility assessments would remain
unchanged. Method validation would have to focus only
on replacing visual growth detection by heat flow analysis
because IMC measurements and VI are both noninvasive.
Interestingly, one sample of A. brasiliensis and Penicil-
lium sp. each produced rather high and steady energy
emissions of 2495 J/4482 J during the measurement per-
iod, being most probably related to biofilm formation
(Said et al. 2014, 2015). Therefore, IMC could be of
additional use in finding efficient ways to detect the pres-
ence of biofilm-forming micro-organisms in, for example,
water pipes or air cooling systems of pharmaceutical pro-
duction facilities—especially as biofilms might be tolerant
to some of the applied sanitizing procedures.
Importantly, in the current study we used smaller volumes
than in conventional sterility tests. This might have slightly
influenced the time of visual growth detection, as initial tur-
bidity is harder to see in smaller formats. During subsequent
validation studies this is an aspect to be considered.
The analytical capacity of the instrument could easily be
adapted, depending on the needs of different drug manufac-
turers, as commercially available instruments have a sample
capacity ranging from 1 up to 48 measuring slots (Braissant
et al. 2010, 2015). It must be noted, however, that some
isothermal calorimeters used in research were built with up
to 100 channels (Wads€o 2002). Such systems could addition-
ally be used for other mandatory microbiological assess-
ments, for example, the determination of the degree of water
contamination (Maskow et al. 2012).
Our findings illustrate that IMC is a methodology with a
high potential for replacing the VI of sterile solutions (for
parenteral and potentially also other drug products). The
main advantages of this method are not only its noninvasive
nature and user friendliness but also its reliability and sensi-
tivity, allowing earlier microbial growth detection than with
VI. This could allow shorter product holding times before
release, resulting in monetary savings that may reduce drug
prices. IMC should not only be compared with VI, however,
but also with other methods currently in use or planned for
future applications such as ‘Growth Direct’ (Rapid Micro
Biosystems 2011) which is also used for bio burden testing.
Such comparisons could provide further insights on the per-
formance of IMC and would therefore be valuable.
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A B S T R A C T
Calorespirometry is the simultaneous analysis of the rate of heat emission (Rq), O2 consumption (RO2) and CO2
production (RCO2) by living systems such as tissues or organism cultures. The analysis provides useful knowledge
about thermodynamic parameters relevant for e.g. biotechnology where parameter based yield maximization
(fermentation) is relevant. The determination of metabolism related heat emission is easy and normally done by
a calorimeter. However, measuring the amount of consumed O2 and produced CO2 can be more challenging, as
additional preparation or instrumentation might be needed. Therefore, tunable diode laser absorption spec-
troscopy (TDLAS) was investigated as an alternative approach for respirometric analysis in order to facilitate the
data collection procedure. The method determines by a spectroscopic laser non-invasively CO2 and O2 gas
concentration changes in the respective vial headspaces. The gathered growth data from Pseudomonas aeruginosa
cultured in two diﬀerent scarce media was used to compute respiratory quotient (RQ) and calorespirometric
ratios (CRCO2 [Rq/RCO2], CRO2 [Rq/RO2]). A comparison of the computed (experimental) values (for RQ, CRCO2
and CRO2) with values reported in the literature conﬁrmed the appropriateness of TDLAS in calorespirometric
studies. Thus, it could be demonstrated that TDLAS is a well-performing and convenient way to evaluate non-
invasively respiratory rates during calorespirometric studies. Therefore, the technique is deﬁnitively worth to be
investigated further for its potential use in research and in diverse productive environments.
1. Introduction
Calorespirometry is the simultaneous analysis of the rates of heat
emission (Rq), O2 consumption (RO2) and CO2 production (RCO2) by
living systems (single cells, tissues, or organism cultures from culture or
environmental samples). Calorespirometry provides useful information
about eﬃciency in metabolic turnover and potentially on corre-
sponding metabolic pathways (aerobe or anaerobe). Especially in bio-
technology where yield maximization of biomass or alternatively of a
certain product is of interest, calorespirometry helps to understand
system thermodynamics, enabling an optimization of culturing condi-
tions (Hansen et al., 2004; Schuler and Marison, 2012; Schuler et al.,
2012). Rq is normally determined using an isothermal heat conduction
or power compensation calorimeter (Wadsö and Hansen, 2015). A
thermoelectric module located between the sample and the calorimeter
heat sink measures the emitted heat and transforms it into an electronic
signal. An accurate determination of RCO2 (and RO2) is more diﬃcult
but has been described (Criddle et al., 1991; Criddle et al., 1990). The
approach was based on the determination of the heat produced by the
reaction of CO2 with a 0.4 M NaOH solution (absorbent) contained in
the reaction container as described by CO2 (g) + 2OH− (aq)→ CO32−
(aq) + H2O (aq) with ΔHabs =−108.5 kJ·mol−1 (Wadsö and Hansen,
2015).
By subtracting heat rate values of samples lacking the absorbent
from those including the absorbent, the amount of produced CO2 can be
determined and conclusions on metabolic eﬃciencies drawn. The de-
scribed approach is used as a gold standard in works of calorespiro-
metric analysis such as feeding control of biopolymer production,
evaluations of soil organic matter decomposition, and metabolic as-
sessments of microorganisms, plants, animals, fruits, and other living
systems (Barros et al., 2015; Criddle et al., 1990; Hansen et al., 2002;
Nogales et al., 2013; Regan et al., 2013; Rohde et al., 2016; Wadsö,
2002). The technique is limited by its invasive nature, leading to the
absorption of the entire CO2 in the system. The eﬀect of CO2 degassing
in combination with the absorbent removes the entire CO2 from the
medium, generating a shift in the carbonate equilibrium
(HCO3–→ CO2 + OH−). Hydroxide ions (OH−) arise therefrom re-
sulting in a pH increase potentially inﬂuencing the cell growth potential
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in weakly buﬀered systems. A more convenient approach to perform
such experiments is the use of optrodes. Several calorespirometric
studies used modiﬁed calorimeters with optrodes included in the
measurement vessel to determine oxygen consumption. For example,
moth metabolism or oxygen consumption by Maple tree leaf buds were
studied using such modiﬁed instruments (Itoga and Hansen, 2009;
Neven et al., 2014). Tunable diode laser absorption spectroscopy
(TDLAS) is discussed in this work as an alternative approach capable to
determine CO2 production and O2 consumption rates non-invasively
and easily. The technology uses a laser to measure relative CO2
(λ= 2000 nm) and O2 (λ= 760 nm) concentrations in the sample
headspace. Of major interest is the investigation of a combined use of
IMC and TDLAS for calorespirometric studies based on one single model
organism (Pseudomonas aeruginosa). Measurements were run in parallel
and in diﬀerent media (M9 and M9 + nitrate) to compare calor-
espirometric ratios under diﬀerent metabolic conditions (respiration
and denitriﬁcation [NO3−→ NO2−→ NO+ N2O→ N2 (g)]). Biomass
(cell count per ml medium, optical density, and protein concentration),
substrate consumption (glucose concentration), gas concentrations and
metabolic byproducts (nitrite concentration) were used to interpret the
obtained respiratory quotient RCO2/RO2 (RQ) and calorespirometric
ratios Rq/RCO2 (CRCO2) and Rq/RO2 (CRO2). Those results were com-
pared to values found in the literature to gain insight into reliability and
applicability of TDLAS in the ﬁeld of calorespirometry.
2. Materials and methods
Pseudomonas aeruginosa was chosen as a model organism for calor-
espirometric studies due to its aerobe and denitrifying metabolic
characteristics. The microorganism was purchased from
ThermoScientiﬁc™ (Quanti-Cult Plus, ATCC 9027,< 100 colony
forming units/0.1 ml) and maintained at 37 °C in minimal salt medium
(M9, Glucose concentration ~3.9 millimolar [mM]) enriched with 1%
BME vitamins. In addition the same medium was supplemented with
100 mM nitrate (M9N) (Williams et al., 1978), which allowed a calor-
espirometric assessment of denitriﬁcation pathways.
Two sample sets (4 ml glass vials, TA Instruments) were prepared
for the study ﬁlled with either 0.9 ml M9 (50 samples) or 0.9 ml M9N
(80 samples). Samples were inoculated each with 0.1 ml media con-
taining 1,000–2,000 CFUs (used microbial units were cultured in their
respective media). Inoculated vials were capped under laminar ﬂow
and transferred into an isothermal micro-calorimeter or an incubator
set at 37 °C. The M9 and M9N sample sets were further split in two
groups for calorimetry and TDLAS measurements, made in parallel (i.e.,
1 M9 + 1 M9N set for calorimetry and 1 M9 + 1 M9N set for TDLAS).
The metabolic heat emission rate was monitored by a 48 channel
isothermal micro-calorimeter (TAM III, TA Instruments, Delaware,
USA) set to an incubation temperature of 37 °C. Two sets of 10 in-
oculated vials and non-inoculated control samples (2×) ﬁlled with
either M9 or M9N were tested. At the same time point, tunable diode
laser absorption spectroscopy (TDLAS) analyzed the respiratory activity
of growing bacteria by measuring O2 (λ= 760 nm) and CO2
(λ= 2000 nm) concentration changes in the headspaces of vials kept
outside the calorimeter but within a thermostatic oven at the same
temperature (i.e., 37 °C). Experiments were started with preheating the
TDLAS analyzers (Lighthouse Instruments, Charlottesville) for mini-
mally 30 min followed by a calibration with certiﬁed standards of
known concentrations (0%, 4%, 8% and 20%). Flushing the TDLAS
measurement channels with nitrogen (4 l/min) allowed a headspace
analysis with improved signal to noise ratio. For both sample sets in-
cubated in parallel in the oven (M9 and M9N) CO2 and O2 concentra-
tions of 15 inoculated and 2 reference vials were tested three times
every 2 to 3 h during ~100 h. Care was taken that the measurement
time per sample was as short as possible to keep the sample tempera-
ture as close as possible to 37 °C. In addition, optical density (Bio
Photometer plus, Eppendorf, λ= 595 nm) and CFU counts (per 0.1 ml
media) were performed on tryptic soy agar (TSA) after each TDLAS
measurement, with samples taken from an additionally prepared
sample stock. To monitor nitrate reduction, glucose consumption, and
protein aggregation, every 2 to 4 h one inoculated sample ﬁlled with
M9N was taken from the sample stock and frozen at−82 °C. At the end
of the experiment the respective glucose content was determined for all
thawed samples with an Accu-Chek Aviva diabetes device (detection
range 0.6 mM–33.3 mM) from Roche Diagnostics. The device was ca-
librated with glucose standard dilutions of 1, 5, 10 and 25 mM prepared
in M9 and M9N. Nitrite concentrations of the same samples were de-
termined by colorimetric analysis using the Griess reagent (Sigma
Aldrich). Assay calibration was performed with 0, 15, 40, 60 and
80 nmol/ml nitrite and absorption measured at a wavelength of
500 nm. Protein concentration changes in the medium were identiﬁed
by the Bradford assay. Dependent on the protein concentration a re-
spective colorimetric change occurred measurable at a wavelength of
586 nm. A standard curve for the assay was performed with 0, 20, 40,
100, 500 and 1000 μg/ml of bovine serum albumin (BSA) per assay.
The data analysis included integration of the measured heat ﬂow
data resulting in sigmoidal heat proﬁles. The respective medians of CO2
production, O2 consumption (inverse values) and heat were ﬁtted using
the Gompertz function in R (“groﬁt” package). Molar amounts of CO2
and O2 were then determined, respecting the size of the vial headspace
(3.31 ml) and assuming that CO2 and O2 behaved as ideal gases. Using
the ideal gas law, we estimated that in our condition (vials closed at
22.5 °C and 1.029 bar, followed by an increase of temperature to 37 °C)
1 mol of gas had a volume of 23.89 l. Calculations relating to the re-
spiratory quotient (RQ: RCO2/RO2) and calorespirometric ratios for CO2
(CRCO2: Rq/RCO2 [kJ·mol−1]) and O2 (CRO2: Rq/RO2 [kJ·mol−1]) were
performed for each data point between 0 and ~100 h by using the
ﬁtted values. Finally, standard deviations were determined for all re-
levant values.
3. Results
Pseudomonas aeruginosa cultured in M9 produced after ~100 h and
in vials with a headspace volume of 3.31 ml, at the maximum (ﬁtted
data) 4.68 ± 0.08% CO2 (6.49 ± 0.11 μmol), consumed
8.70 ± 0.22% O2 (12.06 ± 0.31 μmol) and emitted 5.48 ± 0.19 J
(Fig. 1A–B). Optical density (OD) and bacterial cell number (BCN/ml)
reached their respective maxima after 47 h (absorption = 0.476) and
43 h (2.1 · 109 cells) respectively (Fig. 1C–D, consistent with the de-
velopment of the CO2, O2 and heat proﬁles. Growth of P. aeruginosa in
nitrate supplemented M9 medium (M9N) was, in comparison, margin-
ally lagged and reached after 100 h CO2, O2 and heat values of maxi-
mally 5.43 ± 0.07% (7.53 ± 0.10 μmol), 9.06 ± 0.22%
(12.56 ± 0.31 μmol) and 6.38 ± 0.06 J (Fig. 1A–B) respectively. The
related OD and BCN/ml values attained the top after 61 h (absorp-
tion = 0.295) and 69 h (3.8•109 cells). A slight but steady drop in
biomass after reaching the maximum was observed in both media
(Fig. 1C–D).
A ﬁrst decrease of the glucose concentration in the medium
(~3.9 mM) could be observed after 17 h whereas after 26 h the carbon
source was entirely depleted (Fig. 1E). The protein concentration
started to increase after 17 h reaching a maximum amount of 59 μg/ml
after 40 h incubation (Fig. 1E). Nitrite concentrations (resulting from
denitriﬁcation) increased intensively after 20 h, reached a maximum of
201 nmol/ml within 26 h and equilibrated 20 h later at a level of ap-
proximately 19 nmol/ml (Fig. 1 F, dashed triangles). In addition, the
main peak of the heat ﬂow proﬁle of samples containing M9N (Fig. 1 F
brown curve) was observed at 16 h (65.2 ± 1.2 μW) whereas a second
smaller peak was detected after 25 h (39.6 ± 0.9 μW). For growth in
M9, two heat ﬂow peaks were detected after 15 h (35.5 ± 5.6 μW) and
40 h (43.8 ± 1.7 μW) (Fig. 1F, orange curve). Flat heat ﬂow proﬁles at
baseline level (0 ± 0.2 μW) were observed for all tested references.
Similarly, gas proﬁles remained ﬂat varying very little around their
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initial value for all tested references.
Based on the ﬁtted CO2 (RCO2), O2 (RO2) and heat (Rq) data, re-
spiratory quotient (RQ [RCO2/RO2]) and calorespirometric ratios (CRCO2
[Rq/RCO2] and CRO2 [Rq/RO2]) were calculated with respect to each
medium (Fig. 2A–C). In M9 medium, RQ amounted to 0.54, CRCO2 to
845 kJ·mol−1 and CRO2 to 455 kJ·mol−1. In M9N, values were slightly
higher. RQ was equal to 0.60, CRCO2 reached 848 kJ·mol−1 and CRO2
equilibrated at 509 kJ·mol−1.
4. Discussion
Calorespirometric studies deal with the simultaneous analysis of the
rate of heat emission (Rq), CO2 production (RCO2) and O2 consumption
(RO2) by living systems, enabling an association of observed eﬀects with
metabolic parameters. Pseudomonas aeruginosa, a facultative aerobe
microorganism capable of using nitrate as terminal electron acceptor
(denitriﬁcation), was used to evaluate whether TDLAS is of potential
use in calorespirometric studies. A laser spectrometer measured CO2
and O2 concentration changes in vial headspaces, leaving the in-
vestigated biological system completely unaﬀected. Our results de-
monstrate that TDLAS is a well-performing and convenient way to
evaluate O2 consumption and CO2 production rates non-invasively. This
is an important advantage compared to invasive standard practices
using CO2 absorbing substances (NaOH), O2 electrodes, or optrodes,
that are less practical in such experimental settings and might require
instrument modiﬁcation (Itoga and Hansen, 2009; Neven et al., 2014).
With respect to TDLAS reliability, parameters such as respiratory quo-
tient (RQ) and calorespirometric ratios for O2 (CRO2) and CO2 (CRCO2)
were calculated. They were mainly used to determine if TDLAS is a
useful technique in calorespirometry by comparing them to literature
values. Comparable results were indeed observed (Hansen et al., 2004;
Kemp, 2000) but minor deviations were found (Table 1).
In this study, we chose to use two diﬀerent media, allowing
Pseudomonas aeruginosa to express diﬀerent metabolic activities. Our
Fig. 1. Fitted proﬁles of O2 consumption (RO2), CO2 production (RCO2) and heat emission (Rq) in minimal salt (M9) and nitrite supplemented M9 medium (M9N) are illustrated in plot A
and B. The curve development is based on the ﬁtted median values of the respective measurements. Optical density (absorbance) and the number of counted cells per vial and media are
shown in C and D. Determined concentrations of glucose (red squares [mM]) and protein (blue rhombs [μg/ml]) during the experiment are depicted in plot E. Plot F demonstrates the
averaged heat ﬂow proﬁles [μW] for each medium (orange for M9, brown for M9N) whereas the black triangles represent changes in nitrite concentration [nmol/ml]. Approximations for
Glucose, Nitrite and Protein measurements were done by spline interpolation. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
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objective was to determine whether TDLAS is able to detect subtle
changes in metabolism (i.e., only respiration vs. respiration + deni-
triﬁcation). The calorespirometric growth study involved M9 and M9N
(nitrate supplemented M9) media, whereby M9N was expected to lead
to more growth and higher CO2 production due to the presence of an
additional terminal electron acceptor (Chen et al., 2003). Indeed, in
M9N the maximal amount of growth related heat and CO2 production
surpassed the corresponding production rates in M9 medium
(Fig. 1A–B). In contrast, the reached maximum of O2 consumption re-
mained comparable in both media as denitrifying pathways are of an-
oxic nature. Further evidence of active denitriﬁcation was provided by
the measurement of nitrite concentrations (cmax = 201 nmol/ml after
26 h). The nitrite concentration-time proﬁle correlated with the second
heat ﬂow peak of M9N samples whereas the subsequent nitrite decay
suggested that nitrite was involved in further reduction to NO, N2O and
N2. Here, an analysis of NO and N2O headspace concentrations by a
wavelength adapted TDLA spectrometer would have been interesting to
evaluate denitriﬁcation eﬃciency but, was out of the study scope. The
additional use of nitrate as terminal electron acceptor occurred after
20 h and was probably linked with the exhaustion of media dissolved
O2.
Further diﬀerences in medium could be seen when the respiratory
quotient (RQ) and the calorespirometric ratios for O2 (CRO2) and CO2
(CRCO2) were calculated (Fig. 2, Table 1). In M9N RQ was slightly
higher (0.60) compared to M9 (0.54), as the availability of another
electron acceptor (i.e., NO3−) asides from O2 may have caused a release
of more CO2. In theory, for pure glucose combustion (C6H12O6 (s)
+ 6O2 (g)→ 6CO2 (g) + 6H2O (l) + heat, ΔH=−2813.25 kJ·mol−1)
(Hammes and Hammes-Schiﬀer, 2007), literature refers to an RQ of 1.0
(Kemp, 2000) as same amounts of O2 molecules are consumed as CO2
molecules released. However, microbial growth leads to an uptake of
carbon into biomass and thus lowers the CO2 production, resulting in a
decreased RQ value (RQ < 1.0). In addition, the RQ ratios for M9 and
M9N diﬀered only minimally (table 1) and roughly similar numbers of
cells were found in the medium at the end of the culture (Fig. 1C–D). An
additional protein assay at the end of the experiment (data not shown)
conﬁrmed a similar biomass as well. Thus, it is likely that the biomass
formed is partly limited by the amount of glucose available in the
medium, explaining the little diﬀerences. In both media glucose was
entirely depleted after 26 h. Nevertheless, microbial growth still con-
tinued as illustrated by the ongoing rise in protein concentration, heat
production, cell count, optical density as well as CO2 and O2 con-
centrations. Such growth continuation is explained by the micro-
organism's consumption of metabolic byproducts (such as low mole-
cular weight organic acids, and/or polyhydroxybutyrate which is often
produced for pseudomonads) as they are the only remaining nutrients
in minimal media such as M9 and M9N (Ackermann et al., 1995; Singh
Saharan et al., 2014).
With respect to the oxycaloric parameter (CRO2, which can be de-
ﬁned as the theoretical value for the enthalpy change of the catabolic
part of metabolism (Kemp, 2000)) for M9N samples, CRO2 was
53.82 kJ·mol−1 higher than the one obtained for M9 (Table 1), al-
though comparable amounts of oxygen were consumed in both media.
In M9N medium denitriﬁcation took place besides respiration. There-
fore, the heat emission after ~100 h was slightly increased (by 0.91 J)
and resulted in this higher CRO2 (Rq/RO2) ratio. Comparable CRCO2
ratios (Rq/RCO2) were observed for M9 and M9N (Table 1). The high
and very similar CRCO2 values observed support the hypothesis that
carbon was integrated into roughly the same amount of biomass.
In conclusion this study shows that TDLAS is a technique capable to
fulﬁll the requirements needed for direct calorespirometric analysis.
Therefore, additional TDLAS based evaluations in this ﬁeld would be of
interest as well as the construction of a TDLAS containing calorimeter
prototype since TDLAS and microcalorimetry are complementary. The
potential impact of the laser on heat measurements might be one of the
biggest challenges that needs to be investigated when designing such a
Fig. 2. The media dependent development of the respiratory quotient (RQ [RCO2/RO2]) is
depicted in Plot A. Emitted heat per consumed O2 and produced CO2 is shown in plot B
and C, being base for calculating the calorespirometric ratios CRO2 and CRCO2.
Table 1
Calculated values of RQ, CRO2 and CRCO2 in M9 and M9N medium. Literature values used
for comparison are listed at the table bottom (italic) (Hansen et al., 2004; Kemp, 2000).
RQ CRO2 (kJ·mol−1) CRCO2 (kJ·mol−1)
Calculated values for:
M9 0.54 455 845
M9N 0.60 509 848
Literature values: (< or =) 1.00 450–480 0–600
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prototype. In addition, our comparison of two closely related media
(M9 and M9N) shows that a TDLAS based calorespirometric analysis
might be beneﬁcial for environmental research (e.g. soil analysis
(Barros et al., 2015)) where many diﬀerent electron acceptors such as
sulfate are involved (Traore et al., 1981; Traore et al., 1982). Further-
more, in biotech, oil and food industries (Cocola, 2016; Muyzer and
Stams, 2008; Regestein et al., 2013; Schuler et al., 2012), the non-in-
vasive nature of TDLAS, as well as its eﬃciency and reliability are
desired attributes for investigating metabolic activities, product dur-
ability or other processes happening in reaction vessels. Therefore, an
ongoing investigation of TDLAS' role in calorespirometry is re-
commended. Still, previous studies have reported that the TDLAS O2
measurement was less precise than the corresponding CO2 measure-
ment (Brueckner et al., 2017; Brueckner et al., 2016; Duncan et al.,
2016) which might be an additional source of error, that should be
further investigated. However, we believe that the technique remains of
interest in calorespirometry. Thus, TDLAS allows a non-invasive, reli-
able and convenient determination of CO2 and O2 rates, with compar-
able results to conventional techniques.
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7. General Discussion and Outlook
7.1 The Need for Process Innovation in a Changing Market Environment 
Biologics allowed remarkable advances in the treatment of chronic diseases (such as 
cancer, psoriasis or rheumatoid arthritis) being linked with successes in terms of live 
prolongation and improvement of the overall quality of life. This promoted the demand for 
biologics and allowed manufacturers to charge high product prices. Perceived prospects of 
large profit generation caused a reorientation of corporate strategies towards the 
biopharmaceutical market segment (Figure A). Nowadays, biopharmaceuticals generate 
approximately $163 billion of global revenues being comparable to 20% of the entire 
pharmaceutical market (Otto et al. 2014). However, such favorable market conditions attract 
competition (Figure B). In 2006 Omnitrope from Sandoz, one of the first biosimilar of 
Genotropin (Somatotropin) was approved for market release (Evaluate Ltd. 2017) by the 
European Medicines Agency (Figure C). 
Figure 1: Evolution of the biologics and biosimilar market. Plot A describes the development of 
cumulative (black curve) and specific (violet, blue and red curve) new biological drug entities 
marketed between 1982 and 2012. However, biosimilars are expected to increasingly challenge 
branded biologicals in coming years. An estimated total of $87.4 billion of branded biological sales are 
at patent risk between 2014 and 2020 (B). The count of expected biosimilar approvals between 2006 
and 2015 makes this obvious (C). (Evaluate Ltd. 2017, Kinch 2015) 
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Since then the situation became increasingly challenging for original biologic manufacturers 
as for a growing part of available biologics patent protection (normally 10-14 years from 
market approval) is expiring (Figure and Figure). Between 2014 and 2020 it is expected that 
globally up to ~$87.4 billion of revenues (Evaluate Ltd. 2017) coming from sales of biologics 
are endangered by the launch of biosimilars. 
Figure 2: Patent approval and expiration dates for diverse biological products allocated to 
European Union and United States of America (GaBI 2011). 
The overall pressure originating from patent expiration and biosimilar market intrusion 
redirects innovators to search for alternative strategies decreasing risks on their potential 
turnover. Thus, biologics manufacturers are forced increasingly to face equal challenges as 
other businesses, ensuring affordability, product quality, and delivery performance (Otto et 
al. 2014). Maximal process efficiency is thereby of major relevance being achieved by 
means of lean management  as well as the use of innovative technologies (Chowdary et al. 
2011, Gebauer et al. 2009). Therefore, the constant search, assessment, and 
implementation of technical and methodological innovations are important. 
92
Aseptic manufacturing environments are strictly monitored on their microbial burden as 
already slightest product contaminations can endanger patients. Methodologies used 
nowadays for such control have not changed much since Robert Koch established 
microbiological techniques in 1881 (Miller 2010a). However, during the last years new 
technologies have appeared (Moldenhauer 2008, Miller 2016b, Thorpe et al. 1990, Jimenez 
2001, Miller et al. 2009b, Miller et al. 2009a). Rapid microbial methods (RMM) allow the user 
to get test results for the analysis of microbial growth and presence faster as compared to 
traditional techniques (Figure). RMM techniques use principles of immunology, nucleic acid 
amplification, mass spectrometry, flow cytometry, as well as biochemistry.  
Figure 3: Examples of rapid microbial methods that exist in the market using different principles to 
detect microbial presence and growth (Merck 2017, Chollet et al. 2008, Biomérieux 2017a, Rapid 
micro biosystems 2016, Celsis 2017, Biomérieux 2017c) 
The demand for RMMs is expected to rise in the future from an estimated turnover of ~3.4 bn
$ in 2015 up to ~6.2 bn$ in 2022, showing that the shift from conventional microbiological 
methods towards alternative ones is occurring (Credence Research 2016). Diverse 
documentation is depicting how to go for a structured and secure RMM evaluation allowing 
that such techniques can be successfully implemented at the site of interest (Kielpinski et al. 
2005,  Miller  2010b,  Jasson  et  al.  2010,  Parenteral  Drug   Association  2013,   European 
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Pharmacopoeia 2009, U.S. Pharmacopoeia 2014). This obviously illustrates that despite 
high regulatory requirements for quality related process adaptations, willingness to improve 
exists, outgoing from manufacturers but also from regulatory agencies. Therefore, the time is 
right to move forward in this field and find more efficient ways to perform microbiology 
related quality control mechanisms without compromising drug and patient safety. 
Therefore, tunable diode laser absorption spectroscopy (TDLAS) and isothermal 
microcalorimetry (IMC) were assessed on their innovation potential for mechanisms in 
quality control applied to aseptic manufacturing procedures. Both technologies showed high 
potential in enabling a leaner design of analytical processes related to microbial growth 
detection, being congruent with the nowadays discussed principles of RMM implementation 
and lean manufacturing. 
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7.2 The Role of TDLAS in Aseptic Manufacturing 
Based on our research TDLAS was identified as well-suited for automating the visual media 
fill inspection. Time to detection comparability among TDLAS and conventional visual 
method was shown for diverse microorganism-format combinations (Brueckner et al. 2017, 
Brueckner et al. 2016). However, a convenient, fast and automated documentation is still 
needed and of major interest. Indeed, all containers in a media fill need to be identified and 
linked to a specific process-dependent intervention. In turn, this allows to rapidly spotting the 
breach in the sterility of the filling line which is highly relevant for evaluating a media fill, yet 
makes an automated documentation more complex. An individual vial tagging with 2D 
barcodes or RFID chips containing the relevant information (batch, tray unit and process 
intervention number) would probably fit best to allow such container specific allocation. 
Alternatively, a manual scanning of the tray barcodes being allocated digitally to the 
collection of tested tray units could be another option to automate the documentation. 
Considering GMP conformity (Food and Drug Administration 2016a) and pharmaceutical 
guideline documents, an automated documentation is linked to certain complexity. It 
therefore demands end-users to plan and specify the documentation concept in detail, being 
entirely aligned with the performed media fill procedure, before automation is achievable. 
This has certainly implications on project costs but is necessary before the transition to a 
well-working automated media fill inspection can be completed. Though, the potential of 
TDLAS is not constrained to media fill inspection automation reasoning the evaluation of its 
use in innovating calorespirometric assessments. 
Calorespirometry is the combined study of heat, CO2 and O2 of metabolically active cells 
(Criddle et al. 1990). TDLAS can assist by an entirely non-invasive investigation of a living 
system being of potential benefit for e.g. biotech production process control (i.e. control of 
fermentation procedures) or environmental research (Barros et al. 2015, Rohde et al. 2016a, 
Schuler et al. 2012). However, when talking about the potential of TDLAS for microbiologic 
inquiries it is important to understand that not all metabolisms are based on the principles of 
O2 consumption and CO2 production. For example, most methanogens produce CH4 and 
simultaneously consume CO2, potentially leading to misinterpreted CO2 data (CO2 + 4 H2 → 
CH4 + 2H2O) or even to non-detectability of microbial growth (Thauer et al. 1993). In addition, 
metabolisms of exotic fermenters or chemolithotroph species such as e.g. sulfate reducing 
bacteria (Table 1) can be independent from O2 and/or CO2 (Beijerinck 1895, Madigan 2015).
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Of course exotic metabolisms are for clean rooms of minor relevance but can be 
encountered by environmental researchers willing to use the techniques applied here. In 
such case a combined analysis of TDLAS and IMC is highly recommended as IMC 
measures metabolic activities in a more generic way, as most of the active metabolism types 
emit heat. Still, life based on entropy has been shown and theorized (Liu et al. 2001, von 
Stockar et al. 1999). To approach unambiguous data collection further, TDLAS could be 
adapted in its wavelength to assess, besides CO2 and O2, additional gas types, such as e.g. 
CH4 or N2O/NO (from methanogens or denitrifying microorganisms) accumulating in the 
sample headspaces (Lackner 2007). Such data could be used as complementary 
parameter(s) to study and detect growth of exotic cultures. 
Table 1: Description of CO2 and O2 independent metabolisms. Listed are metabolisms for sulfate 
reduction and exotic fermentation. All listed metabolism types are of minor relevance for cleanrooms 
but can be encountered by for example environmental researchers (Beijerinck 1895, Madigan 2015). 
Besides the use in microbiology, TDLAS can surely add value to general process control and 
supervision of pharmaceutical production procedures. Leakage testing is the standard 
procedure of assessing if primary packaging materials conserve the quality of manufactured 
and fill-finished products. It can be done by the blue dye ingress test where commercial units 
are placed for a certain time in a methylene blue bath (European Pharmacopoeia 2005b, 
U.S. Pharmacopoeia 2009). This allows the dye to penetrate potential leakages of the test 
unit. Such procedure demands hand protection as the dye is hard to be cleaned away from 
the fingers and could be substituted by TDLAS based measurements on CO2. The basic test 
design could follow the principle of positioning a unit under investigation into a pressure 
chamber filled with CO2, being followed by a TDLAS measurement on any increase in CO2 
headspace concentration.  
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During fill-finishing, product headspaces are either gassed with process air (contains 
~0.041% CO2) or N2 (it avoids growth of potentially embedded aerobe microbes). Thus, any 
changes in CO2 headspace concentration would indicate to a leakage of the primary 
packaging material. To show comparability to the blue dye ingress test experimental 
variables such as CO2 pressure, leakage diameter and duration of pressure applied, 
including their correlation would need to be investigated. Once assessed in a laboratory 
setting with benchtop devices, a transfer towards a 100% in-line leakage inspection of 
commercial units after filling might be conceivable. This would minimize production mistakes 
and impact product quality directly as every leakage is spotted straight after filling and 
capping of product units.  
TDLAS could add further value in validating the degree of isolator sterility after 
decontamination. Nowadays, isolator decontamination is performed by H2O2 killing prevailing 
microorganisms. The subsequent distribution of agar plates directly in the isolator checks if 
isolator sterility is given. Such conventional procedure could become obsolete if the H2O2 
distribution during isolator decontamination could be monitored through wavelength adjusted 
TDLAS sensors. Of course, such sensors would need to be placed in isolators at spots less 
exposed to H2O2 and the entire approach be assessed on reliability. 
Such examples for further research of TDLAS based measurements illustrate the 
technologies versatility. Due to its unique characteristics enabling non-invasive 
measurements, simple application and installation, high speed result reception and sample 
analysis without intermediate preparation steps, the technique is dedicated to in process 
control. In process control is a relevant part in lean manufacturing and helps, besides others, 
to keep quality related mechanisms and process interactions as efficient as possible 
(Figure). Furthermore, it targets the realization of quality by design, aiming at integrating 
quality into products through continuous monitoring activities during production. In 
conclusion, TDLAS can be part in performing such principles if applied adequately. 
However, these are only some of the many helpful applications TDLAS could be used for 
bringing manufacturing sites one step closer to a fully optimized operational unit. 
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Figure 4: Comparison of non-lean and lean production procedures. The most important process 
steps in pharmaceutical manufacturing are depicted Non-lean processes generate and accumulate 
waste (black dots and ramp) - or in other words, activities are performed that do not add value to the 
product and customer. Often the performance of unnecessary steps leads to non-aligned processes 
extending the end-to-end throughput time of a product. In contrast, lean manufacturing focuses on the 
most relevant processes allowing a close process-process interaction and a fast product throughput 
time. TDLAS could help in realizing (in certain areas) a lean in process control. (Ams Biotechnology 
2013, Arcane Industries 2017, Bandageer 2013, BioPharma Asia 2015, BioRefinery 2009, Gebauer et 
al. 2009) 
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7.3 General Implications for IMC 
IMC is another technology having comparable advantages as TDLAS. IMC can test samples 
non-invasively and without additional preparation whereas data collection is relatively easy. 
However, differences in terms of usability exist as IMC measurements are more prone to 
variations coming from the environment depending on the instrument used. This demands a 
strictly controlled room temperature that allows the instrument to be efficient. Indeed, the 
surrounding of samples that are measured, needs to remain very stable in terms of 
temperature (0.1mK over 24 hours (TA Instruments 2012)). In optimal (or suboptimal) 
conditions, one of the methods main strengths is the very high sensitivity, detecting minimal 
amounts of heat emitted from biological or chemical reactions in real time. As such heat 
emission is a temporary phenomenon and cannot be detected anymore once over, the 
sample is demanded to stay in the device and on the measurement element during that time. 
This depicts clearly that the technique is suitable for an operational environment where 
samples are evaluated with rather low throughput rates (Wadso 2002). The low throughput 
as well as the unspecific measurement nature (several heat emitting processes cannot be 
differentiated from each other – i.e., only the cumulative heat signal is monitored) make IMC 
ideally for optimizing quality control mechanisms such as the control for microbial presence 
in test samples. Yet, targeting a heat based high-throughput analysis of experimental 
samples infrared thermal imaging might be the method of choice allowing such intention 
(Salaimeh et al. 2011, 2012). 
In this work, studies performed with IMC targeted a substitution of the conventional sterility 
assessment. The sterility assessment tests quality into products which is not in alignment 
with nowadays targeted principles of quality by design. Still, the performance of sterility tests 
is demanded by regulatory agencies as final release assessment of fill-finished products and 
cannot be omitted. Therefore, appropriate measures must be taken to design a more 
efficient test. The IMC analysis of samples prepared similarly as during a sterility test 
delivered highly promising results and inoculated microorganisms could be detected earlier 
by IMC compared to the visual inspection on turbidity. This and the real-time monitoring 
character of IMC could potentially result in a reduction of the incubation procedure and the 
replacement of the sterility test. 
Many companies which are targeting a faster performance of the sterility test are evaluating 
rapid microbial method (RMM) as potential test replacement (e.g. see Figure). Although 
many RMMs exist it is difficult to find an appropriate one, as the measurement must fulfill 
certain requirements to be considered valuable for sterility assessments.  
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The method must detect microbial growth faster than the visual detection on turbidity or 
colony counts and allow a non-invasive and non-destructive measurement so that cross 
contamination can be avoided and identification of grown microorganism by polymerase 
chain reaction is possible. Within this context the potential of IMC is still underestimated 
(shown by our study results) although fulfilling all the requirements to be categorized as 
useful RMM. The sensitivity of IMC as well as its non-invasive and non-destructive 
measurement positions it as well-suited sterility test replacement. 
In addition to the optimization of the sterility test, microcalorimetry could be directly used for 
an assessment of potential microbial contaminants in the fill-finished product containers. 
Aqueous products (proteins such as anti-bodies) theoretically provide to microorganisms 
sufficient nutrition to enable growth until IMC detection is possible (possible with 10K – 100K 
cells per vial). The major benefit of such an approach would be the entire elimination of the 
filtration step of chosen product samples, thus designing a more efficient sterility test. 
However, such a potential process modification would require further investigations as the 
approach was not sufficiently studied in this work. Furthermore, process modifications of 
such kind are related to extensive product and country specific regulatory questions, 
endangering that expected efficiency gains (in case that good study results are obtained) are 
outperformed by regulatory costs. 
In addition, growth promotion testing is the procedure that evaluates growth characteristics 
of microorganisms in media used for aseptic manufacturing control (European 
Pharmacopoeia 2007b). Nowadays, such tests are simply done by inoculating concerned 
media with defined microorganisms, followed by a visual check on colony forming units or 
turbidity (liquid media). Upon positive detection of all tested microorganisms (i.e., according 
to specifications) tested media are released for further use in aseptic manufacturing. By 
using IMC also growth promotion testing could be improved. 
Nevertheless, some obstacles remain for IMC to become more established in the 
pharmaceutical and biotech market. Commercialized isothermal microcalorimeters capable 
to measure with the sensitivity needed for our and potential future studies are relatively 
expensive (500K CHF) and are therefore too costly to replace an analysis with low 
throughput and less burdensome performance such as the sterility test. High costs originate 
from device specifications which are above the demand for targeted applications in 
environmental monitoring. Commercial calorimeters allow for example to perform 
experiments in a relatively wide temperature range (i.e. from 15°C to 150°C (TA Instruments 
2012)) whereas for applications related to microbial growth temperatures between 20°C and 
40°C are already sufficient. 
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In addition, the applicability of such existing calorimeters is not yet fully aligned with a highly 
regulated drug production environment, making a sudden implementation rather difficult. 
Normally, diverse documentation is needed to perform the demanded validation and 
qualification (design qualification, installation qualification, operational qualification, and 
performance qualification) procedures, being prerequisite for device usage in a 
pharmaceutical and biotech environment. To further promote the use of microcalorimetry a 
simpler and more compact instrument with equal sensitivity and higher channel number 
(larger throughput) could be built. A modular design enabling besides the analysis of 
different vial and syringe formats also the assessment of agar plates would be highly 
convincing for usage in environmental monitoring and GPT. However, the realization from a 
technical point of view was not approached so far especially as the device’s sensitivity is 
expected to diminish with reduced size (i.e. a smaller heat sink will be more sensitive to 
potential environmental temperature fluctuations). 
Due to the versatility of IMC its potential is not limited to pharmaceutical quality control but 
can be of further use in clinics as well as research & development. Some studies have been 
performed about the speed in detecting antibiotic susceptibility of microorganisms causing 
urinary tract infections. Microcalorimetry achieved considerably faster times-to-detection 
(approximately 10 hours) as compared to conventional methods used to determine drug 
susceptibilities (Howell et al. 2012, Braissant et al. 2014). This is a considerable advantage 
and again shows the strength of microcalorimetry: its sensitivity. It is therefore only a matter 
of time until the technical evolution of IMC, that took place during the last 20 years, is 
realized promoting the technology’s application for the diverse purposes it is and will be 
dedicated to. 
7.4 Potential Influence of Innovation on Established Procedures 
The performance of media fills, sterility assessments, and the related inspections on turbidity 
and growth are an integral part of the microbiological quality control system of aseptic 
facilities. Such quality control processes are based on a sequential (media-fills) or parallel 
(sterility assessment) two-tiered incubation of 20-25°C and/or 30-35°C. However, besides 
media fills and sterility assessments many other actions are performed to control bio burden 
in clean rooms, which are mostly exposed to the same incubation conditions. Despite 
disparity in guidance documents giving advice for applied incubation time and incubation 
temperature, many drug producers decided for a two-tiered incubation strategy and support 
their decisions with experimental data. The two-tiered incubation is preferred, as high yield of 
fungal growth is obtained at 20-25°C and bacteria grow considerably at 30-35°C.  
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However, recent studies have shown that incubation at 25°-30°C also yielded reasonable 
recovery of bacteria and fungi (Gordon et al. 2014). Such finding is highly promising as it 
theoretically allows facilitating the two-tiered incubation procedure for the entire set of 
microbiologic activities, which is in alignment with discussed lean manufacturing principles. 
All activities relating to transferring the incubated samples to another temperature could be 
omitted. Furthermore, a switch to one single incubation temperature would have implications 
for the media fill inspection automation. During threshold studies performed with TDLAS a 
slightly increased media induced CO2 and O2 variation of headspace concentrations was 
observed after the transfer from 20-25°C to 30-35°C (Brueckner et al. 2017, Brueckner et al. 
2016). By normalizing applied incubation temperatures to 25-30°C such an effect could be 
neutralized which might result in lower thresholds being associated with a reduction of 
detection times. However, to allow such process alteration further experiments would be 
needed with a larger microbial spectrum. 
Nowadays incubation times of the sterility test are set to 14 days at either 20-25°C (aerobe 
organisms) or 30-35°C (anaerobe organisms). Since IMC is more sensitive than the visual 
inspection on turbidity the use of IMC would allow a reduction of the established incubation 
durations. The release of fill-finished products is linked with the availability and quality of the 
sterility test results. Therefore, a reduction of incubation durations could permit an earlier 
availability of sterility test results and allow in parallel a faster market release of stored drug 
batches, being related with a more efficient market supply. 
7.5 Acceptance of Innovation and Change 
Altering established processes as well as implementing innovative technologies and 
methodologies is often costly. New equipment and research effort are necessary for such 
transformation, impacting frequently regulatory specifications. In addition, skepticism as 
against the proper functioning of planned changes exists as unexpected incidents could 
disturb the daily business, potentially endangering the unobstructed market supply. 
Therefore, sponsors are difficult to win for financing change related undertakings, if the 
expected transformation risk is not minimal and profitability not given within less than 2.5 – 3 
years (Figure, Project C – Scenario 1). However, the success rate of projects weak in 
profitability can sometimes be increased through descriptions of qualitative benefits as well 
as risk minimization activities (Figure, Project C – Scenario 2). For the TDLAS based media 
fill inspection automation such challenges had to be overcome to push the technology 
forward. Therefore, the initially designed user requirement specifications for a platform 
allowing inspection automation were downsized, taking small efficiency reductions into 
account. 
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This resulted in a large cost reduction (costs could be reduced from 3’000K to 500K CHF) 
fitting the rather small efficiency gains (expected were ~200K CHF of yearly savings based 
on a process with two inspections) expected after realizing inspection automation. The 
additional description of qualitative benefits (such as data integrity, etc.), and the robust 
experimental data collected with an automated platform provided for free, further decreased 
the risk in acquisition. Chances for project realization increased and finally allowed to bring 
the project close to local and global implementation. Therefore, to successfully transform 
innovation projects with weak profitability, one needs to think about 1) existing qualitative 
benefits (not related to monetary savings), 2) actions helping to minimize the risk of failure 
and 3) possible cost reductions and 4) how to deal with the regulatory impact. This will 
certainly increase chances for project realization, yet there is no guarantee for success.  
Figure 5: Project allowance frontier. Two hypothetic project scenarios A and B are shown whereas 
C represents the scenario applicable to the media fill inspection automation. All projects show a 
different impact on efficiency and have an altering financial demand for realization. The grey line 
illustrates the frontier of accepting a project to be financed. Project A is above this line and therefore 
likely to be realized (low risk of failure, high efficiency increase and low investment, correlate with high 
profitability). Project C is the exact contrary and comparable to the situation faced at the beginning of 
the project when targeting an automation of the visual media fill inspection. Therefore nice-to-have 
attributes needed to be omitted so that a cost reduction could be initiated allowing a move from 
situation C1 to situation C2. Situation C3 is of hypothetical nature showing that even more cost 
reduction would be necessary to assure financing. Generally, if the project is unprofitable, qualitative 
argumentation can help to ameliorate the situation, if the risk for failure is not too high. 
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8. General Conclusion
Due to changes originating from existing and imminent transitions in the biotech and 
pharmaceutical market (patent expiration of blockbusters, release of biosimilars) aseptic 
manufacturers are increasingly forced to reorient their economic strategies. Tunable diode 
laser absorption spectroscopy (TDLAS) and isothermal micro-calorimetry (IMC) can ideally 
contribute to such reorientation through their potential in designing quality control 
mechanism more efficiently. 
In this work TDLAS was used to determine microbial growth through an analysis of CO2 and 
O2 concentrations in the headspaces of media fill vials, targeting a redesign of the visual 
media fill inspection process. TDLAS is suited for automating the visual media fill inspection 
and capable to increase efficiency of the related process by minimally 90%. Neither false 
negative nor false positive results were obtained within the entire study. Therefore, a 
platform implementation is highly recommended although it was observed that a TDLAS 
based detection of microbial growth is slightly slower than the visual inspection on turbidity. 
Aside from many other possible applications (for example leakage detection of primary 
packaging material and assessment of the H2O2 distribution in isolators) TDLAS showed 
large potential in substituting invasive methodologies used nowadays in calorespirometry for 
the determination of CO2 production and O2 consumption of living systems. TDLAS can 
easily and non-invasively quantify CO2 and O2 concentrations whereby comparability to 
conventional techniques is given. Further experimentation is encouraged as the use of 
TDLAS in calorespirometry can be beneficial for more efficient control of fermentation 
conditions, needed to maximize yield of a specific biological products.  
Although IMC is less suited for process automation, it can contribute differently to more 
efficient quality control mechanisms. Its high sensitivity allows a much faster detection of 
microbial growth than realizable by methods used usually (visual inspection on media 
turbidity or colony formation) in aseptic production facilities. IMC can replace the inspection 
procedure of the final sterility assessment of fill-finished products and, with its fast time to 
result, even shorten the duration of sample incubation. A technically simplified, modular, 
miniaturized, but equally sensitive calorimeter allowing the parallel assessment of diverse 
container forms (vials, syringes, agar plates, etc.) could probably promote the application of 
IMC in the pharmaceutical and biotech industry. Unfortunately such a device has not been 
commercialized yet. 
The feasibility of innovating quality control mechanisms in aseptic manufacturing by the use 
of TDLAS and IMC was demonstrated. The mentioned technologies contribute to increase 
process efficiency in practice. However, their potential goes far beyond the value exploited in 
this study being the reason for further recommended research with TDLAS and IMC. 
